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ABSTRACT OF THE DISSERTATION
ANTIBIOTIC RESISTANCE AND CELL-WALL RECYCLING IN PSEUDOMONAS
AERUGINOSA
by
Supurna Dhar
Florida International University, 2018
Miami, Florida
Professor Kalai Mathee, Major Professor
An exponential increase in infections by multi-drug, extensive-drug, and pan-drug
resistant bacteria in both developed and developing countries are poised to return us to
the pre-antibiotic era. Pseudomonas aeruginosa, a Gram-negative bacterium is
frequently associated with fatal infections and has been classified by the WHO and the
CDC as a pathogen of “critical” importance, and serious threat, respectively. P.
aeruginosa infections are often treated using a combination of a ß-lactam and an
aminoglycoside. Resistance to ß-lactams is conferred by the constitutive expression of a
chromosomally-encoded AmpC ß-lactamase. The ampC expression is regulated by
AmpR, a membrane-spanning transcriptional regulator of the LysR family. AmpR is
presumed to be activated by muramyl peptides generated in the presence of ß-lactams.
The muramyl peptides are assumed to shuttle using two permeases, PA4393 (AmpG)
and PA4218 (AmpP), importing and exporting into and out of periplasm from the
cytoplasm, respectively. To date, the identity of P. aeruginosa muramyl peptides, and
the AmpR effectors, the AmpG and AmpP substrates have not been elucidated. Using
liquid chromatography/mass spectrometry analyses, we clarified the structures and
quantified the muramyl peptides of wild-type P. aeruginosa PAO1. Twenty muropeptides
from PAO1 were identified; and the least and the most metabolites are 100 and 55,000
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molecules per bacterium, respectively. Two AmpR-signaling muropeptides, Nacetylglucosamine-1,6-anhydro-N-acetylmuramyl

pentapeptide

and

1,6-anhydro-N-

acetylmuramyl pentapeptide were identified. The role of two permeases in antibiotic
resistance and cell-wall recycling were investigated by comparing PAO1 with its isogenic
∆ampG, ∆ampP, and ∆ampGampP mutants. Our study demonstrates that AmpG and
AmpP may play a role in transport of disaccharide-muropeptides. The muropeptide
profiles alluded to the presence of a novel periplasmic N-acetyl β-D glucosaminidase
and led to the analyses of PA1085 (FlgJ). The loss of flgJ resulted in affecting swimming
and biofilm production but failed to abolish the periplasmic glucosaminidase activity. In
our effort to identify inhibitors of AmpR, novel reporter-based screening assays were
developed using AmpR-regulated PampC, PphzA1, and PmexE promoters. We have identified
pyrollidine-based scaffold library with the highest inhibitory effect against the AmpR
system. In summary, this dissertation increases our understanding of cell-wall recycling
and mechanisms of β-lactam resistance and attempts at establishing novel-antibacterial
targets.
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CHAPTER 1

Introduction

This chapter has been partly published:
Cell-wall recycling and synthesis in Escherichia coli and
Pseudomonas aeruginosa – their role in the development of resistance
Dhar S, Kumari H, Balasubramanian D, Mathee K.
J Med Microbiol. 2018 Jan; 67(1):1-21. doi: 10.1099/jmm.0.000636.
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1.1. Pseudomonas aeruginosa
Pseudomonas

aeruginosa

is

a

Gram-negative

bacteria

of

the

family

Pseudomonadaceae (Kapatral V, 2000). Members of this genus were described the first
time by Walter Migula in late 1800 (Palleroni, 2004). The name was coined as “Pseudo”
meaning false and “monas” refers to a unit (Palleroni, 2010). The species “aeruginosa”
means copper rust or green. This alluded to the characteristic appearance of the
bacteria in a culture owing to its synthesis of pigments such as pyocyanin and pyoverdin
(Reyes, et al., 1981, Cox & Adams, 1985). This organism is found ubiquitously, meaning
in the earth, vegetation, soil, and water. It also has the capacity to survive on surfaces
associated with medical devices like catheters and other instrument associated with
dialysis (Talsma, 2007).
The ubiquity of these bacteria is due to its non-fastidious nature. It is well-known that
P. aeruginosa can survive in minimal and versatile nutrition which contribute to the
pervasive nature of this organism (Palleroni, 2001). Experiments have verified the
presence of these bacteria even in distilled water containing minerals (Favero, et al.,
1971, Legnani, et al., 1999). P. aeruginosa has been characterized as an obligate
aerobe which can grow in anaerobic conditions with nitrate as an alternate electron
acceptor (Carlson & Ingraham, 1983, Davies, et al., 1989). It is both catalase and
oxidase positive which is a distinguishing feature considered during lab. diagnosis and
identification of Pseudomonal infections (Lysenko, 1961).
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Figure 1.1. Pseudomonas aeruginosa bacteria (SEM). These Gram-negative, rodshaped bacteria are ubiquitous, often found in humans as part of the normal flora.
They are also one of the common causes of hospital-acquired infections.
(https://fineartamerica.com/featured/3-pseudomonas-aeruginosa-bacteria-semsemsteve-gschmeissner.html

The complex mechanisms that lie beneath its virulence are also reflected in its large
genome size. The prototypic, lab reference strain of P. aeruginosa PAO1 has a genome
size of more than 6 million base pairs with 5570 open reading frames (Holloway, 1955).
In addition to PAO1, other sequenced strains include Liverpool Epidemic Strain LESB58,
PA14, PACS2, C3719, and PA2192 (Cheng, et al., 1996, Lee, et al., 2006, Mathee, et
al., 2008, Poirel, et al., 2010). A large set of genes that are conserved among these
strains are referred to as the core genes (Mathee, et al., 2008). Besides this, the
accessory genome consists of components that include transcriptional regulators, genes
encoding for two-component systems and genes regulating/involved in antibiotic
resistance as well as the regions of genome plasticity (Mathee, et al., 2008, Klockgether,
et al., 2011). Comparative analysis of the different Pseudomonas species including P.
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aeruginosa, P. syringae, P. fluorescens, P. stutzeri, and P. putida, also highlight the
contribution of horizontal gene transfers and genomic recombination to the versatility
and adaptation that is exhibited by this pathogen (Silby, et al., 2011). All of the above
enable the bacteria to survive, adapt and flourish under hostile conditions often found in
the host, resulting in infections.
Besides the metabolic versatility and minimal nutritional requirements other factors
that contribute to the ubiquitous nature of this bacteria as well as make this a formidable
pathogen in clinical settings are the arsenal of virulence factors (Gellatly & Hancock,
2013). Some of the common infections include hospital-acquired infections of the lung
(Crouch Brewer, et al., 1996, Lyczak, et al., 2000), burn-wound (Estahbanati, et al.,
2002, Dale, et al., 2004), urinary tract (Bouza, et al., 2002, Lamas Ferreiro, et al., 2017),
and cancer chemotherapy (Vento, et al., 2008). It is also the primary pathogen
responsible for morbidity and mortality in cystic fibrosis (CF) (Hoiby, 1974, Marks, 1981,
Davies, 2002) chronic keratitis (Dart & Seal, 1988) and otitis media and externa
(Seyfried & Fraser, 1978, Yeo, et al., 2007). Two main networks which are often
interconnected underlie the severity of these infections; the arsenal of virulence factors
and the variegated and numerous resistance mechanisms.
The initial stage of P. aeruginosa infection includes the process of bacterial adhesion
to a surface followed by its colonization and subsequent invasion (Vasil, 1986).
Remaining unchecked this may progress to a systemic infection. The virulence factors
that are foundational for a successful infection can be broadly divided into those upregulated in chronic and others in acute infections stages.
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1.2 Virulence in P. aeruginosa
Flagella and Type 4 pili: P. aeruginosa flagellum and pili serve as a virulence factor
providing motility and surface adhesion. Flagella are involved in maintaining swimming
motility (Kearns, 2010). The absence of flagellum was found to result in strains that are
deficient in acute infection (Feldman, et al., 1998). Along with pili, flagella also maintain
swarming movements (Kohler, et al., 2000).
P. aeruginosa has multiple pili located at the polar ends. Both flagella and pili assist
in adhesion by binding to receptors asialoGM1 which is expressed on the host
epithelium especially upon a tissue breach (Gupta, et al., 1994, Feldman, et al., 1998).
Pili is responsible for the third type of movement shown by P. aeruginosa; twitching
(Bradley, 1980). Flagella and pili are also a significant player in forming biofilms (O'Toole
& Kolter, 1998). Due to their role in P. aeruginosa pathogenesis, both flagella and pili
have been targeted for anti-bacterial activity (Potvin, et al., 2003, Kipnis, et al., 2006).
Alginate: P. aeruginosa in presence of a stress such as host-response often turn
mucoidy due to the production of an exopolysaccharide known as alginate (Evans &
Linker, 1973). This is composed of repeating units of D-mannuronic acid and L-guluronic
acid (Remminghorst & Rehm, 2006). This phenotype is predominantly seen in chronic
infections especially in CF (Doggett, et al., 1964, Hoiby, 1974). Alginate helps in
maintaining bacterial adhesion by preventing phagocytosis and opsonization (Bayer, et
al., 1991, Pedersen, 1992). It also enhances the binding of the bacteria to lung
epithelium. In addition, elimination of these mucoid strains proves more difficult as this
slime-like substance forms an effective barrier against antibiotics. Mucoid strains of P.
aeruginosa were found to be more resistant to aminoglycoside as well as β-lactams
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(Ramsey & Wozniak, 2005). It was presumed that alginate formed the main matrix in
biofilms, however that was not the case (Stapper, et al., 2004).
Lipopolysaccharide: The lipopolysaccharide (LPS) is an important immunologic
component of P. aeruginosa (Pier, 2007). Although a lot of variabilities exists among its
structure, its basic components include Lipid A, a core oligosaccharide and Ooligosaccharide or -antigen (King, et al., 2009). O-antigen of the LPS specifies the type
of antibody that is produced against the bacteria and is the basis of serotyping (Kaya, et
al., 1989). Lipid A is recognized by the cells of the host immune system, such as Toll like
receptor 4, which induces the release of cytokines resulting in inflammation (Backhed, et
al., 2003, Pier, 2007).
Biofilm: P. aeruginosa exists in organized communities wherein they are embedded
in a heteropolymer mesh composed of extracellular polysaccharides namely Pel and Psl,
protein, DNA with interweaving water channels (Ma, et al., 2012, Jennings, et al., 2015).
This is typically found in chronic infections and it increases the severity and tenacity of
the infection (Costerton, et al., 1999, Bjarnsholt, 2013). Besides localizing on natural
surfaces like respiratory airways, heart valve; biofilms often form on medical devices
such as a catheter or stents (Tacconelli, et al., 2009). Infections found in biofilms are
more difficult to eradicate resulting often in antibiotic resistance (Hoiby, 1974).
Type 3 secretion system (T3SS): One of the critical regulators of acute infection
phenotypes is the T3SS (Hauser, 2009). Activation of this system depends upon hostcell contact and availability of calcium in the extracellular milieu (Frank, 1997, Vallis, et
al., 1999). In P. aeruginosa, there are 43 genes distributed amongst the five operons
that cluster together and a master-regulator ExsA regulates the activity of T3SS (Yahr &
Frank, 1994, Frank, 1997). This system is characterized by the production of toxic
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effector proteins which are secreted into the host-cytosol through a needle-like
appendage similar to the flagellum. It comprises of four major effector proteins including
ExoS, ExoT, ExoU, and ExoY (Frank, 1997). Three proteins PopB, PopD, and PcrV form
the pore of the host cell membrane and assemble the secretory appendage to
translocate the effectors. Effectors ExoS, T, and U prevent endocytosis and
phagocytosis as well as disrupt the epithelial barrier of the host tissue (Heimer, et al.,
2013, Rangel, et al., 2015). ExoU also increases the release of proinflammatory
eicosanoids and is often associated with bacteremia, sepsis and lung damage
(McMorran, et al., 2003, Saliba, et al., 2005). ExoY is an adenylate cyclase that
increases the intracellular cyclic AMP casing cell necrosis and barrier disruption
(Stevens, et al., 2014). Animal models of infections including pneumonia; burn wounds,
sepsis and keratitis were shown to be worsened in the presence of an active T3SS
(Finck-Barbancon, et al., 1997, Sawa, et al., 1998, Lee, et al., 2003, Koh, et al., 2005).
Quorum Sensing (QS): As the name suggests, a process that depends upon the
formation of a “quorum”; a minimum number of bacterial cells (Nealson & Hastings,
1979). In other words, it is dependent on cell-signaling that is active once a certain cell
density has been reached. The cell-signaling is facilitated through the synthesis and
secretion of small-molecules known as “quoromones”, which often have an acylhomoserine backbone (Parsek, et al., 1999). Quorum sensing in P. aeruginosa was
classically known to involve two main players, the Las and Rhl-associated genes (Koch,
et al., 1991, Gambello, et al., 1993, Ochsner, et al., 1994, Pearson, et al., 1995). In
addition, there are two other systems namely the Pseudomonas quinolone system
(PQS) and the relatively recently identified IQS (Pesci, et al., 1999, Lee, et al., 2013).
Earlier studies show these systems are arranged in a hierarchy with the Las system at
the top. However, more recent studies have suggested that the Rhl system may also be
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regulating the Las genes under certain conditions (Dekimpe & Deziel, 2009). The IQS
system is known to be functional only under phosphate starvation (Lee, et al., 2013). All
the systems regulate virulence factors that can overwhelm the immune system of the
host resulting in infection.
QS is involved in the production of pigments known as pyocyanin (Dietrich, et al.,
2006). This is a phenazine compound that helps the bacteria to establish an infection in
a CF patient’s lungs (Kong, et al., 2006, Caldwell, et al., 2009, Carlsson, et al., 2011). It
can also act as an antimicrobial due to its production of superoxide radicals (Hassett, et
al., 1992). Another pigment produced by P. aeruginosa is pyoverdine, a siderophore
(Stintzi, et al., 1998). Iron is one of the critical components essential for maintaining
proper cellular physiology and growth (Ochsner, et al., 2002). Siderophores are ironchelators which transport extracellular iron to the cell-surface receptors and make it
easily available to the bacteria (Visca, et al., 2007).
Besides the pigments, QS is also involved in regulating other virulence factors such
as the production of a staphylolytic protease known as LasA, as well as elastase (LasB)
production (Kessler, et al., 1993, Whiteley, et al., 1999). Both LasA and LasB are
proteases which cause tissue invasion and have immune-modulatory properties
(Kharazmi, 1989, Hobden, 2002). In addition, QS regulates the production of bacterial
surfactants known as the rhamnolipids which play a prominent role in interfering with
host-immune responses during an infection (Alhede, et al., 2009). These bio-surfactants
prevent phagocytosis as well clearance of bacteria from the epithelial surface by
impairing ciliary beat (Read, et al., 1992). Furthermore, motility and biofilm formation,
which are under the influence of multiple genetic networks and environmental cues, are
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also regulated by QS (Kohler, et al., 2000, Davey, et al., 2003, Patriquin, et al., 2008,
Solano, et al., 2014).

1.3 Antibiotic resistance in P. aeruginosa

Supporting the arsenal of virulence factors, P. aeruginosa infections are largely
intractable due to the various mechanisms of resistance shown by this pathogen. Most
commonly used antibiotic therapies include a combination of newer generation
cephalosporins with aminoglycosides (Driscoll, et al., 2007, Kanj & Kanafani, 2011).
Despite this combination therapy, some infections remain unmanageable resulting in
physicians resorting to the use of older antibiotics such as the polypeptide colistin which
had previously been discontinued due to its nephro- and neurotoxic adverse events
(Falagas & Kasiakou, 2005). P. aeruginosa is listed as a pathogen of a serious threat
(Level 2) by the US Center for Disease Control and Prevention as it causes 51,000
infections per year; of which 6,700 are multi-drug resistance with 440 deaths (CDC,
2013). Furthermore, carbapenem-resistant P. aeruginosa is also one of the three
bacterial species listed by the World Health Organization as a pathogen of critical priority
(World Health Organization, 2017). This bacterium is also one of the ESKAPE
(Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, cinetobacter
baumannii, P. aeruginosa and Enterobacter species) pathogens with growing multi-drug
resistance(Figure 1.2.) (Rice, 2008).
The main mechanisms conferring resistance includes an impermeable outer
membrane, expression of efflux pumps, alteration of drug target proteins and the
production of hydrolytic enzymes.
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Figure 1. 2. The ESKAPE pathogens. These include a group of pathogens that show
multi-drug resistance (MDR). It includes: E-Enterococcus faecium, S- Staphylococcus
aureus, K- Klebsiella pneumoniae, A-Acinetobacter baumanii, P- Pseudomonas
aeruginosa, E-Enterobacter species.
Figure adapted from: http://www.bacteriainphotos.com/

1.3.1 Permeability barriers
The outer membrane found in Gram-negative organisms forms the first line of
defense against host-immune stimuli as well as from antibiotics. Most of the antibiotic
targets are located in the cytoplasm of the bacteria and in order to reach the site of
action, the antibiotics must first cross the outer membrane. Movement of smallmolecules across this barrier is facilitated by the presence of multiple channels located
on the outer-membrane called as porin proteins.
Porin protein: The major porin found in P. aeruginosa is OprF (Hancock, et al., 1979,
Nikaido, et al., 1991). Despite its abundance in the outer membrane, the intake of small
molecules through this porin is far lesser when compared to OmpF, the major porin
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found in E. coli, (Yoshimura, et al., 1983). It has been shown that OprF has an open and
a closed conformation (Sugawara, et al., 2006, Li, et al., 2012). At most times, a small
number of the porin channels are open which accounts for the decreased permeability of
P. aeruginosa to small molecules (Yoshimura & Nikaido, 1982). Despite this, OprF is
one of the most significant players’ regulating small molecule uptake into P. aeruginosa
(Nicas & Hancock, 1983). Depletion of OprF from the outer membrane gives rise to
increased resistance for fluoroquinolones and certain β-lactams such as ceftazidime and
carbenicillin. However, the overall effect on resistance is often minimized due to the loss
of membrane integrity in OprF mutants which creates an increased permeability to small
molecules (Gotoh, et al., 1989). In addition to its role in antibiotic resistance, OprF has
been found to be required for the pathogenesis of P. aeruginosa PAO1 and PA14
through modulation of quorum sensing and T3SS phenotypes (Fito-Boncompte, et al.,
2011).
Another resistance determining factor in the outer-membrane is the OprD porin in P.
aeruginosa (Li, et al., 2012). Its absence is most commonly associated with the advent
of carbapenem resistance. The identification of this porin is hence linked with the
discovery of resistance to imipenem, which is considered as the last line of defense
against resistant-pseudomonal infections. Besides carbapenems, OprD also transports
basic amino acids such as arginine, lysine, and histidine as well as peptides (Trias &
Nikaido, 1990). Nutrient media containing these specific amino acids was found to
increase the minimal inhibitory concentration (MIC) of P. aeruginosa to carbapenems
(Ochs, et al., 1999). This may be a concern in clinical settings wherein the presence of
basic amino acids in human serum is not accounted for and hence the MIC obtained in
vitro may not be truly reflective of the bacterial MIC in the patient's infection site. In the
lab, it has been found that OprD expression can be increased when bacteria are grown
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with these amino acids as the sole source of carbon or nitrogen (Muramatsu, et al.,
2003). The presence of trace metals like zinc and copper in the media causes downregulation of this channel (Perron, et al., 2004).

1.3.2 Efflux-mediated resistance
Another mechanism which is often found to act in synergy with an impermeable
outer membrane is the expression of efflux pumps (Lambert, 2002). The efflux pumps
are a predominant factor regulating antibiotic resistance and have been considered as
good targets for novel antibiotics (Schweizer, 2003). The resistance-regulating efflux
pumps found in Gram-negative bacteria including P. aeruginosa belong to the resistance
nodulation-division (RND) family (Schweizer, 2003, Apel & Surette, 2008). Structurally,
these pumps can be divided into three major components wherein a channel is found on
the outer membrane that is dependent on a proton motive force, an adaptor protein seen
in the periplasmic area and an inner membrane transporter which captures and
transports solutes from the cytoplasm to the extracellular milieu (Blair & Piddock, 2009,
Venter, et al., 2015).
P. aeruginosa has twelve efflux pumps which have been characterized. These
include MexAB-OprM (Li, et al., 1995) and MeXY-OprM (Mine, et al., 1999), MexCDOprJ (Gotoh, et al., 1998), MexEF-OprN (Kohler, et al., 1997), MexJK (Chuanchuen, et
al., 2002), MexGHI-OpmD (Aendekerk, et al., 2002), MexVW (Li, et al., 2003), MexPQOpmE (Mima, et al., 2005), MexMN (Mima, et al., 2005), TriABC (Mima, et al., 2007),
MuxAB-OpmB (Mima, et al., 2009) and CzrAB-OpmN (Hassan, et al., 1999). These
efflux pumps have a broad and varied range of antibiotic substrates MexAB-OprM can
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expel the β-lactams including the antipseudomonal penicillins, the monobactams,
cephlaosporins such as ceftazidime and cefotaxime as well as selected carbapenems
such as meropenem and the β-lactamase inhibitors as well as fluoroquinolones and
aminoglycosides (Li, et al., 1995, Srikumar, et al., 1998, Srikumar, et al., 2000) .
Amongst the β-lactams, mostly the fourth generation of cephalosporins is transported by
the MexCD-OprJ efflux pumps (Poole, et al., 1996). MexAB participates in regulating
intrinsic resistance for P. aeruginosa whereas MexCD does not (Kohler, et al., 1996,
Poole, et al., 1996). Carbapenems and cephalosporins are also transported by MexEFOprN (Kohler, et al., 1996, Kohler, et al., 1997). Fluoroquinolones can act as a substrate
for most of the efflux pumps. Aminoglycosides such as gentamicin, amikacin, and
tobramycin are the substrates of specifically MexXY-OprM (Poole, et al., 1996). It has
been found that strains which exhibit multi-drug resistance often show overexpression of
these pumps (Poole, et al., 1996, Oh, et al., 2003).
1.3.3 Target modification.
The sites of action of the β-lactams are the penicillin-binding proteins which are
enzymes essential for the peptidoglycan (PG) synthesis. The PG of bacteria is
composed of two sugar units, N-acetyl glucosamine, and N-acetyl muramic acid. A five
amino acid peptide chain composed of L-alanine, ɣ-D-glutamic acid, mesodiaminopimelic acid (meso-DAP), and D-alanyl-D-alanine is attached to the muramic
acid (Heilmann, 1972, Heilmann, 1974).

The penicillin-binding proteins catalyze an

essential step in the formation of the cell-wall by acting as a transpeptidase and facilitate
the cross-linking of the glycan chain between the third amino acid of one to the fourth
amino-acid of another. The β-lactams act by binding covalently to the active site of the
PBPs to form acyl-enzyme complexes (Wise & Park, 1965, Bycroft & Shute, 1985).
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Mutations occurring in this active site hence prevent the binding of the antibiotic to the
enzyme. Besides specific mutation of the PBP that incapacitates drug-binding, the
deletion of PBP4 was shown to result in high level expression of ampC resulting in βlactam resistance in a clinical setting (Moya, et al., 2009). These specific mutants were
also isolated from clinically resistant strains (Moya, et al., 2009). Decreased binding of βlactam to PBP3 has been reported in P. aeruginosa treated for a long duration with
tobramycin and antipseudomonal β-lactam (Godfrey, et al., 1981).
1.3.4 β-lactamase mediated resistance.
These are hydrolytic enzymes that target the β-lactam antibiotics. These enzymes
were first identified for their role even before the global widespread of the first β-lactam
i.e. penicillin (Abraham & Chain, 1988). Given the diversity of the enzymes, they have
been classified several times depending on their hydrolytic properties or substrate profile
as well as any structural homology between the enzymes. Notable classifications
amongst these include the scheme proposed by Richmond and Sykes who divided the
Gram-negative enzymes into five major groups according to their substrate profile
(Richmond & Sykes, 1973). This was extended by Sykes and Matthew to include the
plasmid-encoded enzymes (Sykes & Matthew, 1976). Mitsuhashi and Inoue also
categorized the enzymes according to their substrate profiles and included very specific
hydrolytic activity such as those targeting a specific generation of cephalosporins
(Mitsuhashi S, 1981). Two of the currently employed classifications are those by Ambler
and Bush.

Bush modified and expanded the classification provided by Richmond and

Sykes to include sub- groups for the enzymes based on substrates and inhibitor profile
(Bush & Singer, 1989, Bush, et al., 1995). The other classification scheme that is in use
currently was proposed by Ambler and divides the enzymes into four groups A, B, C and
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D according to the conserved sequences amongst the amino acids (Ambler, 1980).
Enzymes belonging to A, C, and D classes have a serine in the active site and act by
serine ester hydrolysis. Class B enzymes are also called metallo-β-lactamases and
require a zinc ion in the active site for their activity (Nambu, et al., 1999).
Class A Enzymes: These enzymes are commonly plasmid-borne or encoded in the
integron region with a minority of them being encoded on the chromosome (Matthew,
1979, Medeiros, 1997). The enzymes in this class are commonly known as
penicillinases and demonstrate a broad substrate profile with respect to their hydrolytic
properties (Matthew, 1979). The common groups of enzymes include TEM, SHV, PER,
CTX-M, IMI, SME, GES, and VEB (Datta & Kontomichalou, 1965, Matthew, et al., 1979,
Nordmann, et al., 1993, Poirel, et al., 2000, Karim, et al., 2001, Zhao & Hu, 2010,
Fairfax, et al., 2011). β-lactamase inhibitors such as tazobactam, sulbactam, clavulanic
acid, and relebactam have been found to inhibit their enzyme activities (Weldhagen, et
al., 2003). TEM and its derivatives have been identified in Gram-negative pathogens
including E. coli, K. pneumoniae, H. influenzae and N. gonorrhea (Ambler, 1980).
Another common enzyme found in this class is the SHV. These are structurally
homologous with TEM. Both TEM and SHV confer resistance to the synthetic and semisynthetic penicillins such as ampicillin, amoxicillin, ticarcillin, and carbenicillin as well as
the narrow-spectrum cephalosporins (Livermore, 1995, Tzouvelekis & Bonomo, 1999).
Derivatives of these enzymes such as the TEM-1, TEM-2, and SHV-1 show extended
spectrum providing resistance to 2nd and 3rd generation cephalosporins as well as
monobactams (Weldhagen, et al., 2003). P. aeruginosa has derivatives TEM 21, 24 42
and 4 along with SHV 2, 12 and 5 (Weldhagen, et al., 2003). In addition, clinical isolates
with GES and its related IBC, VEB, and PER and their derivatives have also been
recognized. The affinity is similar to TEM and SHV; they inhibit all the groups of β-
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lactams including penicillins, cephalosporins, imipenem (Weldhagen, et al., 2003). In
addition, GES-1 can also inhibit clavulanic acid, imipenem and as well as cefoxitin- a
third generation cephalosporin (Poirel, et al., 2000). PER1- which has 20% amino acid
identity with TEM and SHV also inhibits the monobactam (Bouthors, et al., 1998).
Class B Enzymes: Instead of a serine moiety in the active site, this enzyme class
requires a zinc (Zn+2) ion (Dufresne, et al., 1988, Palzkill, 2013). These enzymes are
mainly expressed and transmitted through integrons in plasmids or transposons in
pathogenic bacteria such as Enterobacteriaceae and P. aeruginosa (Palzkill, 2013). P.
aeruginosa contains the IMP, VIM, SPM and GIM type of enzymes (Watanabe, et al.,
1991, Lauretti, et al., 1999, Toleman, et al., 2002, Castanheira, et al., 2004). The IMP-,
VIM-, and GIM-type enzymes are encoded within mobilizable units such as the plasmids
and the transposons (Poirel, et al., 2000, Castanheira, et al., 2004, Brizio, et al., 2006).
SPM-1 is closely associated with a genetic element known as ISCR (IS Common
Region) that is related to the spread of antibiotic resistance (Toleman, et al., 2002). The
enzymes in this class can degrade all the β-lactams except for aztreonam (Sacha, et al.,
2008). Furthermore, these enzymes are also resistant to the β-lactamase inhibitors
(Sacha, et al., 2008). There is a considerable homology between these enzymes and
their derivatives. VIM derivative, VIM-1 shows less than 30% identity with the IMP-1
type enzymes whereas the SPM-1 shows 35.5% identity to IMP-1 (Lauretti, et al., 1999).
GIM-1 also shows a high conservation with the IMP-1 enzyme (42%), and slightly lesser
with VIM-1 and SPM-1 (28-30%) (Castanheira, et al., 2004).
Class C Enzymes: These enzymes are mainly chromosomal however plasmid-encoded
forms have been detected (Papanicolaou, et al., 1990, Bauernfeind, et al., 1996,
Walther-Rasmussen & Hoiby, 2002). In P. aeruginosa two chromosomal class C β-
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lactamases have been identified, AmpC and PIB-1 (Fajardo, et al., 2014). Overexpression of PIB-1 was found to confer resistance to carbapenems whereas AmpC
overexpression led to increased resistance for all the groups of β-lactams (Fajardo, et
al., 2014). The regulation of AmpC expression and its influence on β-lactam resistance is
enumerated in detail later in the introduction.
Class D Enzymes: This group of enzymes is commonly known as oxacillinases owing to
their ability to hydrolyze oxacillin, methicillin, cloxacillin, and dicloxacillin (Dale & Smith,
1972). One of the recently identified enzymes in this group is PoxB, previously known as
OXA-50 (Girlich, et al., 2004, Kong, et al., 2005). This enzyme is encoded in the
chromosome and was found to have carbapenemase activity (Zincke, et al., 2016). In
the presence of the primary chromosomally encoded β-lactamase AmpC, the effect of
this enzyme on resistance is minimal. However, upon overexpression, this was found to
render resistance to carbapenems. This effect was especially pronounced in the
absence of the porin for carbapenems, OprD (Zincke, et al., 2016). The β-lactamase
inhibitors (-bactam) do not inhibit this class of enzymes (Payne, et al., 1994). Other than
this specific chromosomal β-lactamase, several plasmids encoded class D-enzymes has
also been characterized. Some of these in P. aeruginosa are OXA-2 and its variants (15, -36), -5, -6,-10 and its variants (OXA-11,-14,-16,-17 and -19), and -20 (Danel, et al.,
1995, Danel, et al., 1998, Mugnier, et al., 1998, Danel, et al., 1999, Poirel, et al., 2010).
Additionally, another enzyme LCR-1 is also found which includes penicillin in its
spectrum (Yang & Bush, 1995).
1.4 Regulation of AmpC β-lactamase expression.
The expression of AmpC β-lactamase is inducible in many bacteria including P.
aeruginosa (Lodge, et al., 1990). The study of AmpC regulation was first demonstrated
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in E. coli using C. freundii AmpR (Lindberg & Normark, 1987). The connection of βlactamase induction with recycling was realized after demonstrating that particular genes
which participate in recycling also affected β-lactamase induction (Wiedemann, et al.,
1998). This specific induction phenomenon was found to occur only in the presence of βlactams,

which

led

to

an

accumulation
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muropeptides.

As

studied

in

Enterobacteriaceae, besides AmpR, other players that are required in this process
include AmpG, AmpD, AmpDh2, AmpDh3, NagZ among others (Wiedemann, et al.,
1998). As this process, has not been investigated in P. aeruginosa the next few sections
entail the details of this process in this pathogen and compares it to the model organism
that was used to study recycling- E. coli.
1.5 Cell-wall recycling and synthesis in Escherichia coli and P. aeruginosa

The cell-wall is an essential component of bacterial architecture that confers cell
shape, prevents lysis under fluctuating internal turgor pressure, and protects from
external assaults, thus enabling their ubiquitous existence. The cell-wall is composed of
tightly cross-linked peptidoglycan (PG) which encircles the inner membrane and forms a
protective layer known as the murein sacculus (Weidel & Pelzer, 1964). The murein
sacculus varies in size and chemical content in distinct species. In Gram-negatives such
as E. coli, the cell-wall is approximately six nanometers (nm), whereas in the Grampositives it may span up to 80 nm providing the capacity to withstand higher amounts of
turgor pressure (Whatmore & Reed, 1990, Matias, et al., 2003, Matias & Beveridge,
2007). Extensive remodeling of the cell-wall occurs during bacterial cell growth and
division. Thus, recycling of the cell-wall components is critical to conserve resources.
Both Gram-positive and -negative bacteria recycle almost 40-50% of the cell-wall
components (Goodell, 1985, Doyle, et al., 1988). Cell-wall recycling and synthesis are
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tightly coordinated to preserve bacterial integrity. Since the survival of bacteria critically
depends on their PG-based cell-walls, it is a selective target of many antibiotics. Hence,
the development of antibiotic resistance in bacteria is intimately tied in with the cell-wall
synthesis and recycling (Jacobs, et al., 1994). Both these processes have been studied
in Citrobacter freundii, Enterobacter cloacae, and E. coli and to some extent in P.
aeruginosa (Jacobs, et al., 1994, Jacobs, et al., 1997, Lee, et al., 2016, Lee, et al.,
2016).
P. aeruginosa infections are a serious clinical challenge due to their multiple antibiotic
resistances and aggressive virulence mechanisms and its ability to establish persistent
chronic infections. A dearth of antibiotics to treat multi-drug resistance threatens to cast
the world back into a pre-antibiotic era (Davies & Davies, 2010). P. aeruginosa shows
both intrinsic as well as acquired resistance towards multiple classes of antibiotics
(Lambert, 2002, Lister, et al., 2009). Intrinsic resistance to a widely used group of drugs,
the β-lactams, is often conferred through the inducible β-lactamase AmpC, a process
which interweaves with the cell-wall recycling pathway (Normark, 1995). Despite the
discovery of cell-wall recycling in E. coli in the 1980’s, technical limitations have hindered
its full characterization in other organisms.
This review provides a brief overview of de novo cell-wall biosynthesis and focuses
on what is known to date regarding cell-wall recycling in E. coli and P. aeruginosa. We
discuss the roles of the genes involved in cell-wall synthesis and recycling in conferring
resistance to both β-lactam and non β-lactam antibiotics. The review also focuses on
the global regulator AmpR that connects cell-wall recycling to other resistance
mechanisms through its diverse regulatory role in P. aeruginosa (Balasubramanian, et
al., 2012, Kumari, et al., 2014).
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1.5.1 Cell-wall biochemistry
The bacterial murein sacculus is composed of a heteropolysaccharide of N-acetyl
muramic acid (MurNAc) and N-acetyl-glucosamine (GlcNAc) linked by β-1→4 glycosidic
linkages, with a short chain peptide containing up to five amino acids, attached to the
muramyl moiety (Salton, 1953, Perkins, 1963, Schleifer & Kandler, 1972). The full-length
pentapeptide side chain in Gram-negative bacteria is typically composed of L-Alanine-ɣD-Glutamate-meso-diaminopimelic acid-D-Alanyl-D-Alanine (L-Ala-ɣ-D-Glu-m-DAP-DAla-D-Ala) (Glauner, et al., 1988). Cross-linking in Gram-negative bacteria between two
adjacent peptide chains commonly occurs between the 3rd residue of one chain (m-DAP)
and the 4th residue (D-Ala) of the other (Schleifer & Kandler, 1972, Sauvage, et al.,
2008). High-performance liquid chromatography analysis of purified murein sacculus has
shown that the extent of crosslinking is comparable between E. coli and P. aeruginosa
(Quintela, et al., 1995). This crosslinking creates a mesh-like structure, which confers
murein sacculus the strength to withstand internal pressure.
The PG in many Gram-negatives including E. coli and P. aeruginosa has linked
proteins known as Braun’s lipoprotein (Braun & Rehn, 1969, Braun & Sieglin, 1970,
Quintela, et al., 1995). The covalent linkage of this lipoprotein between the outer
membrane and the murein sacculus contributes further to the stability of the cell-wall.
There is a considerable variation in the thickness of the murein sacculus amongst Gramnegative bacteria. For instance, the PG thickness of E. coli is 6.35 ± 0.53 nm whereas P.
aeruginosa is at 2.41± 0.54 nm (Matias, et al., 2003). Despite the variations found in the
details of the structural architecture in the Gram-negatives, the cell-wall is highly
conserved across bacteria promoting its use as a valuable antibiotic target.
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1.5.2 Cell-wall biosynthesis
The biosynthesis of the cell-wall can be divided into three phases based on the
localization of the processes; namely, those occurring in the cytoplasm, the inner leaflet
of the cytoplasmic membrane, and the periplasm (Figure1. 3).

Figure 1.3. Peptidoglycan recycling and synthesis pathway in E. coli. The major
cell-wall recycling enzymes found in the periplasm include the low molecular mass
penicillin binding proteins (LMM PBPs: PBP4, PBP5, PBP6, PBP7/8), amidases (AmiAAmiD), and the lytic transglycosylases (LT: MltA, MltB, MltC, MltD, MltE, MltF, MltG, and
Slt70). The major products formed are the N-acetylglucosamine-1, 6-anhydro-Nacetylmuramyl-peptides (GlcNAC-anhMurNAc-peptide) along with GlcNAc-anhMurNAc
and free peptides. These muropeptides are translocated from the periplasm into the
cytoplasm, mainly through a permease AmpG. Some of the muropeptides are also
translocated through the OppBCDF complex with muropeptide-binding protein MppA, as
well as through NagE and MurP. Once in the cytoplasm, these muropeptides are
processed by β-N-acetylglucosaminidase (NagZ) and the N-acetyl-anhydromuramyl-Lalanine amidase (AmpD) and an LD-carboxypeptidase (LdcA). The products are then
acted upon by a kinase (AnmK), an etherase (MurQ), and a deacetylase (NagA) to form
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glucosamine-6-phosphate (GlcN-6-P). The recycling and biosynthesis pathways
converge at this point. GlcN-6-P is converted back to fructose-6-phopshate (Fru-6-P)
through a deaminase (NagB).
In the PG biosynthesis pathway, Fru-6-P is converted to GlcN-6-P through an
amidotransferase (GlmS). The GlcN-6-P undergoes a series of modifications through a
hexosephosphate mutase (GlmM), an uridyltransferase (GlmU), an enolpyruvyl
transferase (MurA), a reductase (MurB) and the Mur ligases (MurC, MurD, MurE, MurF)
to form the uridine-diphosphate (UDP) MurNAc-pentapeptides. In addition to the Mur
ligases is the murein peptide ligase (Mpl) which can catalyze the ligation of tri-, tetraand pentapeptides to MurNAc. A translocase (MraY) transfers the UDP-MurNAc peptide
onto an undecaprenyl-pyrophosphate (UND-PP) group to form Lipid I which anchors the
complex to the inner membrane (IM). A glycosyltransferase (MurG) catalyzes the
attachment of GlcNAc to form lipid II. Lipid II is then flipped from the cytoplasm into the
periplasm using “flippase” (FtsW and MurJ). Once in the periplasmic space, the high
molecular mass penicillin binding proteins (HMM PBPs) with transglycosylase (TG) and
transpeptidase (TP) activities polymerize and cross-link the muropeptides with the
existing peptidoglycan (PG). LMM PBPs with endopeptidase (EP) activity cleave the
existing PG layer, facilitating the insertion of new glycan strands.

Escherichia coli
Cytoplasm
Fructose-6-phosphate is converted to uridine-diphosphate (UDP)-GlcNAc through
series of steps driven by the activities of the GlmS, GlmM, and GlmU (Badet, et al.,
1987, Mengin-Lecreulx & van Heijenoort, 1994, Mengin-Lecreulx & van Heijenoort,
1996). UDP-GlcNAc is further converted to UDP-MurNAc pentapeptide by the activity of
the Mur group of enzymes (MurA, MurB, MurC-MurF ligases) (Benson, et al., 1993,
Barreteau, et al., 2008). To this pentapeptide, a 55-C aliphatic chain called undecaprenyl
pyrophosphate is attached by MraY (Bouhss, et al., 2004). This aliphatic moiety is
attached to the inner face of the cytoplasmic membrane to form Lipid I (Chatterjee &
Park, 1964, Anderson, et al., 1965).
Inner membrane
MurG catalyzes the addition of GlcNAc to the MurNAc moiety of Lipid I to yield Lipid
II (Mengin-Lecreulx, et al., 1991, Barreteau, et al., 2008). The Lipid II is flipped over into
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the periplasmic space using a ‘flippase’ enzyme (Pomorski & Menon, 2006). The identity
of “flippase” remains ambiguous and is the subject of current research (Meeske, et al.,
2015, Ruiz, 2015, Elhenawy, et al., 2016). In E. coli, FtsW and MurJ have been
independently shown to be the proteins responsible for translocation of the lipid-linked
muropeptides from the cytoplasm into the periplasmic space (Ruiz, 2008, Mohammadi,
et al., 2011, Sham, et al., 2014, Leclercq, et al., 2017). Furthermore, in E. coli the
transport and subsequent polymerization of Lipid II by FtsW is regulated via PBP1B and
PBP3 (Leclercq, et al., 2017).
Periplasm
The final steps of the PG synthesis involve the incorporation of the GlcNAc-MurNAc
pentapeptide component of Lipid II into the rapidly evolving murein sacculus. High
molecular mass penicillin binding proteins (HMM PBPs) with a transglycosylase domain
(PBP1A, PBP1B, and PBP1C) facilitate the link between the MurNAc end of the Lipid II
with the GlcNAc of the existing strand (Ishino, et al., 1980, Suzuki, et al., 1980, Tamura,
et al., 1980, Nakagawa, et al., 1984, Schiffer & Holtje, 1999, Terrak, et al., 1999). HMM
PBPs with a transpeptidase domain (PBP1A, PBP1B, PBP1C, PBP2 and PBP3)
catalyze the formation of cross-links between two peptide chains (Ishino, et al., 1980,
Nakamura, et al., 1983, Asoh, et al., 1986, Goffin & Ghuysen, 1998, Nguyen-Disteche,
et al., 1998) (Table 1.1). Cross-linking is composed of two steps wherein the terminal DAla-D-Ala of the peptide chain attached to MurNAc is cleaved with the release of one
alanine (Izaki, et al., 1966). The murein tetrapeptide so formed is known as the “donor”
peptide. Subsequently, the terminal D-alanine of the tetrapeptide attaches to the mesodiaminopimelic acid of an “acceptor” peptide chain (Izaki, et al., 1966).
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Pseudomonas aeruginosa
Bioinformatics analyses suggest the presence of E. coli homologs in P. aeruginosa;
however, the enzymatic characterization of many of the proteins is yet to be done (Table
1.1).
Cytoplasm
Sequence comparison reveals homologs of GlmM (PA4749), GlmS (PA5549) and GlmU
(PA5552) that aids in the synthesis of UDP-GlcNAc from fructose-6-phosphate (Table
1.1). In P. aeruginosa glucosamine-6-phosphate synthetase GlmS is under the
regulation of a repressor GlmR (PA5550) (Ramos-Aires, et al., 2004). A transcriptional
factor NagR regulates both GlmS and GlmU in E. coli, highlighting the difference in
regulation of PG saccharide GlcNAc between the two organisms (Plumbridge, 1995). In
addition to protein homology, the functional activity of GlmM as a phosphoglucosamine
mutase in P. aeruginosa has also been established (Tavares, et al., 2000). Homologs of
the Mur enzymes that lead to the formation of UDP-MurNAc pentapeptide from UDPGlcNAc namely an enolpyruvyl transferase MurA (PA4450), a reductase MurB
(PA2977), as well as the Mur ligases, MurC (PA4411), MurD (PA4414), MurE (PA4417),
and MurF (PA4416) are also encoded in the P. aeruginosa genome (Table 1.1). The
activity of the P. aeruginosa Mur enzymes was analyzed by providing the initial substrate
for MurA, UDP-GlcNAc, and detecting the formation of the final product UDP-MurNAcpentapeptide (El Zoeiby, et al., 2001). The enzymatic properties of all the Mur ligases of
P. aeruginosa were also heterologously characterized in E. coli (El Zoeiby, et al., 2000,
Azzolina, et al., 2001). P. aeruginosa also encodes a homolog of Mpl ligase (PA4020)
which facilitates ligation of tri-, tetra- and pentapeptides to UDP-MurNAc (Table 1.1). The
cytosolic translocase MraY (PA4415) then transfers the UDP-MurNAc pentapeptide to
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an undecaprenol carrier group that anchors the muropeptide to the inner membrane
(Table 1.1) (Azzolina & El-Sherbeini, 2002). P. aeruginosa has homologs of inner
membrane glycosyltransferase MurG (PA4412) and flippases FtsW (PA4413) and MviN
(PA4562) (Table 1.1). A crystal structure of P. aeruginosa MurG has been solved in
complex with its substrate, UDP-GlcNAc (Brown, et al., 2013).

Periplasm
The periplasmic cell-wall synthesis enzymes for polymerization and cross-linking of the
muropeptides include the HMM PBPs, namely PBP1A (PA5045), PBP1B (PA4700),
PBP2 (PA4003), and PBP3 (PA4418) (Table 1.1) (Noguchi, et al., 1979, Handfield, et
al., 1997, Legaree, et al., 2007, Chen, et al., 2017). By sequence homology to E. coli,
PBP1A (PA5045) and 1B (PA4700) contain both transglycosylase and transpeptidase
domains whereas PBP2 (PA4003), and PBP3 (PA4418) have the domain for
transpeptidase activity (Finn, et al., 2016, Marchler-Bauer, et al., 2017). In addition, P.
aeruginosa also contains an additional transpeptidase, PBP3B/3X (PA2272), which is
not found in E. coli (Liao & Hancock, 1997). P. aeruginosa PBP3 and 3B expression
differ temporally, the former being upregulated during the exponential and the latter
during stationary growth-phase (Liao & Hancock, 1997).
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Table 1.1. List of genes involved in cell-wall synthesis
Protein Homology
(%)

Genes
Proteins

E.
coli

P. aeruginosa

Identity

¥

Similarity

Functional
Annotation

¥

Periplasm

PBP1C

pbpC

NF

MgtA

mgtA
pbpA/
mrdA

PA0378

48

65

Transglycosylase and
transpeptidase
Transglycosylase and
transpeptidase
Transglycosylase and
transpeptidase
Transglycosylase

PA4003

43

61

Transpeptidase

PBP1a
PBP1B

PBP2

ponA/
mrcA
ponB/
mrcB

PA5045

41

58

PA4700

38

56

-

-

PBP3

ftsI/pbpB

PA4418

43

60

PBP3b

NF

PA2272

-

-

PBP4

dacB

PA3047

26

40

PBP5
PBP6
PBP6b

dacA
dacC
dacD

PA3999
PA3999
NF

46
46
-

62
65
-

PBP7

pbpG

PA0869

63

75

Transpeptidation.
Important for septa
formation during celldivision
Transpeptidase
D-alanyl-D-alanine
carboxypeptidase and
endopeptidase
DD-carboxypeptidase
DD-carboxypeptidase
DD-carboxypeptidase
DD-carboxypeptidase
and endopeptidase

Inner membrane
FtsW
MurJ

ftsW
murJ

PA4413
PA4562

39
75

55
88

MurG

murG

PA4412

45

62

Flippase (Putative)
Flippase (Putative)
UDP-Nacetylglucosamine-Nacetylmuramylpentapeptide
transferase

Cytoplasm
MraY

mraY

PA4415

67

81

GlmM

glmM

PA4749

60

74

GlmU

glmU

PA5552

56

71
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N-acetylmuramylpentapeptidetransferase
Phosphoglucosamine
mutase
Glucosamine-1phosphate
acetyltransferase,
N-acetylglucosamine1-phosphate

uridyltransferase
MurA

murA

PA4450

60

74

MurB

murB

PA2977

42

56

MurC

murC

PA4411

58

73

MurD

murD

PA4414

50

63

MurE

murE

PA4417

47

58

MurF

murF

PA4416

46

60

Mpl

mpl

PA4020

59

72

GlmS

glmS

PA5549

63

79

Enolpyruvyl transferase
UDP-N-acetyl
pyruvylglucosamine
reductase
UDP-Nacetylmuramate Lalanine ligase
UDP-N-acetylmuramyl
L-alanine-D-glutamate
ligase
UDP-N-acetylmuramyl
L-alanyl-D-glutamatediaminopimelate ligase
UDP-N-acetylmuramy
L-alanyl-D-glutamyldiaminopimelate-Dalanyl-D-alanine ligase
Murein peptide ligase
Glucosamine-6phosphate synthase

The data is compiled from EcoCyc and Pseudomonas Genome database website
(Keseler, et al., 2009, Winsor, et al., 2016).
¥
The value for protein sequence identity and similarity of E. coli and P. aeruginosa
was obtained using ClustalW2 “pairwise sequence alignments”.
NF: Not Found

1.5.3 Peptidoglycan growth
To ensure bacterial growth (elongation and division) while maintaining cellular
integrity, both PG degradative enzymes such as low molecular mass penicillin binding
proteins (LMM PBP), lytic transglycosylases (LT), and amidases and PG synthase
enzymes such as HMM PBPs must perform in a coordinated fashion along with the
various bacterial cytoskeletal elements to avoid cell lysis (Typas, et al., 2011). The
growth of the murein sacculus has been studied extensively in E. coli by Park et al
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(Burman, et al., 1983, Park & Burman, 1985). Using radioactively-labelled PG they
demonstrated that newly formed PG strands are cross-linked with the existing strand at
multiple sites. At the same time, the cross-links in the existing murein strand are
degraded by endopeptidases (Burman, et al., 1983). A three-for-one growth model
suggests that the existing strand acts as a dock that incorporates three newly
synthesized murein chains (Holtje, 1998). The soluble PG fragments that are generated
during this progressive replacement of the existing murein with the new strand are
recycled (Goodell & Schwarz, 1985).

1.5.4 Cell-wall recycling
As the cells divide, the walls break and rejoin at every cycle, thus generating
muropeptides of varying lengths. Gram-positives such as Bacillus sp., Lactobacillus
acidophilus release close to 25-30% of their muropeptides into the culture media
(Mauck, et al., 1971, Boothby, et al., 1973, Doyle, et al., 1988). Only 6-8% extracellular
muropeptides were detected for E. coli (Goodell & Schwarz, 1985). The latter finding
gave rise to the hypothesis that the Gram-negatives recycle their muropeptides. The
hypothesis was confirmed by the detection of tritiated-DAP reuse by the bacteria during
cell growth (Goodell, 1985). Extensive studies in E. coli have provided the knowledge on
cell-wall recycling in Gram-negatives (Park & Uehara, 2008) (Figure1. 4). Though P.
aeruginosa harbors the orthologous genes, their functional roles remain to be elucidated
(Kong, et al., 2010) (Table 1.2). This following section compares cell-wall recycling in
Gram-negative E. coli and P. aeruginosa. The pathway is broken down into processes
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occurring in the subcellular compartments; namely the periplasm, inner membrane, and
cytoplasm (Figure 1.4).

Periplasm
Mainly, three types of lytic enzymes are found in the periplasmic space that creates
the muropeptide intermediates (Figure 1.3, 1. 4). These include the LTs, the LMM PBPs
and the amidases (Park & Uehara, 2008, van Heijenoort, 2011).

Figure 1. 4 Outline of cell-wall recycling in P. aeruginosa. Muropeptides formed in
the periplasm through low molecular mass penicillin binding proteins (LMM PBPs: PBP4,
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PBP, PBP6, PBP7/8), amidases (AmiB, AmiD, AmpDh2 and AmpDh3), and the lytic
transglycosylases (LT: MltA, MltB, MltD, MltF, MltF2, MltG, Slt, SltB2, SltH/SltB, and
RlpA) are internalized into the cytoplasm through a permease AmpG. AmpP is a paralog
of AmpG found in P. aeruginosa whose function in cell-wall recycling has not been
elucidated yet. Muropeptides imported by AmpG are subsequently degraded by a β-Nacetylglucosaminidase (NagZ) which removes the GlcNAc moiety. The product Nacetyl-anhydro muramic acid (anh-MurNAc) peptide is processed by an N-acetylanhydromuramyl-L-alanine amidase (AmpD) which cleaves the peptide chain; and a LDcarboxypeptidase (LdcA) that removes the terminal amino acid D-alanine (D-Ala) from a
tetrapeptide. In P. aeruginosa, anh-MurNAc is reutilized and converted to MurNAc-6phosphate (MurNAc-6-P) by a kinase (AnmK). MurNAc-6-P is then converted to
MurNAC by a phosphatase (MupP). Following this, an anomeric MurNAc/GlcNAc kinase
(AmgK) catalyzes the formation of MurNAc-α-1-phosphate; to which an uridylyl
transferase attaches a uridine-diphosphate (UDP) to facilitate the formation of UDPMurNAc. AmgK, MupP, and MurU cell-wall recycling enzymes are found exclusively in P.
aeruginosa. Following the formation of UDP-MurNAc, the peptide chain is added by a
murein peptide ligase (Mpl) or by Mur ligases (MurC, MurD, MurE and MurF). The UDPMurNAc pentapeptide is converted to Lipid I (undecaprenol-pyrophosphate-UDPMurNAc peptide) by a MurNAc-pentapeptide translocase (MraY) and a
glycosyltransferase (MurG) then attaches the GlcNAc moiety to form Lipid II
(undecaprenol-pyrophosphate-UDP-GlcNAc-MurNAc peptide). Lipid II is flipped into the
periplasm through putative “flippases” (FtsW and MurJ). The GlcNAc-MurNAc peptide is
reincorporated into the growing PG through high molecular mass (HMM) and LMM
PBPs.

Lytic transglycosylases (LTs)
The LTs act on the murein sacculus to release their signature product GlcNAc 1, 6
anhydro MurNAc (Holtje, et al., 1975) (Figure 1.4). The LTs facilitate PG remodeling,
insertion of membrane-associated structures such as flagella and the secretion systems,
and help in cell separation during division (Heidrich, et al., 2002, Koraimann, 2003,
Scheurwater, et al., 2008). Investigation of the E. coli ORFs led to the identification of
eight genes encoding LTs; mltA, mltB, mltC, mltD, mltE (emtA), mltF, mltG and slt70
(Holtje, et al., 1975, Engel, et al., 1992, Romeis, et al., 1993, Dijkstra & Keck, 1996,
Kraft, et al., 1998, Lee, et al., 2013, Yunck, et al., 2016). The enzymatic activities of all
the E. coli LTs were demonstrated using the murein sacculus isolated from the log and
stationary phase as a substrate (Lee, et al., 2013). All the LTs are exolytic and cleave at
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a terminus of the PG strand. However, MltE, MltD, MltB, Slt70 (SltY) and MltC are
endolytic and cleave in the middle of a PG strand (Lee, et al., 2013). Of these, MltA was
reported to have the highest activity on purified murein sacculus. All the enzymes show
a higher activity on the murein sacculus isolated during the log phase than the stationary
phase. The higher activity is in accordance with the extensive remodeling that occurs at
the log phase (Lee, et al., 2013). It may also be due to the structural differences in the
sacculus during the phases of bacterial growth as well as the lack of cell division during
stationary phase (Glauner, et al., 1988). Deletion analyses demonstrate the presence of
extensive functional redundancy within this group of eight genes encoding LTs (Heidrich,
et al., 2002). E. coli tolerate the loss of up to three LTs, but deletion of all eight leads to
cell death (Lommatzsch, et al., 1997, Kraft, et al., 1999, Heidrich, et al., 2002).
The LTs in P. aeruginosa were first identified using renaturing PAGE and
zymograms (Watt & Clarke, 1994, Li, et al., 1996). A total of 11 LTs, MltA (PA1222),
MltB (PA4444), MltD (PA1812), MltF (PA3764), MltF2 (PA2865), MltG (PA2963), Slt
(PA3020), SltB2 (PA1171), SltH/SltB3 (PA3992), and RlpA (PA4000) were reported in P.
aeruginosa (Blackburn & Clarke, 2001, Blackburn & Clarke, 2002, Cavallari, et al., 2013,
Jorgenson, et al., 2014, Lee, et al., 2017). A few studies separately enumerate the
enzymatic activities of all the lytic transglycosylases (Jorgenson, et al., 2014, Lee, et al.,
2016, Lee, et al., 2017). In vitro analyses with purified enzymes demonstrated that all the
P. aeruginosa LTs have both endolytic and exolytic activity. MltD, MltF2, RlpA, and Slt
exhibited higher endolytic activity whereas MltA, SltB1, SltB2, and SltB3 had higher
exolytic activity. The most and least active enzymes are SltB1 and MltF2, respectively.
Some of these enzymes exhibit substrate preference — MltB specifically requires a
peptide chain on the muropeptide to demonstrate its lytic activity whereas RlpA acts on
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the degradation products of amidases, namely GlcNAc-anhMurNAc without the attached
peptide chains (Jorgenson, et al., 2014, Lee, et al., 2017) (Figure 1.4).

Low molecular mass penicillin binding proteins (LMM PBPs)
The LMM PBPs act mostly as endopeptidases and or carboxypeptidases (Goffin &
Ghuysen, 1998, Sauvage, et al., 2008, Vollmer, et al., 2008). The endopeptidase activity
of PBPs leads to hydrolysis of the cross-bridge between m-DAP and D-Ala, whereas the
carboxypeptidases remove the terminal amino acid from a pentapeptide during crosslinking (Strominger, et al., 1967, Sauvage, et al., 2008, Vollmer, et al., 2008).
E. coli have five LMM PBPs, namely PBP4 (DacB), PBP5 (DacA), PBP6 (DacC),
PBP6b (DacD) and PBP7/8 (PbpG) (Spratt & Strominger, 1976, Holtje, 1998, Denome,
et al., 1999, Kong, et al., 2010) (Table 1.2). PBP4/ DacB is a bifunctional peptidase with
both carboxy and endopeptidase activities (Korat, et al., 1991). Together with PBP5
(DacA), PBP4 (DacB) is involved in maintaining normal cell morphology (Korat, et al.,
1991, Meberg, et al., 2004, Clarke, et al., 2009). PBP5 (DacA) is found attached to the
inner membrane (Spratt, 1977). It is the major carboxypeptidase in E. coli; deletion of
dacA is associated with cell shape defects and a striking increase in some
pentapeptides (Matsuhashi, et al., 1979, De Pedro, 1980, Nelson & Young, 2000,
Nelson & Young, 2001). PBP6/DacC and PBP6b/DacD exhibit carboxypeptidase
activities (Tamura, et al., 1976, Amanuma & Strominger, 1980, Baquero, et al., 1996).
An increase in expression levels of dacC is noted during the stationary phase (van der
Linden, et al., 1992).
Another endopeptidase PBP7/PbpG and its proteolytic product PBP8 have been
identified in E. coli (Henderson, et al., 1995). Loss of pbpG did not result in any
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morphological aberrations, however, the absence of both dacA and pbpG encoding
PBP5 and PBP7, respectively resulted in increased cell shape defects as compared to
the loss of dacA alone (Romeis & Holtje, 1994, Meberg, et al., 2004). Expression of
dacA and dacC is regulated by the BolA protein, which is highly conserved in eukaryotes
and prokaryotes (Santos, et al., 2002, Guinote, et al., 2011). BolA maintains cell
morphology in both a PBP5/PBP6-dependent and -independent manner (Freire, et al.,
2009). BolA regulates the carboxypeptidase activities of DacA/PBP5 and DacC/PBP6,
and overexpression of bolA showed a decreased rate of growth which was lost upon
deletion of both dacA and dacC (Santos, et al., 2002, Guinote, et al., 2011).
Overexpression of bolA also impaired PBP2-mediated cell elongation and formation of
cytoskeleton due to spatial disorganization of MreB (Freire, et al., 2009).
LMM PBPs in P. aeruginosa include PBP4/DacB (PA3047), PBP5/DacC (PA3999),
and PBP7/PbpG (PA0869) (Noguchi, et al., 1979, Song, et al., 1998, Smith, et al., 2013,
Lee, et al., 2015, Ropy, et al., 2015). Loss of dacC results in increased pentapeptides
establishing its role as the primary carboxypeptidase in P. aeruginosa (Noguchi, et al.,
1985, Smith, et al., 2013, Ropy, et al., 2015). P. aeruginosa encodes a homolog of BolA
(PA0857), which shows a 46% identity to their E. coli counterpart. However, its role as a
regulator of carboxypeptidases in P. aeruginosa is yet to be investigated. An additional
increase of pentapeptides is also seen upon deletion of dacB and pbpG confirming the
presence of multiple carboxypeptidases (Ropy, et al., 2015). PBP4/DacB and
PBP7/PbpG also act as endopeptidases (Song, et al., 1998, Lee, et al., 2015, Ropy, et
al., 2015). P. aeruginosa appears to not harbor PBP6. However, P. aeruginosa PBP5
shares 48% homology with E. coli PBP6.
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Amidases
The periplasmic amidases remove the amino acid chain from the muramyl moieties
of the sacculus as well as from the recycling by-products such as GlcNAc-anhMurNAc
peptides (Van Heijenoort & Van Heijenoort, 1971, van Heijenoort, et al., 1975, Tomioka,
et al., 1983, Priyadarshini, et al., 2007, Uehara & Park, 2007). E. coli expresses four
periplasmic enzymes amiA, amiB, amiC, and amiD that have N-acetylmuramyl-L-alanine
amidase activity (Tomioka, et al., 1983, Tsui, et al., 1994, Heidrich, et al., 2001). AmiA,
AmiB, and AmiC have a high sequence homology and assist in cell separation during
division (Heidrich, et al., 2001). Loss of these three amidases affected septal formation
resulting in a chaining phenotype with aggregates of three to six cells (Heidrich, et al.,
2002, Priyadarshini, et al., 2007). The activity of these three enzymes is regulated
spatiotemporally by proteins with LytM domains, which have conserved sequences and
are collectively known as dLytM factors (Uehara, et al., 2009). EnvC and NlpD are dLytM
proteins (Uehara, et al., 2009). EnvC belongs to the divisome group of proteins that
participate in cytokinesis and activates AmiA and AmiB, whereas NlpD regulates AmiC
activity (Uehara, et al., 2010). AmiD is tethered to the outer membrane and does not
contribute to cell separation, and its loss has no effect on the cell-wall morphology
(Uehara & Park, 2007, Mercier, et al., 2010). AmiD cleaves at both N-acetylmuramyl and
1, 6 anhydro-N-acetylmuramyl peptides and plays a critical role in generating fragments
for recycling (Priyadarshini, et al., 2007, Uehara & Park, 2007, van Heijenoort, 2011).
The loss of amiD resulted in an accumulation of GlcNAc-anhMurNAc tri- and
tetrapeptides (Uehara & Park, 2007).
P. aeruginosa has homologs of periplasmic AmiA (PA5538) and AmiB (PA4947).
Both these proteins share homology with their E. coli counterparts and have Nacetylmuramyl-L-alanine amidase activity (Scheurwater, et al., 2007). Deletion of amiA
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exhibited no significant effect on P. aeruginosa cell viability or morphology (Yakhnina, et
al., 2015). AmiB (PA4947) in contrast to E. coli AmiB was found to be essential for P.
aeruginosa survival (Yakhnina, et al., 2015). P. aeruginosa AmiB is required for cell
separation during division, as depletion resulted in filamentous growth with a marked
deficiency in the invagination of the inner membrane. Additionally, AmiB depletion
decreased outer membrane impermeability for which the mechanism is unclear
(Yakhnina, et al., 2015). P. aeruginosa AmiB requires the presence of additional
activator dLytM proteins such as NlpD, NlpS, and EnvC (Yakhnina, et al., 2015).
P. aeruginosa also has two periplasmic amidases AmpDh2 (PA5485) and AmpDh3
(PA0807) that play a critical role in cell-wall recycling (Juan, et al., 2006). Both enzymes
have significant homology with E. coli AmiD (Table 2). AmpDh2, akin to AmiD is
anchored to the outer membrane (Uehara & Park, 2007, Martinez-Caballero, et al.,
2013). Both AmpDh2 and AmpDh3 process the peptide chain on the polymeric murein
sacculus as well as 1, 6 anhydromuramyl peptides generated through the activities of
lytic transglycosylases (Zhang, et al., 2013). The preferred substrate, however, for both
these amidases is the murein sacculus (Zhang, et al., 2013). Comparing the activity
between these two amidases, AmpDh3 has a higher specific activity on the murein
sacculus (Lee, et al., 2013, Martinez-Caballero, et al., 2013, Zhang, et al., 2013). Crystal
structures and catalytic activities of all the P. aeruginosa cell-wall recycling amidases
have been reviewed elsewhere (Rivera, et al., 2016).

Inner membrane
The muropeptides that are generated by the periplasmic enzymes are transported
into the cytoplasm via the inner membrane proteins which play an indispensable role in
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the recycling process. The inner membrane AmpG permease facilitates the diffusion of
muropeptides from the periplasm into the cytoplasm (Park, 1993, Jacobs, et al., 1994)
(Figure 1.2). The ampG gene was first identified in Enterobacter cloacae (Werner, et al.,
1985). Since then, it has been found in other members of Enterobacteriaceae
including C. freundii, Serratia marcescens, and Salmonella sp. The earliest indications
that AmpG may be the primary permease in cell-wall recycling came from Normark’s lab
during the investigation of its role in β-lactamase expression (Lindquist, et al., 1993). Its
role as a permease was confirmed when an ampG deletion resulted in the increased
release of muropeptide in the media which was rescued upon complementation in trans
(Jacobs, et al., 1994). The E. coli AmpG transports muropeptides that contain the
disaccharide units GlcNAc-anhMurNAc across the inner membrane into the cytoplasm
(Cheng & Park, 2002). AmpG has 10 transmembrane helices, and ampG is the second
ORF in a two-gene operon which may be post-transcriptionally regulated (Lindquist, et
al., 1993, Chahboune, et al., 2005). Besides AmpG, E. coli also has another unique
permease system, OppBCDF, which complexes with the muropeptide-binding protein
MppA and plays a minor role in PG recycling (Goodell & Higgins, 1987, Park, 1993)
(Figure 1.4).
P. aeruginosa harbors two AmpG homologs, PA4393 (AmpG) and PA4218 (AmpP)
(Table1.2) (Cheng, et al., 2000, Kong, et al., 2010). Both AmpG and AmpP are inner
membrane permeases with 14 and 10 transmembrane helices, respectively (Kong, et al.,
2010). The expression of ampG and ampP is regulated by the transcriptional regulator
AmpR (PA4109) in an inducer (sub-MIC of β-lactam) dependent and independent
manner, respectively (Balasubramanian, et al., 2012). Both ampG and ampP are the
second genes in independent two-gene operons (Kong, et al., 2010). An uptake assay
using fluorophore-conjugated muropeptides demonstrated that P. aeruginosa AmpG
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transports any muropeptides containing GlcNAc-1, 6 anhydroMurNAc (PerleyRobertson, et al., 2016). However, the in vivo role of both the permeases AmpG and
AmpP in muropeptide transport remains to be elucidated. AmpG activity can be inhibited
by the proton gradient uncoupler, carbonyl cyanide m-chlorophenyl hydrazine,
suggesting that its activity is dependent on single proton motive force (Zhang, et al.,
2010).
An alternative route of transfer of GlcNAc into the cytoplasm using NagE exists for
both E. coli and P. aeruginosa (Plumbridge, 2009). The NagE phosphotransferase
phosphorylates and imports GlcNAc into the cytoplasm, adding to the cytoplasmic pool
of GlcNAc-6-P (Plumbridge, 2009). In E. coli, the absence of nagE resulted in a
decrease of 50% of GlcNAc-6-P in the cytoplasm (Plumbridge, 2009). Whether this
phosphotransferase plays a prominent role in cell-wall recycling in P. aeruginosa is yet
to be explored. However, P. aeruginosa nagE (PA3761) mutants cannot grow using
GlcNAc as the sole carbon source, suggesting a significant role for NagE in GlcNAc
uptake (Korgaonkar & Whiteley, 2011). In E. coli, the uptake and metabolism of MurNAc
are mediated by a specific phosphotransferase MurP (Dahl, et al., 2004). This
transporter is required for the growth of this bacterium in the presence of MurNAc as the
sole carbon source (Dahl, et al., 2004). MurP has not been identified in P. aeruginosa.

Table 1. 2. List of genes involved in cell-wall recycling
Genes
Proteins
E. coli

Protein Homology (%)

P.
aeruginosa

Identity¥

Similarity¥

PA5045

41

58

PA4700

38

56

Functional
Annotation

Periplasm
PBP1a
PBP1b

ponA/
mrcA
ponB/
mrcB

37

Transglycosylase
and transpeptidase
Transglycosylase
and transpeptidase

PBP4

dacB

PA3047

26

40

PBP5

dacA

PA3999

46

62

PBP6

dacC

PA3999

46

65

PBP6b

dacD

NF

-

-

PBP7

pbpG

PA0869

63

75

Slt70

sltY/slt7
0

PA3020

32

47

MltA

mltA

PA1222

30

44

MltB

mltB

PA4444

66

78

SltB1

NF

PA4001

-

-

MltC

mltC

PA3020

13

20

MltD

mltD

PA1812

33

50

MltF

mltF

PA3764

33

50

MltE

mltE

NF

-

-

RlpA

rlpA

PA4000

27

40

SltG

NF

PA1171

-

-

MltF2

NF

PA2865

-

-

SltH

NF

PA3992

-

-

AmiA

amiA

PA5538

28

40

AmiB

amiB

PA4947

34

47

AmiC

amiC

PA5538

40

56

AmiC

amiC

PA4947

35

47

AmiD

amiD

PA5485

41

56

38

D-alanyl-D-alanine
carboxypeptidase
and endopeptidase
D-alanyl-D-alanine
carboxypeptidase
D-alanyl-D-alanine
carboxypeptidase
D-alanyl-D-alanine
carboxypeptidase
D-alanyl-D-alanine
carboxypeptidase
and endopeptidase
Lytic
transglycosylase
Lytic
transglycosylase
Membrane-bound
lytic murein
transglycosylase B
Soluble lytic
transglycosylase B
Lytic
transglycosylase
Lytic
transglycosylase
Lytic
transglycosylase
Lytic
transglycosylase
Septal ring protein,
transglycolytic activity
Lytic
transglycosylase
Lytic
transglycosylase
Lytic
transglycosylase
N-acetylmuramoyl-Lalanine amidase
N-acetylmuramoyl-Lalanine amidase
N-acetylmuramoyl-Lalanine amidase
N-acetylmuramoyl-Lalanine amidase
N-acetylmuramoyl-Lalanine amidase
activity

AmiD

amiD

PA0807

39

50

BglX

bglX

PA1726

62

79

FlgJ

flgJ

PA1085

31

46

N-acetylmuramoyl-Lalanine amidase
activity
Beta-glucosidase
Flagellum-specific
glucosaminidase

Inner membrane
AmpG

ampG

PA4393

22

35

AmpG

ampP

PA4218

22

35

OppB

oppB

PA4503

35

56

OppC

oppC

PA1808

24

41

OppC

oppC

PA2060

23

42

OppD

oppD

NF

-

-

OppF

oppF

NF

-

-

MppA

mppA

NF

-

-

MurP

murP

NF

-

-

NagE

nagE

PA3761

41

55

NagZ

nagZ

PA3005

50

63

AmpD

ampD

PA4522

57

69

LdcA

ldcA

PA5198

29

40

AnmK

anmK

PA0666

49

64

MurQ

murQ

NF

-

-

AmgK
MupP

NF
NF

PA0596
PA3172

-

-

MurU

NF

PA0597

-

-

NagA

nagA

PA3758

30

47

Muropeptide
permease
Putative muropeptide
permease
Muropeptide
transporter
Muropeptide
transporter
Muropeptide
transporter
Muropeptide
transporter
Muropeptide
transporter
Periplasmic binding
component of
muropeptide- Opp
transporter
Anhydro-Nacetylmuramic acid
permease
N-acetylglucosamine
phosphotransferase

Cytoplasm

39

β-N-acetyl-Dglucosaminidase
N-acetylmuramyl-Lalanine amidase
L, Dcarboxypeptidase
Anhydro-Nacetylmuramic acid
kinase
MurNAc-6-P
etherase
MurNAc kinase
Phosphatase
Nucleotidyltransferas
e
GlcNAc and
anhMurNAc

Mpl
NagB

mpl
nagB

PA4020
NF

59
-

72
-

deactylase
Murein peptide ligase
Deaminase

The data is compiled from EcoCyc and Pseudomonas Genome database website
(Keseler, et al., 2009, Winsor, et al., 2016).
¥
The value for protein sequence identity and similarity of E. coli and P. aeruginosa
was obtained using ClustalW2 “pairwise sequence alignments”.
NF: Not Found

Cytoplasm
Once in the cytoplasm, the muropeptides are processed by various enzymes to form
Lipid II composed of UDP-GlcNAcMurNac pentapeptide attached to a hydrophobic
undecaprenol-pyrophosphate group (Mengin-Lecreulx, et al., 1991, Bouhss, et al.,
2004). Lipid II is flipped across the cytoplasmic membrane into the periplasmic space,
where GlcNAcMurNac pentapeptide is reincorporated into the growing cell-wall. There
is an overlap between the enzymes mediating these reactions in E. coli and P.
aeruginosa; however, certain enzymes remain unique to each bacterial system. These
enzymes are detailed below.

NagZ
In the cytoplasm, the β-N-acetylglucosaminidase NagZ processes the muropeptides
(Yem & Wu, 1976) (Figure1. 4). The enzymatic activity of NagZ was first identified in E.
coli K-12 mutant strains which showed a deficiency in β-N-acetylglucosaminidase (Yem
& Wu, 1976). The mutation was mapped to ycfO that was renamed as nagZ following
functional characterization of the protein (Yem & Wu, 1976, Yem & Wu, 1976, Hrebenda,
1979). NagZ cleaves the bond between GlcNAc and 1,6 anhydroMurNAc, leading to the
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formation of independent units of GlcNAc, and 1,6 anhMurNAc-peptide (Yem & Wu,
1976). Deletion of the nagZ gene results in the accumulation of GlcNAc-anhMurNAc
peptides (Yem & Wu, 1976, Votsch & Templin, 2000). Bioinformatics analyses of nagZ
sequences led to its identification in numerous Gram-negative pathogens such as
Klebsiella pneumonia, Vibrio cholera, P. aeruginosa, Haemophilus influenza, and
Bordetella pertussis among others (Cheng, et al., 2000).
P. aeruginosa nagZ (PA3005) is predicted as the first gene in a two-gene operon
along with PA3004, which encodes a phosphorylase. Similar to E. coli, NagZ (PA3005)
was demonstrated to act as a β-N-acetylglucosaminidase (Stubbs, et al., 2008). Crystal
structures of NagZ were solved along with its ligand. Using X-ray structures and
molecular dynamics simulation, the enzymatic details of NagZ activity was elucidated
(Acebron, et al., 2017). Most of the studies with NagZ (PA3005) have been done on its
role in regulating antibiotic resistance which will be discussed in the following sections.

AmpD and LdcA
E. coli AmpD cleaves the peptide chain exclusively attached to the 1, 6
anhydromuramyl moieties (Holtje, et al., 1994, Jacobs, et al., 1995). The first indication
that this gene may play a critical role in cell-wall recycling stemmed from observations of
its influence on β-lactamase induction (Tuomanen, et al., 1991). Its specific role as an
amidase in recycling was confirmed when it was noticed that the loss of ampD resulted
in the accumulation of GlcNAc-anhMurNAc with peptide chains (Holtje, et al., 1994,
Jacobs, et al., 1995). Subsequently, a major increase of anhydromuramyl tripeptides in
ampD deficient E. coli cells led to the identification of an LD-carboxypeptidase LdcA
(Templin, et al., 1999). This enzyme removes the terminal D-alanine from the muramyl-
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tetrapeptides, thereby creating the tripeptides (Templin, et al., 1999). To this tripeptide,
MurF attaches a dipeptide D-alanyl-D-alanine (D-Ala-D-Ala) forming a pentapeptide that
participates in cross-linking (Uehara & Park, 2007). The loss of ldcA results in the
formation of GlcNAc-MurNAc-tetrapeptides as the donor muropeptide, which is
incapable of cross-linking as it does not contain the terminal D-Ala-D-Ala moiety. This
deficient PG backbone eventually leads to cell lysis during the stationary phase of
growth (Templin, et al., 1999).
P. aeruginosa also harbors an AmpD homolog (PA4522) (Table 1.2). The enzymatic
activity of purified P. aeruginosa AmpD was demonstrated using synthetic muramyl and
1, 6 anhydromuramyl derivatives (Zhang, et al., 2013). AmpD activity was higher with the
1, 6 anhydromuropeptides as substrates as opposed to the muramyl derivatives (Zhang,
et al., 2013, Rivera, et al., 2016). The cytoplasmic LD-carboxypeptidase in P. aeruginosa
(PA5198) was also identified as a functional equivalent of E. coli LdcA (Korza &
Bochtler, 2005).
In the final steps of recycling processes, the PG sugars, GlcNAc, MurNAc,
anhMurNAc, and the PG peptides L-Ala-ɣ-D-Glu-meso-DAP-D-Ala-D-Ala rejoin the PG
biosynthesis pathway in the cytoplasm.

1.5.5 Convergence of recycling and biosynthesis
The recovery of PG intermediates and its convergence into the biosynthesis pathway
is a widely conserved process in bacteria and demonstrates their efficiency in preserving
critical energy resources. The muropeptides generated in the cytoplasm through the
activities of NagZ, AmpD, and LdcA rejoin the biosynthesis pathway through the
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sequential activity of AnmK, MurQ, NagA, and NagB in E. coli (White & Pasternak, 1967,
Calcagno, et al., 1984, Uehara, et al., 2005, Uehara, et al., 2006) (Figure 1.4).
In E. coli, AnmK kinase phosphorylates anhMurNAc to MurNAc-6-P which is
processed by MurQ etherase to form GlcNAc-6-P (Uehara, et al., 2005). GlcNAc
generated in the cytoplasm after the NagZ activity is phosphorylated to GlcNAc-6-P by
NagK (Uehara & Park, 2004). NagA deacetylates GlcNAc-6-P to GlcN-6-P (Park, 2001,
Uehara, et al., 2006). GlcN-6-P undergoes deamination by NagB to form fructose-6phosphate, the initial substrate for glycolysis, PG and lipopolysaccharide synthesis
(Calcagno, et al., 1984). GlcN-6-P can also be converted to GlcN α-1P by GlmM which is
an intermediate in the PG synthesis pathway (Mengin-Lecreulx & van Heijenoort, 1996)
(Figure 1.4).
The set of enzymes for the reutilization of the PG sugars GlcNAc and MurNAc differ
among P. aeruginosa and E. coli (Figure 1.4). In P. aeruginosa, an AnmK homolog
PA0666 phosphorylates anhMurNAc to form MurNAc-6-P; subsequently, the phosphate
is removed by MupP (PA3172) resulting in MurNAc (Bacik, et al., 2011, Borisova, et al.,
2014, Borisova, et al., 2017, Fumeaux & Bernhardt, 2017). MurNAc is further processed
by two enzymes AmgK (PA0596)

and MurU (PA0597) unique to Pseudomonads

encoded in the same operon (Gisin, et al., 2013). AmgK (PA0596) converts MurNAc to
MurNAc α-1P (Borisova, et al., 2014). A uridylyltransferase MurU (PA0597) acts on
MurNAc α- 1P to form UDP-MurNAc (Gisin, et al., 2013). The presence of these two
proteins bypasses the need for MurQ, NagA (PA3758), NagB, NagK, GlmM (PA4749)
and GlmS (PA5549) that are otherwise required for the synthesis of UDP-MurNAc in E.
coli (Figure 1.4). This novel alternate pathway was identified in P. aeruginosa and P.
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putida (Gisin, et al., 2013, Borisova, et al., 2014). Homologs of AmgK and MurU have
been identified in Proteobacteria but not in Enterobacteria (Borisova, et al., 2014).
AmpD amidase cleaves the peptide side chain from UDP-MurNAc resulting in the
formation of free tri-, tetra-, and pentapeptides (L-Ala-ɣ-D-Glu-meso-DAP-D-Ala-D-Ala)
(Holtje, et al., 1994). LdcA carboxypeptidase cleaves the terminal D-alanine from a
tetrapeptide resulting in tripeptides (Templin, et al., 1999). In E. coli, murein peptide
ligase (Mpl) recycles the tri-, tetra- and pentapeptides by ligating them to UDP-MurNAc
formed in the PG biosynthesis pathway (Mengin-Lecreulx, et al., 1996, Herve, et al.,
2007). Another enzyme, MurF can also ligate dipeptide D-Ala-D-Ala formed by an ATPdependent ligase Ddl, to a UDP-MurNAc tripeptide to form UDP-MurNAc pentapeptide
(Duncan, et al., 1990, Zawadzke, et al., 1991, al-Bar, et al., 1992). Homologs of Mpl
(PA4020) and MurF (PA4416) and Ddl (PA4201/PA4410) are found in P. aeruginosa;
however, their role in cell-wall recycling has not been elucidated.
The tripeptide, L-Ala-ɣ-D-Glu-m-DAP, can be broken down into individual amino
acids. The E. coli MpaA amidase removes the meso-DAP from L-Ala-D-Glu (Uehara &
Park, 2003). E. coli YcjG epimerizes D-glutamate to L-glutamate forming L-Ala-L-Glu,
which is hydrolyzed to individual amino acids by PepD (Schroeder, et al., 1994, Schmidt,
et al., 2001). This pathway of amino acid degradation has not been studied in P.
aeruginosa and bioinformatics analyses of the protein sequences of MpaA, YcjG, and
PepD revealed no homologs in the P. aeruginosa PAO1 strain.
1.6 Cell-wall recycling and antibiotic resistance
Resistance is a distinctive quality of pathogens that have ensured the long tug of war
between the discovery of novel antibiotics and bacterial survival. Antibiotics act at
several checkpoints in the bacterial life cycle such as DNA replication, RNA, protein
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synthesis and activity as well as cell-wall biogenesis and recycling (Kohanski, et al.,
2010). Being unique to bacteria, cell-wall synthesis and recycling are often the targets
for many widely-used antibiotics such as β-lactams, fosfomycin, and glycopeptides
(Bush, 2012). Consequently, the components of cell-wall recycling process play a key
role in the development of resistance to the targeting antibiotics. Through a complex
network of regulators, some of the cell-wall recycling components are also involved in
the elaboration of cross-resistance to other classes of

antibiotics such as

fluoroquinolones, aminoglycosides, and macrolides (Kumari, et al., 2014). Here, we
describe the role of cell-wall components in promoting antibiotic resistance in Gramnegative bacteria, focusing on P. aeruginosa.

1.6.1 β-Lactam resistance involving Amp pathway
β-lactams are the one of the earliest discovered and most commonly administered
antibiotics worldwide. The β-lactams act by disrupting the cell-wall synthesis in bacteria
(Tipper & Strominger, 1965). Specifically, β-lactam antibiotics mimic the terminal D-AlaD-Ala residues of the amino acid side chains that serve as the substrates for the
transpeptidase domains of HMM PBP’s such as PBP1A, PBP1B, PBP2 and PBP3,
locking them into an inactive state, thereby preventing PG cross-linking leading to cell
lysis and death (Tipper & Strominger, 1965, Zemelman, et al., 1987). Thus, it is not
surprising that with the intracellular activation of ampC, encoding a β-lactamase, the
expression is tightly coordinated with the cell-wall recycling process in Gram-negative
bacteria (Wiedemann, et al., 1998, Zeng & Lin, 2013). The AmpR-AmpC system has
been investigated thoroughly in Enterobacteriaceae. In many members of the
Enterobacteriaceae, the induction of ampC expression in response to β-lactam
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antibiotics is triggered through the activation of a transcriptional regulator AmpR by the
cell-wall degradation products (Lindberg & Normark, 1987, Lindquist, et al., 1989, Tolg,
et al., 1993, Wiedemann, et al., 1998, Dik, et al., 2017). The induction of ampC by AmpR
also requires the products of ampG, ampD, ampDh2, ampDh3, and nagZ, all of which
are involved in PG recycling, as described in previous sections. Studies from the Mathee
lab suggest that the AmpR-AmpC (PA4109-PA4110) system might operate differently in
P. aeruginosa (Balasubramanian, et al., 2015). Expression of the genes ampG, ampP,
ampD, ampDh2, ampDh3, and nagZ in P. aeruginosa are differentially regulated by
AmpR in the presence and absence of β-lactam (Balasubramanian, et al., 2012). AmpG
is the permease that transports PG degradation products from the periplasm to
cytoplasm. In Enterobacteriaceae members, an ampG mutant is unable to recycle PG
and loses the ability to induce ampC expression (Korfmann & Sanders, 1989, Jacobs, et
al., 1994) (Table 1.3). Inactivation of ampG can restore susceptibility to β-lactams even
in pan-resistant P. aeruginosa clinical isolates (Zamorano, et al., 2011). P. aeruginosa
also has an additional AmpG homolog known as AmpP (PA4218), both of which are
presumed to be involved in ampC induction (Kong, et al., 2010, Zhang, et al., 2010).
The AmpD amidase was identified as being important for β-lactamase induction in C.
freundii and Enterobacter cloacae (Lindquist, et al., 1989). The absence of ampD leads
to the accumulation of anhMurNAc-tripeptide in the cytosol and constitutive
overproduction of β-lactamase even in the absence of induction, resulting in a high
resistance to β-lactams (Jacobs, et al., 1995). The most common mechanism for
constitutive ampC overexpression in clinical strains leading to β-lactam resistance in
Enterobacteriaceae, as well as P. aeruginosa, is to mutate ampD (Langaee, et al., 2000,
Juan, et al., 2005, Kaneko, et al., 2005, Babouee Flury, et al., 2016) (Table 1.3). P.
aeruginosa has three different AmpD homologs, AmpD (PA4522), AmpDh2 (PA5485),
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and AmpDh3 (PA0807) that are responsible for de-repression of ampC expression in a
step-wise manner (Juan, et al., 2006, Schmidtke & Hanson, 2008). Deletion of all three
ampD genes results in increased resistance due to complete de-repression of ampC
expression resulting in very high MIC for the β-lactams drugs including cephalosporins
and monobactams (Juan, et al., 2006, Moya, et al., 2008).
NagZ is a β-N-acetylglucosaminidase that removes GlcNAc to generate the 1, 6anhydromuropeptides, the putative activators of AmpR that are required for the induction
of ampC (Asgarali, et al., 2009). Mutations in nagZ result in low levels of ampC
expression that enhances the susceptibility to β-lactam antibiotics (Asgarali, et al., 2009,
Zamorano, et al., 2010). Deletion of nagZ also reversed the resistance due to ampC
hyper-expression in ampD and dacB mutants (Zamorano, et al., 2010). Based upon
these findings, to increase the bacterial susceptibility to β-lactams, small molecule
inhibitors gluco-nagstatin, LOGNAc, and PUGNAc which are analogous to the NagZ
substrates that have oxocarbenium-like transition states have been synthesized (Figure
1.5) (Stubbs, et al., 2007, Mondon, et al., 2013). Among the three, PUGNAc was the
most potent inhibitor of β-N-acetylglucosaminidase (Horsch, et al., 1991). However, all
three were found to inhibit human glucosaminidases rendering them less useful (Stubbs,
et al., 2007).
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Figure 1.5. Small molecule inhibitors of N-acetyl-β-glucosaminidase NagZ. (a) O(2-Acetamido-2-deoxy-D-gucopyranosylidene) amino N-phenylcarbamate (PUGNAc) (b)
1, N-acetylglucosaminono-1,5-lactone oxime (LOGNAc) (c) gluco analogue of 8acetamido-5,6,7,8-tetrahydro-6,7-dihydroxy-5-(hydroxymethyl)imidazo[1,2-a] pyridine-2acetic acid nagstatin (gluco-Nagstatin) (d) Transition state of NagZ substrate analogous
to the small molecule inhibitors (Horsch, et al., 1991, Stubbs, et al., 2007).
Table 1.3. MIC of mutant strains of P. aeruginosa
Strains
PAO1
dacB*
dacC*
pbpG*
ampC*
dacB
ampC*
dacC
ampC*
pbpG
ampC*
dacB
dacC *
dacB

AMP
1024
1024
1536
512
32

PIP
3.2
16
4
4
2

CTX
7
256
8
16
8

32

2

8

MIC (μg/mL)
CAZ CEF FOX ATM
1.4
1.53 1024 10.4
8
4
1024
8
1
0.5 1024
2
1
1
1024
4
1
1
64
4
1

0.5

96

4

IMI
1.2
1
0.5
1
0.12

MER
0.41
0.5
0.5
0.5
0.25

0.12

0.25

16

2

4

0.75

0.5

64

2

0.06

0.25

32

4

8

1

0.5

96

3

0.12

0.25

1024

128

512

16

4

1024

16

0.5

0.5

16

2

4

1

0.5

64

2

0.06

0.12

48

References

(Ropy, et
al., 2015)

dacC
ampC*
dacB
pbpG*
dacB
pbpG
ampC*
dacC
pbpG*
dacC
pbpG
ampC*
sltB1^
mltB^
slt^
mltF^
sltB1
ampC^
mltB
ampC^
sltB1
dacB^
mltB
dacB^
mltB
sltB1^

2048

16

256

8

4

1024

8

0.5

0.25

32

2

6

0.75

0.5

64

2

0.12

0.5

1024

6

8

1

0.5

1024

2

0.5

0.25

24

3

4

0.75

0.5

64

3

0.06

0.25

nd
nd
nd
nd

12
8
1.5
2

16
12
6
6

1
1.5
0.19
0.38

nd
nd
nd
nd

nd
nd
nd
nd

nd
nd
nd
nd

0.75
1.5
1
1

nd
nd
nd
nd

nd

1.5

2

0.5

nd

nd

nd

0.25

nd

nd

6

8

1

nd

nd

nd

0.38

nd

nd

>25
6

>256

24

nd

nd

nd

1

nd

nd

192

>256

16

nd

nd

nd

1.5

nd

nd

24

64

2

nd

nd

nd

1

nd

ampG*

32

nd

8

1

nd

nd

nd

nd

nd

ampD^
ampDh2
^
ampDh3
^

nd

nd

nd

8

4

nd

6

2

1

nd

nd

nd

0.75

1

nd

1

1

0.38

nd

nd

nd

1

1

nd

nd

1

0.38

ampR^

12

1.5

nd

1

1

nd

0.75

0.38

1.5

poxA^
poxB^
ampC
poxB^
nagZ^
creD*
creD
nagZ*
dacB

256
256

4
4

6
6

1.5
1.5

1.25
1

nd
nd

2
2

1.25
1.5

24

4

6

1.5

1

nd

3

0.44

nd
nd

nd
nd

nd
nd

1
8

1.5
4

nd
nd

4
12

1
2

0.44
0.38
0.31
5
0.38
1

nd

nd

nd

2

1.5

nd

4

1

0.38

nd

nd

nd

1.5

2

nd

4

1

0.38
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(Cavallari,
et al., 2013)

(Zhang, et
al., 2010)
(Juan, et al.,
2006)
(Balasubra
manian, et
al., 2012)
(Zincke, et
al., 2015)

(Zamorano,
et al., 2011)

nagZ*
creD
dacB*
creD
dacB
nagZ*

nd

nd

nd

96

48

nd

24

2

0.5

nd

nd

nd

4

3

nd

4

1

0.5

Table 1. 3. MIC levels of PAO1 and the corresponding deletion strains are indicated in
the left. The MIC values of PAO1, shown in yellow, is an average of values as found in
the cited references. Any values greater than PAO1 are shown in gradation of orangered. Values lower than PAO1 shown in gradations of yellow- green.
AMP, Ampicillin; PIP, Piperacillin; CTX, Cefotaxime; CAZ, Ceftazidime; CEF, Cefepime;
FOX, Cefoxitin; ATM, Aztreonam; IMI, Imipenem; MER, Meropenem.
*MIC determined by broth microdilution
^MIC determined by E-test
nd: not determined.

Details of PG recycling and their ties with β-lactam resistance have been studied in
Enterobacteriaceae members. The role of many orthologous proteins including AmpR,
AmpC, AmpD, and AmpG have been demonstrated in P. aeruginosa and appear to have
similar roles to their Enterobacteriaceae counterparts (Langaee, et al., 2000, Kong, et
al., 2010, Johnson, et al., 2013). In addition, new players such as ampP, ampDh2, and
ampDh3 have been identified in P. aeruginosa (Juan, et al., 2006, Kong, et al., 2010).
Moreover, the localization of P. aeruginosa AmpR as an inner membrane protein with
the helix-turn-helix domain in the cytoplasm and effector-binding domain in the periplasm
leads to unique questions as to how the effector molecules are transported to their
binding sites on AmpR (Caille, et al., 2014).
1.6.2 β-Lactam resistance through other cell-wall-related genes
Other members involved in cell-wall recycling, namely, the LTs and the LMM PBPs
also modulate β-lactam resistance. The periplasmic LTs are the major PG degradative
enzymes that generate 1, 6-anhydro-MurNAc muropeptides (Lee, et al., 2013). In E. coli,
a double deletion of LT encoding genes mltA-mltB, slt70-mltA or slt70-mltB and a triple
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deletion mltA-mltB-slt70 exhibit a higher loss in β-lactamase activities than any one
single deletion that correlates with the increasing decline in murein turnover (Kraft, et al.,
1999). In P. aeruginosa, the loss of Slt and MltF is associated with a decrease in βlactam resistance (Cavallari, et al., 2013). However, the loss of SltB1 and MltB led to an
AmpC-independent increase in resistance to β-lactams, piperacillin, and cefotaxime
(Cavallari, et al., 2013, Lamers, et al., 2015). The loss of the other P. aeruginosa LTs’
MltA, MltD, MltF2, SltG, and SltH did not change the resistance profile (Cavallari, et al.,
2013)
The LMM PBPs comprise a group of enzymes that have endopeptidase and
carboxypeptidase activity (Sauvage, et al., 2008). Three of the five LMM PBPs (PBP4,
PBP5, PBP6, PBP6b, PBP7/8) were investigated for their role in β-lactam resistance in
E. coli (Sarkar, et al., 2010, Sarkar, et al., 2011). Loss of PBP5 reduces the MIC for
penicillins and cephalosporins whereas PBP6 and PBP6b removal have no resistance
phenotype (Sarkar, et al., 2010). However, the lower MIC in PBP5 mutants can be
partially restored by PBP6B. This suggests that PBP5 is important for β-lactam
resistance followed by PBP6b (Sarkar, et al., 2011). However, the role of PBP4, PBP6,
and PBP7/8 in antibiotic resistance is not well understood.
P. aeruginosa has three LMM PBPs (PBP4, PBP5, and PBP7) whose role in βlactam resistance has been investigated (Moya, et al., 2009, Ropy, et al., 2015). Clinical
mutants of PBP4 (PA3047) are associated with increased β-lactam resistance (Moya, et
al., 2009). In fact, a mutation in PBP4 leads to a one step upregulation of ampC resulting
in clinical β-lactam resistance (Moya, et al., 2009). Similar to PBP6b in E. coli, the role of
PBP5 is not evident, unless in the PBP4 background where the double mutant further
increases β-lactam resistance (Table 3).
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Interestingly, the PBPs in E. coli and P. aeruginosa play contradicting roles in βlactam resistance. This may be reflective of the different mechanism of resistance, as E.
coli has a non-inducible ampC (Honore, et al., 1989). One speculation is that E. coli
PBP5 could act as a “trap” for β-lactams thereby preventing access to their targets, the
HMM PBPs whereas in P. aeruginosa loss of PBP4 results in increased production of
the AmpR effector which escalates ampC β-lactamase expression and thereby the MIC
(Moya, et al., 2009, Sarkar, et al., 2010, Moya, et al., 2012, Lee, et al., 2015).

1.6.3 Indirect regulation of β-lactam resistance through AmpR
Although P. aeruginosa AmpR acts as the nexus for AmpC β-lactamase induction
and cell-wall recycling processes, it also modulates the activity of other proteins that
regulate β-lactam resistance. One of these is the second chromosomally encoded βlactamase, PoxB (PA5514) in P. aeruginosa (Kong, et al., 2005). PoxB is a
carbapenemase, which affects β-lactam resistance, in the absence of the major βlactamase AmpC and outer membrane porin OprD (Zincke, et al., 2015). Although no
direct relation is seen between cell-wall recycling and poxB, AmpR is found to be a
negative regulator of poxB through a yet unknown mechanism (Kong, et al., 2005,
Zincke, et al., 2015).
Another mechanism of β-lactam resistance is through expulsion via efflux pumps
namely MexAB-OprM (Poole, et al., 1993). Expression of mexAB is repressed by a
regulator MexR (Poole, et al., 1996). AmpR is required for mexR expression, suggesting
an opposite impact on β-lactam resistance (Balasubramanian, et al., 2012). Moreover,
deleting ampC and or ampR in PAO1 abolishes β-lactam resistance despite having a
functional MexAB system or PoxB, suggesting that the AmpC is the major determinant of
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β-lactam resistance (Balasubramanian, et al., 2012, Kumari, et al., 2014, Zincke, et al.,
2015).
Another mechanism of β-lactamase induction is mediated through the twocomponent system CreBC and its effector, an inner membrane protein CreD (Moya, et
al., 2009). In E. coli, CreB has been identified as a transcriptional factor that differentially
regulates up to eight genes under diverse nutritional conditions (Avison, et al., 2001). E.
coli CreB was also found to regulate the expression of Aeromonas hydrophila βlactamase (Avison, et al., 2004). This two-component system in P. aeruginosa plays a
pivotal role in β-lactam resistance and bacterial fitness (Zamorano, et al., 2010,
Zamorano, et al., 2014). The inactivation of dacB (PBP4) leads to an increased
expression of creBC, creD, and ampC. The increased expression of ampC is
accompanied by elevated MIC of β-lactams, which reverts to wild-type levels upon
deletion of creBC (Zamorano, et al., 2014). The association of creBC and β-lactam
resistance was seen only in dacB mutants and not with other mutations that confer high
resistance namely, ampD, ampDh2 and ampDh3 (Moya, et al., 2009). Moreover, these
resistance phenotypes regulated through creBC were lost in the absence of NagZ and
AmpG (Moya, et al., 2009, Zamorano, et al., 2010, Zamorano, et al., 2014) (Table 3).
Although the interplay of the cell-wall recycling components, ampC expression, and the
creBC-creD system is found to regulate β-lactam resistance, the underlying details
remain to be elucidated.

1.6.4 Cell-wall components contributing to non-β-lactam resistance
In addition to the various mechanisms by which the different components involved in
PG biosynthesis and recycling confer β-lactam resistance, some cell-wall components
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acting through AmpR also play a role in resistance to non-β-lactam antibiotics (Kumari,
et al., 2014). Some specific examples are discussed below.

Fluoroquinolone resistance
Quinolones, specifically fluoroquinolones, are potent, broad-spectrum synthetic
antibiotics that inhibit DNA replication by targeting bacterial DNA gyrase (Gramnegatives) or topoisomerase II (Gram-positives) (Drlica, et al., 2008). Due to their
effectiveness against both Gram-positive and Gram-negative bacteria, extensive use of
fluoroquinolones has led to a rapid rise in resistance (Chatterjee, et al., 2016, Dan, et al.,
2016, Bader, et al., 2017). Development of resistance to quinolones entails multiple
mechanisms (Hernandez, et al., 2011, Hooper & Jacoby, 2015). The primary mechanism
of quinolone resistance in Gram-negative bacteria is through mutations in target genes
gyrA and gyrB (Yamagishi, et al., 1981, Yamagishi, et al., 1986, Nakamura, et al., 1989,
Drlica & Zhao, 1997). Overexpression of MDR efflux pumps can also add significantly to
the quinolone resistance especially in the presence of target mutations (Poole, 2000).
Unexpectedly for synthetic antibiotics, horizontal gene transfer also plays role in
quinolone resistance. A plasmid-mediated resistance gene qnr encoding a pentapeptide
repeat protein protects the bacterial topoisomerases (gyrase and topoisomerase IV)
from quinolone activity (Tran & Jacoby, 2002, Robicsek, et al., 2006).
In P. aeruginosa, the MexEF-OprN system is involved in efflux of fluoroquinolones,
chloramphenicol, and trimethoprim (Kohler, et al., 1997). This efflux system is under the
control of three different regulators; the positive regulator MexT, and the negative
regulators MexS and MvaT (Kohler, et al., 1999, Westfall, et al., 2006, Uwate, et al.,
2013). P. aeruginosa AmpR negatively regulates the expression of the mexEF-oprN

54

operon and MexT (Balasubramanian, et al., 2012). Consequently, PAOΔampR mutants
are more resistant to fluoroquinolones compared to the wild type (Balasubramanian, et
al., 2012). Repression of the mexEF operon by AmpR is β-lactam independent
(Balasubramanian, et al., 2012), suggesting that AmpR functions diversified from the
cell-wall synthesis pathway. It is important to note that AmpR positively and negatively
regulates resistance to β-lactams and quinolones, respectively, highlighting the intricate
and complex balance of regulation of antibiotic resistance (Balasubramanian, et al.,
2012, Balasubramanian, et al., 2015).

Aminoglycosides resistance
Traditionally, the aminoglycoside class of antibiotics is used to treat Gram-negative
infections. They bind to the 16S ribosomal subunit causing it to mistranslate leading to
the synthesis of aberrant proteins (Davies, et al., 1964, Kotra, et al., 2000).
Aminoglycosides, such as tobramycin, along with β-lactams form the first line of P.
aeruginosa treatment for cystic fibrosis patients (Waters & Smyth, 2015). One of the
primary determinants of aminoglycoside resistance in P. aeruginosa and other Gramnegative pathogens are the presence of active efflux pumps (Moore, et al., 1999, Morita,
et al., 2012). The upregulation of the MexXY efflux pump in P. aeruginosa is considered
the

most

common

mechanism

of

aminoglycoside

resistance

(Poole,

2011).

Aminoglycoside resistance can also be conferred by drug modifying enzymes such as
aminoglycoside acetyl-, nucleotidyl-, and phospho-transferases (Lovering, et al., 1987,
Jacoby, et al., 1990, Shaw, et al., 1993, Azucena & Mobashery, 2001, Ramirez &
Tolmasky, 2010). Mutations in aac, aphA1, and aadB that encode the aminoglycoside
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modifying genes have been identified in clinical P. aeruginosa isolates (Kitao, et al.,
2009, Coyne, et al., 2010, Teixeira, et al., 2016).
In the presence of β-lactams, P. aeruginosa AmpR negatively regulates the
expression of

mexX, mexY,

and aph;

the latter

encodes aminoglycoside

phosphotransferse (Kumari, et al., 2014). However, this negative regulation is not
translated into an observable phenotype. On the contrary, loss of ampR increases
aminoglycoside (amikacin and tobramycin) susceptibility in P. aeruginosa suggesting a
positive regulation (Kumari, et al., 2014). Thus, even with an increased expression of
efflux and drug-modifying proteins, the ampR mutants are more susceptible to
aminoglycosides, suggesting the existence of post- translational modifications in this
complex regulatory network.

1.7 Dissertation overview
Pseudomonas aeruginosa and its various aspects of pathogenicity including
antibiotic resistance has been the focus of researchers for many years. Previously our
lab has explored the transcriptional factor AmpR that is known to regulate AmpC
expression. Its role in P. aeruginosa was found to be more diverse and far-reaching
when compared to that in other Gram-negatives such as E. coli and C. freundii
(Balasubramanian, et al., 2015). However, similar to what is found in C. freundii and E.
cloacae, it is that P. aeruginosa AmpR binds with an activating effector generated during
cell-wall recycling under β-lactam stress, which results in induction of AmpC (Vadlamani,
et al., 2015, Dik, et al., 2017). The identity of this effector had not been previously
established in P. aeruginosa. Also, cell-wall recycling has predominantly been studied
only in E. coli.
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In this dissertation, we investigate cell-wall recycling in P. aeruginosa. The structures
of cell-wall recycling products or muropeptides found in P. aeruginosa are described as
well as a method to quantitate muropeptides (Chapter 2). Additionally, we were able to
identify the AmpR effector that is generated under β-lactam induction and binds to AmpR
(Chapter 2). Futhermore, the role of permeases PA4393 and PA4218 in cell-wall
recycling and antibiotic resistance are also investigated (Chapter 3). We also investigate
a putative periplasmic N-acetylglucosaminidase that may play a role in generating the
periplasmic effectors of AmpR (Chapter 4).

Finally, the localization of AmpR is

investigated and given its extensive regulon in P. aeruginosa, it is developed as an
antibacterial target (Chapter 5). A novel phenotypic screening assay that identifies
inhibitors of AmpR is discussed (Chapter 5).
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Chapter 2

Muropeptides in Pseudomonas aeruginosa and their role as elicitors of β-Lactam
antibiotic resistance

This chapter has been published:
Mijoon Lee+, Supurna Dhar+, Stefania De Benedetti, Dusan Hesek, Bill Boggess, Blas
Blzquez, Kalai Mathee, and Shahriar Mobashery
Angew. Chem. Int. Ed. 2016, 55, 1 – 6

+

Authors contributed equally
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2.1. Overview
This chapter is reproduced verbatim from the manuscript published in
Angewandte Chemie International Edition. The supplementary portion of the manuscript
has been integrated in the main text. I performed the murpeptide isolation from wholecell and fractions, the induction experiments with P. aeruginosa PAO1 strains, and the
colony forming unit for muropeptide quantitation. The synthesis of muropeptide
standards was perfomed by Dr. Mijoon Lee and Dr. Dusan Hesek. The LC/MS analysis
was performed by Dr. Mijoon Lee and Dr. Bill Bogess. The induction with mutant strains
of P. aeruginosa was performed by Dr. Blas Blazquez and Dr. Stefania DeBenetti.
2.2 Abstract
Muropeptides are a group of bacterial natural products generated from the cell
wall in the course of its turnover. These compounds are cell-wall recycling intermediates
and are also involved in signaling within the bacterium. However, the identity of these
signaling molecules remains elusive. The identification and characterization of 20
muropeptides from Pseudomonas aeruginosa is described. The least abundant of these
metabolites is present at 100 and the most abundant at 55,000 molecules per bacterium.
Analysis of these muropeptides under conditions of induction of resistance to a b-lactam
antibiotic identified two signaling muropeptides (N-acetylglucosamine-1,6-anhydro-Nacetylmuramyl pentapeptide and 1,6-anhydro-N-acetylmuramyl pentapeptide). Authentic
synthetic samples of these metabolites were shown to activate expression of blactamase in the absence of any β lactam antibiotic, thus indicating that they serve as
chemical signals in this complex biochemical pathway.
Keywords: antibiotic resistance; bacteria; muropeptides; peptidoglycan; β-lactamase
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2.3. Introduction
The cell wall (also known as the sacculus) is a complex macromolecular polymer
that encases the bacterium. Its major constituent is comprised of repeating Nacetylglucosamine (NAG)-N-acetylmuramic acid (NAM), with a pentapeptide stem
attached to the NAM unit (Vollmer, et al., 2008, J. F. Fisher, 2015). Cell wall is critical for
survival of the bacterium, hence, the cell wall and its biosynthetic machinery are targets
of antibiotics (Bush, 2013). Cell wall is synthesized by polymerization of Lipid II, (van
Heijenoort, 2007, Qiao, et al., 2014) resulting in the NAG-NAM backbone, which is
subsequently crosslinked to the neighboring strand through the peptide stem (Figure
2.1). In parallel, degradative processes that turn over segments of the assembled cell
wall also take place (van Heijenoort, 2007, Park & Uehara, 2008). An important event in
this turnover is mediated by a family of enzymes called lytic transglycosylases (LTs),
whose reactions generate a series of natural products referred to collectively as
muropeptides.
The reactions of all eight Escherichia coli LTs have been studied in vitro
(Scheurwater, et al., 2008, van Heijenoort, 2011, Lee, et al., 2013, Yunck, et al.,
2016).These enzymes generate a transient oxocarbenium species (1) at the muramyl
moiety of the peptidoglycan, which results in the cleavage of the β-1,4-glycosidic bond
between a NAM and a NAG (Figure 2.1), giving rise to the 1,6-anhydromuramyl moiety
(2 and 3). Some LTs perform this reaction at the ends of the peptidoglycan, the so called
exolytic reaction, giving rise to the NAG-anhNAM disaccharides (2). Others perform the
reaction in the middle of the peptidoglycan, the endolytic reaction, which gives rise to a
longer backbone for the sugar (3). These released muropeptides are translocated to the
cytoplasm by the permease AmpG (and possibly by AmpP in Pseudomonas aeruginosa)
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(Kong, et al., 2010). Once in the cytoplasm, the muropeptides enter the cell-wall
recycling process, regenerating Lipid II (van Heijenoort, 2007, van Heijenoort, 2011,
Johnson, et al., 2013). Alternatively, other muropeptides are involved in signaling
functions, leading to disparate responses such as antibiotic resistance, virulence, and
inflammation (Boudreau, et al., 2012, Fisher & Mobashery, 2014, Balasubramanian, et

Figure 2.1. Muropeptides in recycling. The reactions of LTs produce
muropeptides containing the 1, 6-anhydromuramyl moiety, which are
translocated by the permease AmpG (and AmpP in P. aeruginosa). In normal
growth of the bacteria, 4 would initiate recycling events to regenerate lipid II.
However, as an offshoot of the recycling events, accumulation of 4 induces βlactamase (AmpC) expression (indicated by red arrows).
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al., 2015). The functions in resistance to β-lactam antibiotics involve binding to the gene
regulator AmpR, which allows for transcription of the gene ampC for the Gram-negative
AmpC β-lactamase (Figure 2. 1) (Jacobs, et al., 1997, Kong, et al., 2005). β-Lactamase
hydrolyzes β-lactams antibiotics, which inhibit the action of penicillin-binding proteins by
mimicking the structure of the terminal d-Ala-d-Ala in the stem peptides of the
peptidoglycan.
The processes that muropeptides mediate are not fully understood due to
impediments such as the minute quantities, rapid metabolic flux, and complexity of the
structures. Once the structures are elucidated, they need to be prepared in the
laboratory for validation of the assigned structure and for the conduct of biochemical
studies. Here, we report the identification, characterization, and quantification of several
muropeptides from periplasm of P. aeruginosa, an opportunistic human pathogen.
2.4. Materials and methods
2.4.1 Strains, media and growth conditions. Pseudomonas aeruginosa PAO1 and P.
aeruginosa Z61 (ATCC 35151) were used in this study. P. aeruginosa was cultured in
Luria Bertani broth (5 g tryptone, 10 g sodium chloride, and 5 g yeast extract per liter)
supplemented with 1.5% agar when needed at 37 °C (Holloway, 1955). The antibiotic
cefoxitin was added when required.
2.4.2 Induction and β-lactamase assay. Cefoxitin at half minimal-inhibitory
concentration (512 μg/mL) was used for induction of β-lactamase in P. aeruginosa PAO1
(Livermore, 2002). The antibiotic was added when cell culture was at OD600 0.2 and
grown until OD600 of 1.2. The culture was harvested, washed once and resuspended in
50 mM sodium phosphate buffer (pH 8). The suspension was sonicated. The sonicated
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suspension was centrifuged, and the supernatant was used for analysis of β-lactamase
activity. A 7.5-μL portion of the supernatant of both induced and non-induced samples
were added to 1 mL of the assay buffer with nitrocefin in a final concentration of 100 μM.
The absorbance at 500 nm was observed for 5 min (O'Callaghan, et al., 1972). The
ΔA500/min was recorded for both induced and non-induced solution. The protein
concentrations of the supernatants were estimated by BCA assay (Walker, 1994). The
enzyme activity was expressed as the nanomole of nitrocefin hydrolyzed per min per mg
of protein (Kong, et al., 2005). Compounds 2e and 4e were used for induction of βlactamase in P. aeruginosa Z61 (ATCC 35151) at 100 µg/mL. Cefoxitin at quarter
minimal-inhibitory concentration (0.0156 μg/mL) was used as control. Compounds 2a
and 4a were used (as negative control). The culture was grown to OD600 of 0.1 (~108
CFU/mL) in LB medium and, subsequently, diluted 100-fold. LB medium (2.5 mL)
containing the compound or the antibiotics were inoculated with 2.5 mL of the inoculum.
Various cultures were allowed to grow within the range of OD600 of ~1.0 – 1.8. The rest
of the protocol is the same as for the wild type. The result is summarized in Table 2
2.4.3. Bacterial cell counting. P. aeruginosa PAO1 was grown in LB broth until early
stationary phase (OD600 of 1.2) was reached. Serial dilutions of the bacterial culture were
plated on LB agar plates and incubated at 37 °C for 16-18 h. Colonies were counted and
expressed as colony-forming units (CFU) per mL. Only plates with 30-300 colonies were
considered. The average number was 4.9 x 0.5 x 108 cell/mL of culture.
2.4.4 Syntheses of authentic muropeptides. The chemical structure of authentic
compounds used in this study is given in Chart S1. Synthetic methods for 2e, 4c, 4d, 4e,
7, and 8 were reported previously by Dr. Mobashery’s laboratory and were followed for
the samples used in the present study (Hesek, et al., 2009, Lee, et al., 2009, Lee, et al.,
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2010). Compound 4a was synthesized for this study by catalytic hydrogenation of the
intermediate 9. 1H NMR (500 MHz, CD3CN) δ 1.37 (d, J =6.8 Hz, 3H), 1.93 (s, 3H), 3.37
(s, 1H), 3.55 - 3.72 (m, 3H), 3.90 (d, J = 8.4 Hz, 1H), 4.11(d, J = 7.4 Hz, 1H), 4.24 (q, J =
6.8 Hz, 2H), 4.50 (d, J = 5.2 Hz, 1H), 5.31 (s, 1H), 6.79 (d, J = 8.6 Hz, 1H); 13C NMR
(126 MHz, CD3CN) d 18.7, 23.0, 50.5, 66.1, 69.7, 74.8,77.2, 79.8, 101.5, 118.3, 171.3,
175.0; HRMS (ESI-QTOF) m/z [M+H]+ Calcd 276.1078 for C11H17NO7; found
276.1101.Compound 2a was obtained from incubation of compound 2e with an amidase
AmpDh3 of P. aeruginosa (Martinez-Caballero, et al., 2013, Zhang, et al., 2013). The
reaction product 2a was confirmed by high-resolution mass spectrometry, which is
consistent with the chemical formula of C19H30N2O12: HRMS (ESI-QTOF) m/z [M+H]+
Calcd 479.1872; found 479.1844. Its chemical nature was further confirmed by
LC/MS/MS experiment (Figure S1A). Compound 2d was obtained from incubation of
compound 2e with penicillin-binding protein 4 of P. aeruginosa. [9] The reaction product
2d was confirmed by high-resolution mass spectrometry, which is consistent with the
chemical formula of C37H59N7O2: HRMS (ESIQTOF) m/z [M+H]+ Calcd 922.3888;
found 922.3840. Its chemical nature was further confirmed by LC/MS/MS experiment
(Figure S1B).
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Figure 2.2. The chemical structure of authentic muropeptides used in this
study.
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Figure 2.3. Collision-induced dissociation spectra. Of 2a (A), 2d (B), and side-by
side comparison to authentic synthetic standard 2d (C and D). Losses of Ala are
indicated in red bar in (B).
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2.4.5 Sample preparation: release of muramyl peptides from whole-cell. P.
aeruginosa PAO1 with and without induction (cefoxitin 512 µg/mL) was grown until late
log to early stationary phase (OD600 1.2). The culture was harvested by centrifugation at
4,500 g for 20 min and the supernatant discarded. The cell pellet was resuspended
gently in cold sucrose solution (20% sucrose, 1.2 mM EDTA, 30 mM Tris, pH 8) and left
at 4 °C for 10 min. This was centrifuged, and the pellet resuspended in ice-cold water.
The suspension was incubated at 4 °C for 10 min, and then centrifuged at 11,000 g for
20 min and the supernatant was discarded. The pellet was then boiled for 3 min and
sonicated to ensure complete release of muropeptides. The sample was filtered using
the 30-kDa molecular weight cut off mini-column. The flow-through was boiled for 6 min
to remove any residual enzymatic activity, concentrated by speed vacuum at 50 °C and
used for LC/MS analyses.
2.4.6 Detection and quantification of muropeptides by LC/MS. LC/MS conditions for
muropeptide detection corresponded to those in the method developed by Dr.
Mobashery’s laboratory (Lee, et al., 2013). Peak areas from extracted ion
chromatograms of corresponding muropeptides were integrated and normalized to
internal standard (compound 8). Quantification of muropeptide was done from the
standard curve of synthetic compound 2e. Standard curves for 2e, 4c, 4d, 4e, and 7
were determined and they were very similar within 7% variation of each other (Figure
S2). The collection of our synthetic standards covers distinctive chemical structures of
>95% of detected muropeptide. So, we chose 2e as a synthetic standard for
quantification, as it has the closest structure to 2d, the most abundant detected species.
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Figure 2.4. Standard curves of synthetic standards, 2e, 4c, 4d, 4e, and 7.
2.4.7 Calculation of number of muropeptides per cell. The concentration of 2d was
calculated from the standard curve of authentic standard 2e, which is 4.5 x10-11 mol/mL
of culture. This was converted to mol/cell (x) using the value obtained from bacterial cell
counting, described above. The value x then was converted to number of molecules (y)
using Avogadro’s number, 6.022 x 1023/mol. The rest of muropeptides were calculated
the same way as 2d and numbers are given in Table 1.
𝑥 = 4.5 X 10−11 𝑚𝑜𝑙/𝑚𝐿
4.9 X 108 𝑐𝑒𝑙𝑙/𝑚𝐿 = 9.2 X 10−20 𝑚𝑜𝑙/𝑐𝑒𝑙𝑙
1 : 6.022 X1023 = 9.2 X 10−20 𝑚𝑜𝑙 : y
y = 5.5 X 104 molecules/cell
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2.5. Results and Discussion
Sample preparation is important, as dilution of the minute quantities and contamination
could confound analysis. Initially, osmotic shock was used for liberation of the
periplasmic content that contains the muropeptides. This would have separated the
periplasmic and cytoplasmic metabolites before attempt at isolation of muropeptides.
Unfortunately, 10-30% cytoplasmic contamination was noted in these samples. The
results were also not reproducible, and muropeptides could merely be identified near the
detection limit of 0.4 pmol by our instrumentation.
The muropeptides that enter the cytoplasm via the permease AmpG (or AmpP)
are expected to undergo rapid metabolic flux (Figure 2.1). This assertion was
documented by preparing spheroplasts of P. aeruginosa PAO1. The cytoplasmic content
from the lysed spheroplasts were analyzed by LC/MS for muropeptides. None could be
detected, suggesting that the cytoplasmic muropeptides were rapidly metabolized to
Lipid II, with concentrations below our detection limit. Hence, the whole bacterium was
grown and lysed, an approach that proved to be reliable and reproducible. The
muropeptides that were generated under these conditions could only have come from
the intact periplasm in the whole bacterium. After sample preparation, the LC/MS
analyses were performed for detection and identification of muropeptides. The
muropeptide content of the whole cells of P. aeruginosa PAO1 was compared in the
absence and presence of half of the minimal-inhibitory concentration (MIC) of antibiotic
cefoxitin, a β-lactam that interferes with cell-wall synthesis (Livermore, 1995). Cefoxitin
at sub-MIC levels activates the expression of β-lactamase efficiently, thereby leading to
antibiotic resistance in P. aeruginosa. This is believed to be mediated by a messenger
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function of a muropeptide. Hence, one or more of the muropeptides listed in Figure 2A is
expected to serve as the signaling molecule for antibiotic resistance.
As shown in Figure 2A, compounds are numbered according to the nature of the
sugar, 2 for NAG-1,6-anhNAMand 4 for 1,6-anhNAM. For the peptide component, a has
no peptide, b, c, d, and e carry di-, tri-, tetra- and pentapeptide, respectively (full
pentapeptide

is

l-Ala-γ-d-Glu-m-DAP-d-Ala-d-Ala;

bottom

right

of

Figure

2A).

Compounds 3 are (NAG-NAM-peptide) n-NAG-1,6-anhNAM-peptide and compounds 5
are for cross-linked species. For example, compound 5dd indicates cross-linked peptide
between two tetrapeptides. Compounds with reducing-end sugars, which lack the 1, 6anhNAM, were also detected as minor components and are designated with the letter R.
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Figure 2. 5. A) Chemical structures of detected muropeptides. B) The
chemoenzymatic syntheses of six muropeptides.

Four muropeptides, 2e, (Hesek, et al., 2009) 4c, 4d, and 4e (Lee, et al., 2009,
Zhang, et al., 2013) were synthesized. A few of these authentic samples were also
converted to new species by known enzymatic reactions (Figures. 2B and S1). For
example, 2e was converted to 2d by the use of penicillin-binding protein 4 (PBP4),(Lee,
et al., 2015) and 2e to 2a using AmpDh3,(Zhang, et al., 2013) both purified recombinant
enzymes from P. aeruginosa. Figures. 3C-3F show EICs of the detected metabolites 2a,
2d, 2e, 4c, and 4d, and their comparison to the authentic standards (Figure 3G).
Analysis was further done with comparison of MS and MS/MS with authentic samples,
as exemplified in Figure S1. For structure assignment of metabolites whose authentic
standards were not available, the method that was developed previously by Dr.
Mobashery’s laboratory to analyze turnover products of sacculus by LTs and PBP4 was
used (Lee, et al., 2013, Lee, et al., 2015).
Quantification was done by integrating peak areas from EICs of the
corresponding m/z values of the individual muropeptide. This was converted to
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concentration using standard curves generated with the authentic 2e. The concentration
was converted to numbers of molecules (of each compound) per bacterium (Table 1; SI).
Standard curves for 2e, 4c, 4d, 4e and 7 (β-methoxy-NAG-NAM (pentapeptide)-NAGNAM (pentapeptide))(Lee, et al., 2010) were very similar within 7% variation of each
other (Chart S1 and Figure S2). The collection of our synthetic standards covers
distinctive chemical structures of >95% of the detected muropeptides. So, 2e was
chosen as a representative synthetic standard for quantification. The most abundant
muropeptide in wild-type PAO1 strain is NAG-1, 6-anhNAM-tetrapeptide (2d). The di-,
tri-, and pentapeptide variants (2b, 2c, and 2e) are also found, along with 2a (with no
peptide). These are reaction products of LTs, mostly from the exolytic activity. The
discovery of compounds with the core 1,6-anhNAM-peptides (4c and 4d) suggests the
existence of the N-acetylglucosaminidase activity in P. aeruginosa. The presence of
such an enzyme (FlgJ) in the periplasm was recently documented in Salmonella enterica
(Herlihey, et al., 2014). This activity in P. aeruginosa might be mediated by PA1085,
which has an identity of 31% and a similarity of 46% at the amino-acid level to FlgJ from
S. enterica (Figure S3) (Herlihey, et al., 2014).To our knowledge this is the first
documentation of a periplasmic N-acetylglucosaminidase reaction product in P.
aeruginosa (Herlihey, et al., 2014). Oligomeric sugars (up to hexamers) with tetrapeptide
(3dd and 3ddd) or a mix of tetra and tripeptide (3cd and 3cc) were also found. These
are products of the endolytic reactions of LTs (Johnson, et al., 2013).
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Figure 2.6. Analysis of P. aeruginosa muropeptides. The LC–MS TICs
of sacculus digested by MltA (A) and whole-cell analysis (B). EICs of 2a
(C), 4c (D), 4d (E), and 2d (F) from whole-cell samples, and the TIC of
authentic synthetic standards mixed together (G).
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Table 2.1 Detected muropeptides from whole-cell analysis (in molecules per
bacterium X 104 [a] Average of two runs. [b] PAO1 was exposed to cefoxitin at 512
mg/mL1. [c] p-values from Students t-test. * Significant difference (p<0.05) between
the wild-type and induced samples. [d] Not detected. [e] Total detected
muropeptides.
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Cross-linked muropeptides such as 5cd, 5dd, and 6dd were also found. As
minor components, muropeptides containing a sugar with a reducing end (2a-R, 2c-R,
2d-R, 5dd-RR, and 5dd-R) were also detected. This indicates that the reactive
oxocarbenium species partitions between either entrapment of the internal C6-hydroxyl
or of a water molecule, or there exists a yet-to-be identified hydrolytic glycosidase in this
organism. The ratio of the two types of products (non-reducing to reducing) is ∼14:1.

Figure 2.7. Alignment of PA1085 (PA) and FlgJ (SE) sequence

Same sample preparation and analyses were carried out with P. aeruginosa
PAO1 exposed to a cell-wall-active antibiotic cefoxitin at half of the MIC (i.e., 512
μg/mL), hence a non-lethal concentration (Livermore, 1995). The exposure to the
antibiotic alters the pool of muropeptides, where one or more is understood to enter the
cytoplasm via AmpG (or AmpP) permease and upregulate production of β-lactamase,
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the antibiotic-resistance determinant (Kong, et al., 2010, J. F. Fisher, 2015). The
induction of resistance was confirmed by the β-lactamase assay using nitrocefin.
The same number of bacteria and the same conditions were used in both cases;
hence, the values of the two columns of Table 1 can be compared to each other. The
analysis showed that the total muropeptide (molecules/bacterium) was significantly
reduced (p-value < 0.05 by Student's t-test) in the induced vs the uninduced case:
24,000 vs. 111,000 (Table 1). The most abundant muropeptide in the uninduced sample
was 2d (NAG-1, 6-anhNAM-tetrapeptide). Muropeptide 2e (NAG-1, 6-anhNAMpentapeptide) was enriched at 46-fold upon antibiotic induction (1000 in 24,000
molecules vs. 100 in 111,000 molecules). That is to say that the β-lactam antibiotic
inhibits the targeted PBP, whose lack of activity leaves its peptidoglycan substrate in the
sacculus intact. This observation in living bacteria agrees with the finding of the in vitro
sacculus analysis of the induced P. aeruginosa (Moya, et al., 2012, Lee, et al., 2015).
Compound 4e was detected only in the induced sample. This observation suggests that
as the concentration of 2e increased upon induction, the compound was likely turned
over by the aforementioned N-acetylglucosaminidase to produce 4e. Other than 2e and
4e, the rest of muropeptides detected in the induced sample were similar to those in the
uninduced. It is not immediately obvious as to why the total quantity of muropeptides is
lower in the induced sample (one fifth of the uninduced). This likely reflects the altered
cell-wall modifications of the bacterium in the presence of the sub-lethal concentration of
the antibiotic.
The obvious question now becomes whether exogenously added authentic
muropeptides 2e or 4e could cause induction of antibiotic resistance in the absence of
antibiotic. We investigated this first with the wild-type P. aeruginosa PAO1 strain.
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Addition of muropeptide 2e or 4e at upwards of 500 μg/mL failed to induce β-lactamase
expression (Table 2.2). Going with the premise that the Gram-negative outer membrane
is a formidable barrier to penetration of most small molecules into the periplasm, we
procured a mutant strain defective in its outer membrane. The strain P. aeruginosa Z61
has the full complement of the genes necessary for induction of β-lactamases, but it
expresses a mutant version of the β-lactamase with diminished activity (Angus, et al.,
1982). Nonetheless, using the nitrocefin assay we observed a 4.7-fold increase of
induction of β-lactamase at quarter-MIC level of cefoxitin.

Table 2.2. Induction of β-lactamase activity by three inducers [a] Average
of two runs. [b] The strain is defective in its outer membrane. [c] The number
(the left column) is calculated from β-lactamase activity in the presence of an
inducer divided by that without an inducer (the right column) under the same
conditions. The enzyme activity was expressed as nmol of nitrocefin
hydrolyzed per min per mg of protein for wild-type and pmol/min/mg for mutant.
[d] Cefoxitin and compounds 2a and 4a were used as positive and negative
controls for induction, respectively. [e] β-Lactamase activities were significantly
different (p<0.05) between induced and uninduced samples. [f] Not measured.
[g] Owing to limited supply of compound, we could only assess the effect at the
lower concentration.
The same experiment performed with the bacteria exposed to 100 μg/mL
muropeptides 2e or 4e resulted in 1.4 or 1.7 induction, respectively (Table S1). This is a
large excess of these compounds, but we used them so, as we had expected that the
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exogenously added compounds would undergo turnover by periplasmic enzymes.
Hence, the two metabolites—both produced in response to the exposure of bacteria to
the antibiotic inducer cefoxitin—collectively account for most of the induction observed
by cefoxitin. We note that compound 2a and 4a (metabolites without a peptide stem;
products of the reaction of AmpD) as negative controls. As expected, under the same
conditions, induction was not observed. Activity of AmpD (Figure 1) is at the crossroads
of induction of resistance vs. cell-wall recycling (reversal of induction).
This study reports the nature and quantities of 20 muropeptides from P.
aeruginosa. The levels of muropeptide 2e became elevated by 46-fold on exposure of
bacteria to sub-MIC levels of a good inducer, cefoxitin. We also observed muropeptide
4e only in the induced cells. This study discloses that authentic synthetic samples of
muropeptides 2e and 4e could serve as inducers of β-lactam-antibiotic resistance in the
absence of antibiotic. These experiments clearly document that at least muropeptides 2e
and 4e are chemical elicitors of induction of antibiotic resistance.
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Chapter 3

Role of P. aeruginosa permeases PA4393 and PA4218 in
antibiotic resistance and cell-wall recycling
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3.1 Abstract

Pseudomonas aeruginosa is well-known for its intrinsic as well as acquired
resistance to multitude of antibiotics including fluoroquinolones, aminoglycosides,
macrolides and the β-lactams. A frequent mechanism of resistance to β-lactams is
through expression of the hydrolytic enzymes, β-lactamases. Expression of the major βlactamase AmpC is regulated by a LysR-type transcriptional regulator AmpR, contingent
upon its binding with specific muropeptides.

In P. aeruginosa, there are two inner

membrane permeases that may serve as muropeptide transporters; PA4393 (AmpG)
and PA4218 (AmpP). It was postulated that AmpG imports the muramyl peptides into the
cytoplasm whereas AmpP exports into the periplasm. In this research, we investigate the
role of AmpG and AmpP in antibiotic resistance and as muropeptide transporters. To
address their role three in-frame deletion mutants were constructed ΔampG, ΔampP,
and ΔampGΔampP in PAO1. The resistance and muropeptide profile of these three
mutants were compared against PAO1, respectively. A single deletion of ampG resulted
in decreased resistance profile as compared with the wild-type PAO1, for many of the βlactams as well as for fosfomycin. ampP deletion however, did not result in altering
susceptibility. The profile of muropeptides was investigated by LC/MS/MS. The wholecell extracts across all the strains (wild-type and permease mutants) were examined for
muropeptides and it was found that the relative levels of muropeptides were similar in
PAO1 and PAOΔampG deletion. The levels of disaccharide peptides in ΔampP and
ΔampGΔampP were lower in the periplasm and the cytoplasm respectively, compared to
PAO1. This is indicative of AmpP playing a role in muropeptide transport and supports
our hypothesis.

Periplasmic analysis of the muropeptides revealed that levels of

monosaccharides were lower for all the strains in the periplasmic space as compared
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with whole-cells. This method of muropeptide detection is highly sensitive and allows us
to compare the relative levels of muropeptides across bacterial strains.

3.2 Introduction
Muropeptides or cell-wall fragments are created whenever the bacterial cell divides.
Gram-negative and Gram-positive pathogens have a dedicated recycling pathway that
salvages these muropeptides and utilizes them during rebuilding of the cell-wall
(Boothby, et al., 1973, Goodell, 1985). The muropeptides besides being recycled to
conserve energy resources also play critical roles in bacterial survival and virulence. In
Gram-positive pathogen Bacillus subtilis, Gram-negative bacteria Myxococcus xanthus
and Micrococcus luteus, muropeptides trigger reactivation of dormant spores in
response to environmental cues (Shimkets & Kaiser, 1982, Mukamolova, et al., 2006,
Shah, et al., 2008). In P. aeruginosa, production of a toxin, pyocyanin is modulated by
peptidoglycan fragments containing N-acetylglucosamine (Korgaonkar & Whiteley,
2011). The muramyl peptides also have well defined role as stimulants of the host
immune system (Takeuchi & Akira, 2010). This immune response in a healthy individual
is triggered partly by certain elements of the bacterial cell itself known as pathogen
associated molecular patterns (PAMP) (Janeway, 1989). These include mainly the
lipopolysaccharide, peptidoglycan, flagellin proteins and lipotechoic acid in Grampositive bacteria. These structures are recognized by the innate immune system, namely
the Toll-like receptors (TLR) and the nucleotide-binding oligomerization domain (NOD)
(Takeuchi & Akira, 2010, Fujimoto & Fukase, 2011). Peptidoglycans in specific are
recognized by the NOD family- Nod 1, Nod 2, cryopyrin and the peptidoglycan response
proteins (PGRP) (McDonald, et al., 2005, Fujimoto & Fukase, 2011). Specifically, ɣ-D
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glutamyl-meso-diaminopimelic acid muramyl dipepetides act as recognition moieties and
activate the pro-inflammatory cytokines (Chamaillard, et al., 2003, Girardin, et al., 2003,
Boudreau, et al., 2012). Due to the key role of muropeptides both within the bacteria as
signaling components as well as in the eukaryotic host as an immune stimulus,
identifying the muropeptides and the recycling process becomes significant in
understanding bacterial activity and its interaction with host. The recycling pathway has
evolved in many Gram-negative pathogens however it has been best studied in E. coli
(Park & Uehara, 2008, Johnson, et al., 2013, Dhar, et al., 2018).
During the cell wall recycling process in E. coli, PG fragments are generated in
periplasm through the activity of lytic transglycosylases, penicillin binding proteins (PBP)
and amidases (Holtje, et al., 1975, Park & Uehara, 2008). PG fragments enter the
cytoplasm through permease AmpG (Jacobs, et al., 1994). In the cytoplasm, they are
initially processed by two enzymes, NagZ that removes the N-acetylglucosamine residue
followed by AmpD which cleaves the peptide chain from the muropeptide (Yem & Wu,
1976, Jacobs, et al., 1994, Jacobs, et al., 1995, Hesek, et al., 2009). The recycling
process in P. aeruginosa has not been completely elucidated and there have been no
studies that determine the muropeptide profile of P. aeruginosa. Bioinformatic analyses
led to the identification of E. coli homologs of the recycling pathway (Kong, et al., 2010,
Dhar, et al., 2018). However, there are differences in the recycling pathway in P.
aeruginosa when compared with other members of Enterobacteriaceae. P. aeruginosa
has periplasmic paralogs of AmpD known as AmpDh2 and AmpDh3 (Juan, et al., 2006,
Lee, et al., 2013, Martinez-Caballero, et al., 2013, Zhang, et al., 2013). It also has a
AmpG paralog, AmpP which we hypothesize is a second muropeptide transporter (Kong,
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et al., 2010). This part of the research addresses the role of the permeases AmpG and
AmpP in P. aeruginosa with regards to cell-wall recycling in P. aeruginosa.
AmpG (PA4393): AmpG has been identified in 134 distinctive genera of bacteria
including pathogens such as P. aeruginosa, Neisseria gonorrhea, Serratia marcescens,
Vibrio cholerae, Acinetobacter baumanii and Salmonella species (Folkesson, et al.,
2005, Garcia & Dillard, 2008, Adin, et al., 2009, Li, et al., 2016). Most AmpG proteins
were found to have 12-14 transmembrane (TM) domains (Li, et al., 2016). The crucial
role of AmpG in β-lactam resistance was realized for the first time upon its identification
in Enterobacter cloacae (Korfmann & Sanders, 1989). P. aeruginosa AmpG has a
particularly long sequence with 14 transmembrane spanning domains. A high degree of
sequence conservation is observed amongst AmpG found in different bacteria. A
previous study showed that P. aeruginosa AmpG can be successfully complemented by
AmpG from other Gram-negative pathogens such as Acinetobacter baumanii,
Escherichia coli, and Vibrio cholera (Li, et al., 2016).
The vital role played by AmpG in muropeptide recycling modifies not just β-lactam
resistance but also the pathogenicity. This has been the research focus regarding AmpG
in Neisseria species (Garcia & Dillard, 2008, Woodhams, et al., 2013). It was found that
non-pathogenic strains of Neisseria sp. such as N. sicca and N. mucosa were more
efficient at recycling their muropeptides (Chan & Dillard, 2016). Furthermore, replacing
AmpG of pathogens such as N. gonorrhea by its homolog from a human colonizer such
as N. meningitides or with AmpG from E. coli decreased the virulence of the pathogen
(Chan & Dillard, 2016). The diminished pathogenicity after AmpG substitution was
correlated with a reduced release of muropeptides and more efficient recycling (Garcia &
Dillard, 2008, Chan & Dillard, 2016). Another example is Bordetella pertussis where the
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causative agent of whooping cough, the tracheal cytotoxin, is a muropeptide (Goldman &
Herwaldt, 1985, Luker, et al., 1993). Specifically, it is composed of N-acetylglucosamine
1, 6 anhydro N-acetylmuramic acid tetrapeptide (Goldman & Herwaldt, 1985, Goldman &
Cookson, 1988). The release of this tracheal cytotoxin into the host was depleted when
the B. pertussis ampG gene was replaced by that of E. coli (Feunou, et al., 2008). ampG
is also one of the genes targeted during the construction of a live-attenuated vaccine for
B. pertussis (Mielcarek, et al., 2006). This reflects once again upon the fact that
pathogenic bacteria, unlike in non-pathogens often have an inefficient muropeptide
recycling due to a deficient AmpG.
In P. aeruginosa, AmpG is encoded by PA4393 and localized to the inner membrane
and act as a permease for the muropeptides transport from periplasm into the cytoplasm
(Kong, et al., 2010, Perley-Robertson, et al., 2016). Its role in β-lactam resistance was
further proved when a decrease in MIC was noted upon the deletion of this gene (Kong,
et al., 2010, Zhang, et al., 2010). This decrease was relevant not just in the lab reference
strain PAO1, but in clinical strains as well wherein attenuating AmpG resulted in
restoring the MIC to below CLSI breakpoints by blocking the expression of AmpC
(Zamorano, et al., 2011).

Besides P. aeruginosa, the importance of AmpG as an

activator of AmpC expression and resistance has been examined in Xanthomonas
campestris, Strenotophomonas maltophila, Enterobacter cloacae, Citrobacter freundii
(Korfmann & Sanders, 1989, Lindquist, et al., 1993, Huang, et al., 2010, Yang, et al.,
2013).
AmpP (PA4218): P. aeruginosa PA4218 encodes for a protein that was shown to be
involved in β-lactam resistance in P. aeruginosa (Kong, et al., 2010). Previous research
in the lab showed that inactivating AmpP resulted in a sub-maximal β-lactamase
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expression (Kong, et al., 2010). This phenotype was restored to that of wild-type by intrans ampP complementation. This indicated to us that AmpP plays a role in β-lactam
resistance. Protein structure analysis also indicated that this is a permease with a Major
Facilitator Superfamily domain. Localization studies using LacZ-PhoA fusions found that
it lies in the inner membrane with ten TM spanning regions (Kong, et al., 2010). Its role
in regulating β-lactamase expression along with its activity as a permease and significant
homology with P. aeruginosa AmpG led to the hypothesis that this protein may be
involved in the cell-wall recycling pathway. AmpP is the second gene of a two-gene
operon whose expression is found to be controlled by a transcriptional regulator AmpR
independent of any β-lactam induction (Kong, et al., 2010, Balasubramanian, et al.,
2012). Besides the research in our lab, AmpP was also found to be involved in pyochelin
utilization which is one of the two siderophores found in P. aeruginosa (Michel, et al.,
2007, Cunrath, et al., 2015).
Although it has been known that AmpG acts as a muropeptide transporter in P.
aeruginosa, its specific role in cell-wall recycling has not been studied. Similarly, the role
of AmpP in cell-wall recycling has not been explored. Thus, this research addresses the
gap in knowledge regarding the function of these inner membrane permeases in cell-wall
recycling. This study will compare the accumulation of the muropeptides in the parent
reference strain PAO1 with its isogenic permease mutants.

3.3 Materials and Methods
3.3.1 Strains, media and growth conditions. Pseudomonas aeruginosa PAO1 and its
derivatives (PAOΔampG, PAOΔampP, PAOΔampGΔampP) and Escherichia coli DH5α
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were used in this study. For in vivo homologous recombination, the yeast model
Saccharomyces cerevisiae InvSC1 strain (Invitrogen™, Life Technologies, Carlsbad, CA,
USA) was used (Shanks, et al., 2006). E. coli and P. aeruginosa were cultured in Luria
Bertani broth (5 g tryptone, 10 g sodium chloride, and 5 g yeast extract per liter) with
supplements of 1.5% agar when needed at 37° C. For triparental mating experiments,
Pseudomonas Isolation Agar (Difco) was used along with LB for P. aeruginosa selection.
S. cerevisiae was cultured in YEPED media (Yeast extract-peptone-dextrose media: 20
g Bacto Peptone, 10 g yeast extract, and 20 g dextrose per liter) at 30 °C. Selection of
yeast colonies with transformed pMQ30 was done using synthetic define agar-uracil
media.

For

plasmid

selection

and

maintenance,

antibiotics

at

the following

concentrations were used: gentamicin (Gm) 15μg/mL for E. coli, 75 μg/mL for P.
aeruginosa, chloramphenicol (Cm) 10 μg/mL and kanamycin (Km) 20 μg/mL for E. coli.

3.3.2 Construction of ampG and ampP deletion mutants by homologous
recombination. The deletions were constructed in Pseudomonas aeruginosa PAO1
genomic background (Holloway & Morgan, 1986). Upstream and downstream regions of
ampG (PA4393) were amplified to generate what we refer to as P1 and P2. The P1 and
P2 were produced by PCR using primers pairs LS_PA4393 UF, LS_PA4393 UR and
LS_PA4393DF, LS_PA4393DR that gave amplicons of 986-bp and 991-bp, respectively.
Similarly, for ampP (PA4218), primer pairs LS_PA4218 UF, LS_PA4218 UR and
LS_PA4218 DF, LS_PA4218 DR were used to generate 997-bp and 926-bp P1 and P2,
respectively. The amplified fragments were checked by PCR and its fidelity was
determined by sequencing. The P1, P2 of ampG and ampP were transformed into
Saccharomyces cerevisiae respectively, with a linearized (BamH1 digested) vector
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pMQ30 to generate the spliced product (P3) (Shanks, et al., 2006). PCR and agarose
gel electrophoresis were used to screen the yeast colonies for the presence of the P3
following which yeast DNA was isolated from the positive clones. The recombinant
construct was extracted from yeast and introduced in E. coli. The positive colonies were
selected by their growth on gentamicin and the presence and fidelity of the P3 with the
deleted target gene was checked by PCR and sequencing. The P3 constructs was
conjugated into P. aeruginosa PAO1 independently by triparental mating using
E.coli/pRK2013 and pRK600 as helper strains (Figurski & Helinski, 1979, Finan, et al.,
1986). The single and double crossover products were confirmed by Gm sensitivity
followed by selection for loss of pMQ30 plasmid through sucrose resistance (Oldenburg,
et al., 1997, Shanks, et al., 2006). The integration of the DNA fragment in the
chromosome and the loss of the target genes were verified by PCR and sequencing.
The ampP deletion (plasmid with P3 fragment) was also introduced in the ampG deletion
to create the permease double deletion mutant, PAO∆ampG∆ampP.

Table 3. 1: Strains, plasmids and primers used in this study.
Strains

Relevant phenotype and genotype

Reference/
Source

Escherichia coli
F- Φ80lacZΔM15 Δ(lacZYA argF)U169 deoR
New
DH5α
recA1 endA1 hsdR17 (rk-mk+) phoA supE44 λ England
thi-1 gyrA96 relA1
Biolabs
Saccharomyces cerevisiae
MATa/MATα leu2/leu2 trp1-289/trp1-289 ura3- Invitrogen
INVSc1
52/ura3-52 his3-Δ1/his3-Δ1
Pseudomonas aeruginosa
(Holloway,
PAO1
Wild-type
et al., 1979)
PAO∆ampG
PAO1 containing in-frame deletion of ampG
This study
PAO∆ampP
PAO1 containing in-frame deletion of ampP
This study
PAO1 containing in-frame deletions of ampG and
PAO∆ampG∆ampP
This study
ampP
PAO∆ampG containing ampG on plasmid
PAO∆ampG(pAmpG)
This study
pMQ72
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PAO∆ampP(pAmpP)
Plasmids

PAO∆ampP containing ampP on plasmid pMQ72

This study

pGEMT

TA cloning vector for PCR products; ApR,
ColE1 f1 ori lacZα

Promega

pRK600

CmR; colE1 tra+RK2 mob+; Helper plasmid for
conjugation

pRK2013

KmR; colE1 tra+ RK2 mob+; Helper plasmid for
conjugation

pMQ30

GmR; colE1, oriT

pSD51

pSD57

pSD55
pSD61

ApR; A ~1.8-kb NheI-SacI fragment containing
ampG ORF (PA4393) amplified from PAO1
genome
using
SD_ampG_FW
and
SD_ampG_Rev primers and cloned into pGEMT
ApR; A ~1.2-kb NheI-SacI fragment containing
ampP ORF (PA4218) amplified from PAO1
genome
using
SD_ampP_FW
and
SD_ampP_Rev primers and cloned into pGEMT
GmR; The ampG ORF sub-cloned from pSD as
an NheI-SacI fragment into pMQ72
GmR; The ampP ORF sub-cloned from pSD as
an NheI-SacI fragment into pMQ72

(Figurski &
Helinski,
1979)
(Finan, et
al., 1986)
(Shanks, et
al., 2006)
This study

This study

This study
This study

Primers
LS_PA4393 UF

LS_PA4393 UR

LS_PA4393 DF

LS_PA4393 DR

LS_PA4218 UF

LS_PA4218 new UR

LS_PA4218 new DF
LS_PA4218 DR

5’GGAATTGTGAGCGGATAACAATTTCACACAG
GAAACAGCTCGAAGAAGCGATCGAGGTCG3’
5’CGAATGCCGGCCTTTTTCATTCTCGCCTAGC
TAGCTAGGGGTAACCGTTCCGCAAAA-3’
5’TTTTGCGGAACGGTTACCCCTAGCTAGCTAG
GCGAGAATGAAAAAGGCCGGCATTCG-3’
5’CCAGGCAAATTCTGTTTTATCAGACCGCTTC
TGCGTTCTGATGGAAACGTCGCCCCACGG3’
5’GGAATTGTGAGCGGATAACAATTTCACACAG
GAAACAGCTGACCTGCATGGCCTGATCGG3’
5’GCCTATCGGCAGCGCCTCACGCTAGCTCAA
GCATGGTGGTCTCCGGTGAC-3’
5’GTCACCGGAGACCACCATGCTTGAGCTAGC
GTGAGGCGCTGCCGATAGGC-3’
5’-
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This study

This study

This study

This study

This study

This study

This study
This study

SD_PA4218_Fw_Nhe1
SD_PA4218_Rev_Sac
1
SD_PA4393_Fw_Nhe1
SD_PA4393_Rev_Sac
1

CCAGGCAAATTCTGTTTTATCAGACCGCTTC
TGCGTTCTGATCTCGGCGTGGAGCGTATC-3’
5’GGGCTAGCAGGAGAGACCTCACCCTGATCC
TCT-3’
5’GGGAGCTCGCGGGAGAGGCGGCATCCGT3’
5’GGGCTAGCAGGAGATTGCGCGAGGAAGGC
GTTCT-3’
5’GGGAGCTCGCGATGGCCGACTGAGGTCCG
TGC-3’

This study

This study

This study

This study

3.3.3 Construction of complementing plasmids. DNA fragments from P. aeruginosa
PAO1 with ampG (~1.78 kb) and ampP (~1.2 kb) were PCR amplified using primer pairs
SD_PA4393_Fw_Nhe1 and SD_PA4393_Rev_Sac1 and SD_PA4218_Fw_Nhe1 and
SD_PA4218_Rev_Sac1, respectively (Table 2.1). The PCR amplified products were
cloned into pGEMT (Promega Corporation, USA) using manufacturers protocol to
generate plasmids pSD51 and pSD57, respectively. The fidelity of the PCR amplified
product was confirmed by sequencing. The fragments carrying ampG and ampP were
moved into a broad host range pMQ72 plasmid as NheI-SacI fragments, downstream of
an inducible PlacUV5 promoter to generate plasmids pSD55 and pSD62, respectively.
Henceforth, these plasmids are referred to as pAmpG and pAmpP. These expression
plasmids were then introduced into wild-type PAO1, PAOΔampG, and PAOΔampP
deletion mutants by electroporation and gentamycin resistant colonies were selected.
3.3.4 Growth curves. P. aeruginosa PAO1 and its derivatives were grown overnight at
37°C in LB broth with or without antibiotics. Overnight cultures were washed with sterile
0.85% NaCl (wt/vol) solution to remove spent media. Cultures were diluted in fresh LB
broth to obtain equal optical densities (OD600) of 1. From this culture, they were diluted
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again to a starting OD600 of 0.05. Growth was monitored by determining absorbance at
600 nm using BioTek Synergy HT (Winooski, VT, USA) plate reader for 16–18 h at 37°C.

3.3.5 Determination of minimum inhibitory concentration (MIC). The MIC was
determined using the E-test (BioMerieux) (Melvin P. Weinstein, 2018). Briefly, overnight
cultures of bacteria were diluted to an OD of 0.02-0.2 and spread on an LB-agar plate.
An E-strip which contains antibiotics at an increasing concentration along its length was
placed on the plate. The MIC was determined by the zone of clearance on the plate after
16-18 hr incubation at 37 °C.
3.3.6 Quantifying β-lactamase activity. β-lactamase activity was quantified as
described previously (O'Callaghan, et al., 1972, Kong, et al., 2005). Briefly, cells in LB
broth at an OD600 of 0.5-0.6 were treated with 100 μg/ml Penicillin G for two hours at 37
°C. The cells were then harvested, OD normalized, and lysed with BugBuster Protein
Extraction Reagent (Novagen, WI) and r-Lysozyme (Novagen, WI) and treated with
Benzonase nuclease (Novagen,WI). The amount of β-lactamase was quantified in the
soluble fraction by determining hydrolyzing activity on nitrocefin (Oxoid, England).
Protein concentrations in the samples were determined by Bradford assay. Enzyme
activity was expressed as milliunits of β-lactamase (nanomoles of chromocef hydrolyzed
per minute per microgram of protein).
3.3.7 Release of muramyl peptides from whole cell extracts. P. aeruginosa (wild
type; PAO1 and mutants; PAOΔampG, PAOΔampP) was grown until late log phase. The
culture was harvested by centrifugation at 11, 000 g for 20 min and the supernatant
discarded. The cell pellet was resuspended gently in cold shrinking solution (20%
sucrose, 1.2 mM EDTA, 30 mM Tris, pH 8) and left with shaking at 4° C for 10 min. This
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was centrifuged followed by resuspension of the pellet in ice cold water. The suspension
was kept at 4° C for 10 min, and then centrifuged at 11,000 g for 20 min and the
supernatant discarded.

The pellet was then boiled to quench enzyme activity and

sonicated to ensure complete release of muropeptides. The sample was filtered using 30
KDa molecular weight cut off mini-column. The remaining solution was concentrated
through speed vacuum at 50° C and used for LC/MS analysis. Dionex Ultimate 3000
Rapid Separation UPLC system coupled to Bruker MicrOTOF-Q II Mass spectrometer
was used for the analysis (Lee, et al., 2013).
3.3.8 Release of muramyl peptides from periplasm. Periplasmic extraction was done
using osmotic shock, as previously described with minor modifications (Nossal &
Heppel, 1966). The culture was grown until OD600 1.2. The bacteria was harvested and
suspended in buffer containing Tris-Cl (pH-7.4) and magnesium chloride 200 mM. This
suspension was kept under rotation for 15 minutes at room temperature and reharvested again. The culture was then re-suspended in ice-cold water and kept under
shaking at 4 ⁰C. The culture was harvested again, and the supernatant collected. This
contains the periplasmic proteins. For our analysis by LC/MS, this was filtered through
30KDa mini-column and the filtrate was collected. The filtrate was boiled to quench any
enzyme activity and concentrated using a speed-vacuum. This sample was analyzed by
LC/MS.
3.3.9 Detection of muropeptides by liquid chromatography/mass spectrometry.
The conditions used for LC/MS have been previously developed for muropeptide
analysis (Lee, et al., 2013). Briefly, the separation was done using a Dionex Ultimate
3000 Rapid Separation UPLC system equipped with a Dionex Ultimate 3000
autosampler and a Dionex Ultimate 3000 photodiode array detector. Separations were
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performed on a Dionex Acclaim™ PolarAdvantage II C18 column (3 μm, 120 Å, 2.1 mm
i.d. × 150 mm). The mobile phase consisted of A = 0.1% formic acid in water; B = 0.1%
formic acid in acetonitrile. This was coupled with a Bruker MicrOTOF-Q II quadrupole
time-of-flight hybrid mass spectrometer. The Bruker electrospray ionization source was
operated in the positive ion mode.
3.3.10 Statistical analyses. All data were analyzed for statistical significance using the
Student’s t-test on GraphPad or Analysis of Variance (ANOVA) with post-hoc testing
when appropriate.

3.4 Results and Discussion
This study was done by extracting cell-lysates during log growth phase of bacteria
and determining the relative levels of individual muropeptide. Instead of radioactivity
which was previously used to study muropeptide levels, a liquid chromatography/massspectrometry approach is utilized here. This allowed us to identify muropeptides at the
micro molar concentrations as well as to pin-point subtle changes in the profile of PG
fragments between different strains. This approach of muropeptide analysis was
however only possible as synthetic muropeptides were available (Hesek, et al., 2009).
3.4.1 Growth analysis of mutant strains. The PAOΔampG, PAOΔampP and
PAOΔampGΔampP mutants exhibited no discernible phenotype in growth compared to
the parent PAO1 when tested in LB media over 16-18 hours (Figure 3.1). This
demonstrates that the permeases in cell-wall recycling are not essential for growth in P.
aeruginosa.

92

Figure 3. 1. Growth curve analysis of mutants. Growth curves of PAO1 and the
mutants PAOΔampG, PAOΔampP and PAOΔampGΔampP was analyzed in LB broth at
37 ⁰C over 16 hours. No difference was seen in the growth of mutants in this media.

3.4.2 MIC of β-lactams is altered in ampG deletion. To investigate the role of ampG in
P. aeruginosa, precise in-frame deletion of the gene was generated. The susceptibility of
selected antibiotics was compared with that of the parent strain PAO1. Antibiotics were
chosen based upon two criteria. This included firstly the antibiotics which are
predominantly used in the clinical setting in case of a multi-drug resistant infection.
These include a combination therapy with aminoglycosides, fluoroquinolones, and
fosfomycin (Samonis, et al., 2012, Tangden, 2014). Secondly, as the role of ampG in
resistance is manifested through cell-wall recycling and AmpR, the antibiotics that have
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previously shown a differential MIC in PAOΔampR were selected (Balasubramanian, et
al., 2013).
The MIC for the β-lactams which include aminopenicillins (ampicillin) cephalosporins
(ceftazidime and cefoxitin) and carbapenems were reduced in the absence of ampG
when compared with the wild-type PAO1. This phenotype was restored to the wild-type
levels upon in-trans complementation. However, the MIC of ceftazidime which is a weak
inducer of AmpC was unaltered. Interestingly, the MIC to one of the last-resort antibiotics
for resistant infection, fosfomycin, was also decreased in PAOΔampG (Table 3.1).
3.4.3 β-lactamase expression is reduced in ampG deletion mutants. Previously, a
study in our lab had shown that deletion of ampG resulted in the production of submaximal levels of β-lactamase (Kong, et al., 2010). As an insertional inactivation mutant
had been used in the earlier study, we verified our observations with a precise deletion.
Upon comparing the results with PAO1, it was found that PAOΔampG had significantly
(p < 0.05) decreased levels of β-lactamase expression.
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Table 3.1. Susceptibility profiles of PAOΔampG, PAOΔampP and PAOΔampGΔampP.
Minimum Inhibitory Concentration (µg/ml)
Antibiotics

PAO1

PAO∆ampG

PAO∆ampP

PAO∆ampG(pAmpG)

PAO∆ampP(pAmpP)

PAO∆ampG∆ampP

Ampicillin

>256

32-64*

>256

>256

>256

16-32*

1.5

1.5

2-1.5

2

1.5

2

Cefoxitin

>256

64*

>256

>256

>256

64*

Imipenem

2-1.5

.38-.5*

2

2

1.5

.38*

Doripenem

0.25

0.19

0.19

0.125

0.125

.25

Meropenem

0.38

0.38-0.5

0.25

0.38-0.5

0.38-0.5

.5

0.25-0.5

0.25

0.25

0.25

0.5

.19

Ofloxacin

2

1

1.5

1.5

2

1

Fosfomycin

32

8*

32

24-16

16

8-16

Colistin

0.75

0.75

0.75

0.75

1.5

0.75-1.5

Trim-sox

4

3

6

4

3

4

Ceftazidime

Ciprofloxacin

*Significance was noted using student’s T-test (PAO1 vs mutants, p <0.05)
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3.4.4 MIC and β-lactamase expression is unaltered in ampP deletion. To investigate
the role of ampP in P. aeruginosa, a precise in-frame deletion of the gene was
generated. Previously, a study had shown that upon insertional inactivation of ampP,
the β-lactamase expression was decreased (Kong, et al., 2010). However, no change
was found in the MIC of β-lactams (Table 2.1). For induction of β-lactamase similar
conditions as that for ampG strains were used. No significant differences were found in
the β-lactamase expression levels of ampP deletion when compared with the wild-type
PAO1.
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Uninduced

β-lactamase activity

100

Induced

80
60

*

40
20
0

PAO1

PAOΔampG

PAOΔampP

Figure 3.2. β-lactamase expression of PAOI and permease mutants. The
β-lactamase activity was quantified for PAO1, PAOΔampG, and PAOΔampP in
the presence and absence of a β-lactam (Penicillin 100ug/ml).*p-value = 0.004
for β-lactamase activity in PAOΔampG vs PAO1 induced, as determined by
unpaired t-test.
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A.

B.

Figure 3.3. (A) A brief scheme of the muropeptide extraction protocol. (B) The
structures of muropeptides. As found in P. aeruginosa as per our previous
study are listed here (Lee, et al., 2016).
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3.4.5 Muropeptide profile of whole-cell extract in mutant strains. In this study, we
compare the trend and profile of muropeptides in the permease mutant strains with the
parent wild-type PAO1. We used LC/MS was used to qualitatively analyze the
muropeptides from the bacterial lysate that was extracted during the late-log phase of
growth. Standards included synthesized muropeptides and were run with every set of
samples to ensure the LC column sensitivity and specificity (Figure 3.3). The trend of
individual and total muropeptides were compared between ampG, ampP and the double
permease deletion; PAOΔampGΔampP with the wild-type PAO1.
It was found that across the mutant strains, the relative levels of a group of
muropeptide such as disaccharide-peptide, monosaccharide peptides and larger
muropeptides which include tetra-saccharide and the cross-linked peptides were not
significantly different (Figure 3.4). Besides ampG, we also studied the muropeptide
levels in ampP deletion mutant. Given its homology to E. coli AmpG (41%), we
hypothesize that this permease acts as a muropeptide transporter, possibly for the
processed muropeptides from the cytoplasm to the periplasm (Kong, et al., 2010).
When compared with the wild-type PAO1 and ampG deletion, it showed a lower relative
level of disaccharide-peptides and a higher level of monosaccharide-peptides. The
levels of the larger saccharide including the cross-linked are similar in both the strains
(Figure 3.4).
The profile of muropeptide in the double deletion PAOΔampGΔamp mutant was
similar to ampP deletion. The relative levels of disaccharide were low when compared
with the PAO1. The levels of monosaccharide muropeptides were higher than PAO1 and
similar to that of ampP deletion (Figure 3.4).
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Figure 3. 4. Relative levels of muropeptides in whole-cells. The muropeptides
extracted from whole cells. The area of individual muropeptides was calculated using
area- under-the curve. They were grouped according to their saccharide backbone and
compared across the strains. The disaccharides-peptide ranged from 0-4 amino acids
i.e. no peptide to tetrapeptide moieties were found. Monosaccharide peptides include
tri-and tetrapeptides. Tetrasaccharide peptides included tri and tetrapeptides.
Crosslinked peptides detected were tri- and tetrapeptides, with reduced ends.

3.4.6 Muropeptide profile of periplasmic extract in mutant strains. As AmpG is a
permease that localizes to the inner membrane and imports muropeptides from the
periplasm to the cytoplasm, the profile of muropeptides in the periplasm was analyzed.
The expectation was that most of the muropeptides would be unprocessed by
cytoplasmic enzymes. In accordance with this most of the muropeptides in the periplasm
were disaccharides (Figure 3.5). The major products in all the strains for the periplasmic
cell-extract were the GlcNAc 1, 6 anhydroMurNAc without any peptides. This could be
due to the action of the periplasmic AmpDh2 and AmpDh3 amidases which cleave the
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peptide chain. Although these enzymes have been noted to favor the full-sacculus, they
also retain activity on the PG fragments (Zhang, et al., 2013). There was no significant
difference between the individual muropeptides on comparing the single permease
deletion mutant strains PAOΔampG or PAOΔampP with PAO1 (Figure 3.5). However,
deletion of both ampG and ampP permeases resulted in lowering the levels of
disaccharide- muropeptides. There was a minor presence of monosaccharide peptides
in the periplasm; namely the 1, 6 anhydro MurNAc tri-and tetrapeptides when compared
with that seen in whole-cell extracts (Figure 3.6). This concurs with the hypothesis that
the major or predominant N-acetylglucosaminidase enzyme lies in the cytoplasm, also
known as NagZ. However, in agreement with our previous observation of
monosaccharides in the periplasm, there may be a periplasmic N-acetylglucosaminidase
(Lee, et al., 2016). Indeed, this was recently found to be the case for S. enterica where
one of the PG hydrolyzing enzymes of the flagellar operon was found to have this
activity (Herlihey, et al., 2014).
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Figure 3.5. Relative levels of muropeptides in periplasm. Muropeptides extracted
from the periplasm consisted primarily of disaccharide-peptides across all the strains.
Higher levels of monosaccharides were detected in PAO∆ampG∆ampP.

Figure 3.6. Relative levels of monosaccharides in whole-cell and periplasm. 1, 6
anhydro MurNAc peptides tri and tetrapeptide were monosaccharides detected in both
whole cell and periplasmic extracts. The levels of monosaccharides in the periplasm
were lower when compared to those in the whole-cell extracts.

Similarly, for the larger muropeptides such as the tetra-saccharide peptides and the
cross-linked PG fragments, minute quantities were detected in the mutant strains as well
as in PAO1. When compared across strains for the whole-cell and the periplasmic
extract, levels of the larger peptides were found to be higher (Figure 3.6). This may be
due to the sample preparation method as sonication is used to isolate the whole-cell
extracts which may result in displacing the larger muropeptides that may otherwise be
stuck with the sacculus (Lee, et al., 2016).
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Figure 3.7. Relative levels of larger muropeptides in whole-cell and periplasm. The
larger peptides included tetrasaccharides tri-tri peptide and tetra-tetra peptides. The crosslinked peptides included disaccharides- tri-tri peptides and tetra-tetrapeptides. Relatively
higher levels were found in the whole cell preparation.

3.4.7 Decrease of disaccharide in PAOΔampP periplasm and increase presence of
disaccharide in PAOΔampG periplasm. As we had the levels of muropeptides in the
whole-cells and the levels of muropeptides in the periplasm, by subtraction analyses, the
muropeptides in the cytoplasm was inferred. Upon comparing the different groups of
muropeptides, it was found that decrease in accumulation of disaccharides was found in
ampP deletion in the periplasm and an increase of disaccharides was detected in the
ampG deletion suggesting that the permease encoded
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by these genes may play a role in import of these muropeptides into the periplasm and
cytoplasm, respectively (Figure 3.8).The levels of monosaccharide and larger
muropeptides remain similar in all the strains.

9,000,000.00

Whole cell_Disaccharide

8,000,000.00

Periplasm_disaccharide
Cytoplasm_ disaccharide

Peak area

7,000,000.00
6,000,000.00
5,000,000.00
4,000,000.00
3,000,000.00
2,000,000.00
1,000,000.00
-

PAO1

PAOΔampG

PAOΔampP PAOΔampGP

Figure 3. 8. Comparison of disaccharide levels in sub-cellular fractions. The
levels of disaccharide muropeptides were calculated in the whole-cell and
periplasmic fraction. The levels of muropeptides in the cytoplasm were obtained by
subtracting the values of muropeptides in periplasm from whole-cell. It was found
that deletion of ampG showed a significant accumulation of muropeptides in the
periplasm compared to the wild-type PAO1. The levels of disaccharidemuropeptide in the ampP deletion strain were decreased compared to PAO1. This
was also seen upon in the double-deletion strain.

3.5 Concluding Remarks
Cell-wall recycling has been researched since the 1960-70s (Chaloupka, et al., 1962,
Boothby, et al., 1973, Beck & Park, 1976). Early studies were performed mostly on E.
coli or C. freundii as model systems. Most of these studies conducted pulse-chase
experiments with H3-GlcNAc or H3-DAP which was incorporated in the cell-wall and
henceforth recycled and detected in spent media or in cell-fractions (Glauner, et al.,
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1988, Dietz, et al., 1997). Muropeptide detection without any radioactivity has been
performed only recently (Borisova, et al., 2016, Lee, et al., 2016). Pseudomonas
aeruginosa, a portentous opportunistic pathogen exhibits an exceptional capability to
resist antibiotic treatment. In this study we explored the link of β-lactam resistance with
the two permeases AmpG and AmpP in cell-wall recycling by comparing the wild-type
PAO1 with isogenic single and double-deletion permease mutants. The involvement of
the permeases in antibiotic resistance was investigated by E-test and β-lactamase
assay. We also looked at the levels of muropeptides in vivo in P. aeruginosa without
employing any radioactivity. Studying muropeptides in vivo poses its own challenges.
Muropeptides in the bacteria are continuously being turned –over and hence obtaining a
snapshot of this dynamic process is technically challenging. One of the main technical
difficulties, while quantifying the PG fragments at a certain phase of bacterial growth, is
quenching the recycling enzymes namely the amidases, lytic transglycosylases, and the
N-acetyglucosaminidases that are usually involved in muropeptide processing. We find
that quenching enzyme activity to a large extent can be obtained by boiling the cellextracts without lessening the muropeptide levels.
Previous studies involving non-pathogenic and pathogenic bacteria suggested that
ampG plays a role in cell-wall recycling as a permease (Park, 1993). It has also been
shown that pathogenic bacteria such as B. pertussis and N. gonorrhea have an
inefficient AmpG and when compared with non-pathogens such as E. coli (Chan &
Dillard, 2016). Both AmpG and AmpP are permeases in P. aeruginosa that may play a
role in cell-wall recycling. It is shown here that the presence of these permeases is not
essential for the growth of the bacteria in a rich medium. Since the elucidation of
recycling process and its connection to β-lactamase already that AmpG is used to import
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the muropeptides into the cytoplasm from the periplasm. Absence or deletion of this
permease often results in increase release of muropeptides to extracellular milieu which
triggers an inflammatory response in the host (Garcia & Dillard, 2008). However, this
was not seen in P. aeruginosa wherein deletion of AmpG resulted in similar total levels
of muropeptides as in PAO1. AmpP is unique to the Pseudomonads (Kong, et al., 2010).
In P. aeruginosa, overall trends of muropeptides were similar across the strains. One of
the findings was that our periplasmic preparation yielded less monosaccharides
compared to the whole-cell. This is in accordance with the localization of the enzymes in
the recycling pathway and indicates that the method of extraction developed here can be
used for studying periplasmic PG fragments. We also found increased relative levels of
disaccharide in the periplasm of ampG deletion cells and the vice-versa for ampP and
ampG ampP deletion. This confirms the earlier reports of AmpG importing disaccharides
and also suggests that AmpP may play a role in transporting disaccharide-muropeptides
from the cytoplasm into the periplasm. Although, a permease assay done with E. coli
spheroplasts using fluorophore- conjugated GlcNAc-MurNAc showed that AmpG was
the only muropeptide importer whereas AmpP was unable to import (Perley-Robertson,
et al., 2016). However, our speculation is that AmpP may be involved in export of
disaccharide muropeptide rather than import.
Significantly diminished MIC for selected β-lactams and a decrease in β-lactamase
expression was also found in the absence of ampG. This suggests also that the role of
AmpG in antibiotic resistance is mediated specifically via the cell-wall recycling pathway
and the activation of AmpR. Considering that AmpG is a key player in regulating
antibiotic resistance and is not essential for growth, it has been developed as an
alternate target for drug development (Collia, et al., 2018).
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Chapter 4

Elucidating the role of PA1085 in Pseudomonas aeruginosa
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4.1 Abstract
Infections by the opportunistic human pathogen Pseudomonas aeruginosa are
largely intractable due to the various resistance mechanisms demonstrated by this
pathogen. One of the primary mechanisms of resistance towards a class of drugs known
as β-lactams is the expression of a hydrolytic enzyme, AmpC. The coordinated activities
of the amp genes regulate this enzyme’s expression. NagZ is an N-acetyl β-Dglucosaminidase that plays a seminal role in regulating AmpC β-lactamase expression.
LC/MS analyses of muropeptides in PAO1 and the permease mutants eluded that there
may be a periplasmic paralog of NagZ. P. aeruginosa genome analyses revealed the
presence of PA1085 that had 31% identity with S. enterica FlgJ. We hypothesize that
PA1085 is the P. aeruginosa periplasmic glucosaminidase. PA1085 is the fifth gene of a
seven-gene operon and a precise in-frame deletion of flgJ (PA1085) was constructed
using Gibson cloning. To verify if deleting a gene that is part of the flagellar operon
disrupted motility, phenotypic assays such as swimming, swarming and biofilm were
performed. For evaluating if flgJ plays a role in regulating β-lactam resistance the MIC
was compared in flgJ deletion strains to the wild-type PAO1 using the Epsilometer test
method. An enzyme assay was conducted to determine if assess whether FlgJ
possesses β-N-acetylglucosaminidase activity. We found that flagellar-dependent
swimming motility was decreased in the mutant strain, but flagellar and pili-dependent
swarming motility were not significantly affected. Our experiments with the deletion strain
did not show any differences in the MIC for selected antibiotics. Deletion of PA1085 also
did not alter the β-N-acetylglucosaminidase enzyme activity in whole-cell.

108

4.2 Introduction
Pseudomonas aeruginosa, an opportunistic, nosocomial pathogen is associated with
serious and challenging infections in immunocompromised individuals (Lang, et al.,
2004, Sadikot, et al., 2005). In cystic fibrosis patients, with an increase in age, there is a
steady decline of lung function and an increase in P. aeruginosa colonization (Koch &
Hoiby, 1993, Gisin, et al., 2013). P. aeruginosa infections can at times be resolved with
monotherapy but it can also range to highly recalcitrant and deadly episodes. Often for
treatment of serious infections, a combination therapy of two or more anti-pseudomonal
agents such as aminoglycosides, fluoroquinolones, and β-lactams is recommended
(Flume, et al., 2009, Fothergill, et al., 2012). The underlying factors for the lifethreatening infections are the arsenal of virulence factors and the extraordinary innate
and acquired antibiotic resistance mechanisms exhibited by this pathogen (Lister, et al.,
2009, Gellatly & Hancock, 2013). One of the predominant mechanisms of β-lactam
resistance is the expression of chromosomally-encoded AmpC β-lactamase and its
regulation by the global transcriptional factor, AmpR (Lodge, et al., 1990, Lodge, et al.,
1993, Kong, et al., 2005). The activity of AmpR as a resistance determinant is further
influenced by the products of the cell-wall recycling pathway, known as muropeptides
(Wiedemann, et al., 1998, J. F. Fisher, 2015, Lee, et al., 2016, Lee, et al., 2016, Dik, et
al., 2017, Dhar, et al., 2018).
Previously, our analyses by liquid chromatography/mass spectrometry identified over
20 muropeptides in P. aeruginosa (Lee, et al., 2016). Muropeptides are composed of Nacetylglucosamine-N-acetylmuramic acid with a peptide side chain (L-Ala-ɣ-D-Glu-mesodiaminopimelic acid [DAP]-D-Ala-D-Ala) and are created whenever the bacterial cell
divides or elongates and its components are recycled for biogenesis (Glauner, 1988).
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The muropeptides detected by our analysis include disaccharide-peptides such as Nacetylglucosamine N-acetylmuramic acid with peptide side chains ranging from zero to
five amino acids. Both reduced and non-reduced saccharides were detected (Lee, et al.,
2016). Monosaccharides detected include N-acetylmuramic acid with peptide side
chains. In addition, larger peptides such as cross-linked di- and monosaccharides were
also detected (Lee, et al., 2016). In addition to elucidating the structural details of the
muropeptides, we were also able to distinguish the GlcNAc pentapeptide and 1.6
anhMurNAc pentapeptides as activating effectors of AmpR (Lee, et al., 2016, Dik, et al.,
2017).
Recycling of muropeptides occurs through the combined action of numerous genes
dedicated to this pathway (Park & Uehara, 2008, Johnson, et al., 2013). The groups of
enzymes

include

lytic

transglycosylases,

amidases,

permeases,

N-

acetylglucosaminidases and penicillin-binding proteins (Park, 1993). The muropeptides
are translocated into the cytoplasm through permease AmpG (Jacobs, et al., 1997).
NagZ N-acetylglucosaminidase activity in the cytoplasm leads to the formation of 1, 6
anhydroMurNAc peptides which have been identified as the AmpR effectors (Jacobs, et
al., 1994, Dietz, et al., 1997, Lee, et al., 2016, Dik, et al., 2017). AmpD amidase cleaves
the peptide chain from the muropeptides (Carrasco-Lopez, et al., 2011, Zhang, et al.,
2013). Upon β-lactam induction, loss of nagZ is associated with a decrease in ampC
expression whereas loss of ampD is associated with an increase in ampC expression
(Jacobs, et al., 1995, Juan, et al., 2005, Juan, et al., 2006, Asgarali, et al., 2009, Lee, et
al., 2009).
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Locus Tag

P. aeruginosa PA1085
% Identity

% Similarity

S. enterica FlgJ

31

46

P. aeruginosa NagZ

20.7

32.9

Table 4.1. Protein homology between S. enterica and P. aeruginosa FlgJ. S.
enterica data was obtained from NCBI. P. aeruginosa sequence was obtained from
Pseudomonas website (Winsor, et al., 2016). Identity was computed using CLUSTAL
W2 “pairwise sequence alignment”.

Therefore, NagZ is established as an antibiotic target and small molecule inhibitors
of NagZ have been synthesized which impair β-lactam resistance (Balcewich, et al.,
2009, Yamaguchi, et al., 2012, Acebron, et al., 2017). During our analysis of P.
aeruginosa muropeptides, the NagZ products 1, 6 anhydroMurNAc peptides

were

detected in the periplasm (Lee, et al., 2016, Lee, et al., 2016). This suggested the
existence of

a novel periplasmic

N-acetylglucosaminidase.

A periplasmic N-

acetylglucosaminidase FlgJ had been detected in Salmonella sp. (Herlihey, et al., 2014).
Bioinformatics analysis of the P. aeruginosa genome with 31% identity to S. enterica
FlgJ (Table 4.1). Furthermore, sequence alignment of P. aeruginosa FlgJ and S.
enetrica FlgJ shows that the catalytic residue (Glutamate 184) is conserved (Figure 4.1).
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Figure 4. 1. Amino acid sequence alignment of PA1085/FlgJ with S. enterica
FlgJ (Lee, et al., 2016). Residues in the red box denote the Glu residues which are
predicted as the catalytic acid/base residues in the respective enzymes. Protein
alignment was done using CLUSTAL W2 (Winsor, et al., 2016).

The synthesis and assembly of the flagellar system have been best investigated in
Salmonella species (Aizawa, 1996, Apel & Surette, 2008). The C-terminal domain of
FlgJ has a peptidoglycan lytic activity whereas the N-terminal domain is required for
proper flagellar assembly (Nambu, et al., 1999, Hirano, et al., 2001). FlgJ is part of the
the flagellar biosynthesis operon in P. aeruginosa (Dasgupta, et al., 2003). The flagellar
biosynthesis genes are clustered in three regions on the PAO1 genome (Dasgupta, et
al., 2003). Region I comprises of genes that encodes proteins which build the flagellar
structure (Dasgupta, et al., 2003). Region II encodes for the accompanying regulatory
components whereas Region III encodes for proteins which help in export of the flagella
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and other chemotaxis regulatory factors (Dasgupta, et al., 2003). FlgJ is encoded by the
fifth gene of a six gene operon flgF-flgG-flgH-flgI-flgJ-flgK found in Region I. All the other
genes in this operon encode structural components of flagella whereas FlgJ is
hypothesized to act as a peptidoglycan specific muramidase (Dasgupta, et al., 2003).
FlgJ was found to have N-acetyl β-D glucosaminidase activity in Salmonella species
and it is likely that this enzyme may have a similar function in P. aeruginosa (Figure 4.2).
The overall goal of this research project is to investigate the role of flgJ in P. aeruginosa.
Specifically, its role in antibiotic resistance will be ascertained. In addition, the enzyme
activity of FlgJ will also be discerned through enzyme assays. Besides its putative role in
cell-wall recycling and antibiotic resistance, as this gene is a part of flagellar biosynthesis
assembly, its role in motility and motility- associated phenotypes will also be
investigated.
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Figure 4. 2. Flagellar assembly. The model for flagellar assembly is best studied in
Salmonella sp. The flagellum has to cross through three main barriers, the inner
membrane, the peptidoglycan layer and the outer membrane to reach the
host/extracellular milieu. This transport process is facilitated by the flagellar transport
system (Aizawa, 1996). The transport of the flagellar rod through the inner membrane is
achieved by creating gaps by the activity of FliF (Ueno, et al., 1992). FlgJ creates holes in
the PG layer allowing its export through the periplasmic space and through the
peptidoglycan (PG) layer. PG fragments are produced at this point which may enter the
PG recycling pathway and may also act as AmpR effectors. FlgH and FlgI allow the
penetration of the flagellar rod through the outer membrane (Vogler, et al., 1991). Land P
rings are usually formed at the intersection of the flagellar rod with the outer membrane
and PG, respectively (Jones, et al., 1989, Nambu, et al., 1999).

4.3. Materials and Methods
4.3.1 Strains, media and growth conditions.

Pseudomonas aeruginosa PAO1

(Stover, et al., 2000) and its derivatives (PAOΔflgJ) and Escherichia coli DH5α were
used in this study. For triparental mating experiments, Pseudomonas Isolation Agar
(Difco, NJ, USA) was used along with LB (1:1) for P. aeruginosa selection. For plasmid
selection and maintenance, antibiotics at the following concentrations were used:
Gentamicin (Gm) 15 μg/mL for E. coli, 75 μg/mL for P. aeruginosa, Carbenicillin (Cb) at
50 μg/mL for E. coli, 150 μg/mL for P. aeruginosa, Chloramphenicol (Cm) and
Kanamycin (Km) at 20 μg/mL for E. coli.

Table 4. 2. Strains, plasmids and primers used in this study.
Strains

Relevant phenotype and genotype

Reference/
Source

Escherichia coli
F- Φ80lacZΔM15 Δ(lacZYA argF)U169 deoR
recA1 endA1 hsdR17 (rk-mk+) phoA supE44
DH5α
λ- thi-1 gyrA96 relA1
Pseudomonas aeruginosa

New England
Biolabs

PAO1

(Holloway, et
al., 1979)

Wild-type
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PAO∆flgJ
PAO1(pET 15bvp)
PAO∆flgJ (pFlgJ)

PAO1 containing in-frame deletion of flgJ
PAO1 containing plasmid pET15BVP
PAO∆flgJ containing flgJ on plasmid p
ET15BVP

This study
This study
This study

Plasmids
pGEMT
pRK600
pRK2013
pEXG2
pET15bVP

pSD194

pSD197

TA cloning vector for PCR products; ApR,
ColE1 f1 ori lacZα
CmR; colE1 tra+RK2 mob+; Helper plasmid for
conjugation
KmR; colE1 tra+ RK2 mob+; Helper plasmid for
conjugation
GmR; pMB1ori sacB
ApR; pBR322 origin, oriV, expression vector,
T7 promoter, His tag coding sequence
ApR; A ~1.2-kb XhoI-BamHI fragment
containing flgJ ORF (PA1085) amplified from
PAO1
genome using PA1085_fw_Xho1 and
PA1085_Rev_BamH1 primers and cloned
into pGEMT
GmR; The flgJ ORF sub-cloned from pSD194
as an XhoI-BamHI fragment into pET15BVP

Promega
(Figurski &
Helinski, 1979)
(Finan, et al.,
1986)
(Rietsch, et al.,
2005)
(Arora, et al.,
1997)

This study

This study

Primers
Gibson_flgJ_Fw

SD_PA1085_UR

SD_PA1085_DF

Gibson_flgJ_Rev

PA1085_fw_Xho1
PA1085_Rev_BamH1

5’tgggctagcgaattcgagctAGGAGATATACCATGG
ATTCCCGTTTGCTCAGC
-3’
5’CGGACATGGGTCAGTTCCTCCTTGCTAGC
TAGCTAGGCGTCGTCCTCAAATCACG-3
5’CGTGATTTGAGGACGACGCCTAGCTAGCT
AGCAAGGAGGAACTGACCCATGTCCG-3’
5’ggatccccgggtaccgagctTCAACCCAGAGGCGG
CGT
-3’
5’ACACTCGAGAGGAGATATACCATGGATTC
CCGTTTGC-3’
5’-GGATCCTCAACCCAGAGGCGGCG-3’

This study

This study

This study

This study

This study
This study

4.3.2 Construction of flgJ deletion mutants by homologous recombination using
Gibson cloning. A deletion strain of flgJ (PA1085) was constructed using a Gibson
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cloning kit (Gibson, et al., 2009). The DNA sequences upstream (P1) and downstream
(P2) of the gene to be deleted were amplified by PCR using High-fidelity polymerase
(Pfu DNA Polymerase, Promega, Madison, WI) and primer pairs Gibson_flgJ_Fw,
SD_PA1085_UR and SD_PA1085_DF, Gibson_flgJ_Rev (primers listed in table 4.2).
The amplicons generated were fused with the EcoR1-linearized plasmid pEXG2 to
regenerate the recombinant plasmid (Hoang, et al., 1998). The amplicons were
sequenced to ensure fidelity. Henceforth, a similar protocol as used for deletions by
yeast-method was followed. The recombinant plasmid was conjugated into P.
aeruginosa PAO1 by tri-parental mating for homologous recombination with PAO1
genome (Figurski & Helinski, 1979, Finan, et al., 1986).

The colonies that showed

integration of the deletion product, as well as the presence of the target gene, also
known as single-crossovers, were selected for generating double-crossovers. The
double-crossovers were identified by screening for their gentamycin sensitivity and
sucrose resistance. The deletion product was verified by PCR amplification and
sequencing. Henceforth, this strain is referred to as PAO∆flgJ.

4.3.3 Construction of flgJ complementing clones. The flgJ (~1.2 kb) gene was PCR
amplified using primer pairs PA1085_fw_Xho1 and PA1085_Rev_BamH1 (Table 4.2)
from P. aeruginosa PAO1 genome. The PCR-amplified product was cloned into pGEMT
(Promega, Madison, WI). The fidelity of the PCR-amplified product was confirmed by
sequencing. The insert carrying flgJ was then moved into a broad-host range pET15bVP
plasmid as Xho1-BamH1 fragment , henceforth known as pFlgJ (Arora, et al., 1997).
These plasmids were introduced by triparental mating into PAOΔflgJ.
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4.3.4 Minimum-inhibitory concentration (MIC). The MIC was determined using the Etest (BioMerieux), which is extensively viewed as a reliable method of susceptibility
analyses (Jorgensen, 1993, Amsler, et al., 2010). Briefly, overnight cultures of bacteria
were diluted to an O.D. of 0.02-0.2 and spread on a Mueller-Hinton-agar plate. Following
this, an E-test containing antibiotics at an increasing concentration along the length of
the strip was placed on the plate. The MIC was determined by the zone of clearance on
the plate after 16-18 hr incubation at 37 ⁰C.

4.3.5 Motility assays. Swimming assays were done by stabbing 0.3% LB agar plates
with a single colony of PA01, PAOΔflgJ, PAO1(pET15bVP), and PAOΔflgJ(pFlgJ)
bacteria (Henrichsen, 1972). Swarming plates made of 0.5% LB agar were inoculated
with a single colony of the above-mentioned strains and incubated at 30°C overnight
(Allison & Hughes, 1991). The swimming and swarming zone were measured after
overnight incubation at 30 °C.

4.3.6 Biofilm assay. Biofilm assay was performed in tubes as described previously
(Friedman & Kolter, 2004). Briefly, overnight cultures of PAO1 and mutant strains were
grown on LB agar plates were resuspended in LB and diluted to final OD of 0.0025.
PAOΔretS and PAOΔalgDΔpelΔpsl were kept as positive and negative controls,
respectively. All the tubes were incubated at 37 ⁰C for 24 hours. Subsequently, the
culture was discarded, and the tubes washed in bins containing water and left at room
temperature for ten minutes. This was stained with 0.1% crystal violet. The dye was
removed after 20 minutes and the tubes were washed thoroughly with running tap-water.
The attached dye was then solubilized with absolute ethanol and biofilm formation was
quantified by recording the absorbance at 590nm.
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4.3.7 N-acetylglucosaminidase assay. This assay was performed as stated previously
(Asgarali, et al., 2009). Briefly, the whole cell and periplasmic fractions from bacteria at
late-log phase were extracted. To the sample buffer containing 1xPBS, the substrate 4methylumbelliferyl N-acetyl β-D-glucosaminide (4-MUGlcNAc) was diluted to a final
concentration of 2 mM. Extracts containing 20 µg of protein was added to a 100 µl PBS
with substrate. This was incubated at 37 ⁰C for 4 and 8 hrs. At the end of each time-point
the reaction was quenched by adding 900 µl of 0.1 M glycine-NaOH (pH-10.5). The
fluorescence was measured by using an excitation wavelength of 360 nm and
monitoring the emission wavelength of 450 nm on a Synergy H1 Hybrid Reader (Biotek,
Winooski, VT). The assay was carried out in triplicates on black 96 well-plates with
optical bottom (Thermo Fisher). Controls contained wells with PBS and substrate (2 mM
of 4-MUGlcNAc), and PBS alone. As a control, PAOΔnagZ was used which has a
deletion of the gene encoding the cytoplasmic N-acetylglucosaminidase NagZ/PA3005.
The results were quantified by measuring the fluorescence against our experimental
time-points.

4.4. Results
4.4.1 flgJ is required for swimming motility. Motility is one of the primary virulence
factors of P. aeruginosa. P. aeruginosa shows three main types of motilities which
include swimming, swarming and twitching (Henrichsen, 1972). Swimming occurs on a
relatively more liquid surface as compared to swarming (0.3% agar vs 0.6% agar).
Swimming is mainly a flagella-regulated movement whereas swarming is regulated
partially by flagella and pili (Henrichsen, 1972, Rashid & Kornberg, 2000). It was found
that deletion of flgJ led to a deficiency in swimming motility when compared to the wild-
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type PAO1, whereas swarming motility was unaffected. This may be since swarming
movements are the result of the polar flagellum usually found in P. aeruginosa, as well
as pili and additional alternative motors (Doyle, et al., 2004, Toutain, et al., 2005).

Figure 4. 3. Swimming motility of PAOΔflgJ vs PAO1. FlgJ was found to be
required for regulating swimming motility in PAO1. Values were significant at p
<0.05 (PAOΔflgJ vs PAO1 p=0.02, as determined by unpaired student’s T-test)

4.4.2 flgJ is required for initiation of biofilm. The formation of biofilms was measured
by growing the culture in polystyrene tubes over 24 and 48 hours. Biofilm is an
aggregate of polysaccharides, mainly Pel and Psl, extracellular DNA and water channels
formed as an extracellular matrix by P. aeruginosa (Branda, et al., 2005, Ryder, et al.,
2007). An important consequence of this feature is the increased resistance of the
bacteria to antibiotics (Stewart, 2002). A biofilm is formed when the bacteria adhere
firmly to an abiotic or biotic surface and clinically, is associated with chronic infection
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phenotypes. Quantitation was done by staining the biofilm formed at the air-liquid
interphase with 0.1% crystal violet. PAOΔretS was used as the positive control as retS is
involved in inhibition of GacA phosphorylation which promotes biofilm (Goodman, et al.,
2009). PAOΔpelΔpslΔalgD, a biofilm non-former was used as the negative control for
this assay (Balasubramanian, et al., 2012). It was found that in initial stages at 24 hours,
where the bacteria attach to the surface, flgJ deletion strains were lagging slightly as
compared to the wild-type PAO1, whereas over a time-period of 48 hours, this was
negated. In fact, absence of flagella seemed to contribute to higher levels of biofilm
formation. This data concurs with previous studies which demonstrate that the flagellum
is required only at the initial stages of biofilms.

*

Figure 4. 4. Biofilm formation assay. Biofilms were measured over 24 and 48 hour
time-period for all the strains. Differences between the parent PAO1 and deletion was
found to be significant at 48 hours (* p value = 0.03 as determined by unpaired T-test)

4.4.3 MIC of selected antibiotics is unaltered in absence of flgJ. To investigate the
role of flgJ in P. aeruginosa, a precise deletion of the gene was constructed in the wild-
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type reference strain, PAO1. The β-lactam susceptibility of this strain was investigated
using the E-test. The antibiotics chosen were based on our hypothesis that FlgJ
hydrolyzes the peptidoglycan and generate the monosaccharide muropeptides namely
the 1, 6 anhydro peptides which have been shown to act as effectors of AmpR. Hence βlactams and other antibiotics which show differential expression in absence of AmpR
were investigated (Balasubramanian, et al., 2012). However, no difference was noted in
the mutant strain PAOΔflgJ in comparison to the parent strain PAO1.

Figure 4. 5. MIC of mutant strains PAOΔflgJ. The MIC of β-lactams and other
antibiotic that exhibit a differential difference with AmpR deletion was investigated
in PAOΔflgJ and compared to the parent strain PAO1. No significant difference is
found between the groups as determined with T-test.

4.4 N-acetylglucosaminidase assay. This assay is based on the conjugation of a
fluorogenic substrate, 4- methyl umbelliferyl attached to N-acetyl β-D glucosaminide
(4MU GlcNAc). This assay has been used previously to detect N-acetylglucosaminidase
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activity from lysates of P. aeruginosa to determine NagZ expression (Asgarali, et al.,
2009). NagZ (PA3005) is currently the only known enzyme in P. aeruginosa to possess
N-acetylglucosaminidase activity.

P. aeruginosa strains that do not have this gene,

hence, have decreased fluorescence in the presence of 4-MUGlcNAc (as was confirmed
in this assay). The fluorescence emitted due to the fission of 4-MUGlcNAc from the
different bacterial whole-cell extracts were quantified after normalizing with the
fluorescence detected from PAOΔnagZ. Wells were kept with just the substrate in buffer
and the fluorescence recorded from these wells was subtracted from all the test sample
wells. When compared with the wild-type PAO1, no significant difference in fluorescence
was found in PAOΔflgJ. As flgJ is believed to be periplasmic, the cleavage of 4MUGlcNAc will be compared between periplasmic fractions of PAO1 and PAOΔflgJ.
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Figure 4. 6. N-acetylglucosaminidase activity in whole-cell extracts. The activity
of N-acetylglucosaminidase in whole cell extracts were measured using 4Methylumbelliferyl N-acetyl-β-D-glucosaminide as a substrate. Fluorescence was
measured using an excitation wavelength of 360nm and emission at 450nm. Values
were normalized to that of nagZ deletion strain. No significant difference in
fluorescence was observed in PAO1 and PAOΔflgJ whole-cell lysates (p>0.05, as
determined by unpaired students T-test).

4.5 Discussion

Cell-wall recycling is closely related to β-lactam resistance. A particular focus of our
lab was to elucidate the profile of muropeptides generated during cell wall recycling in P.
aeruginosa (Lee, et al., 2016).

In our studies, elevated levels of two periplasmic

muropeptides GlcNAc anhydroMurNAc- and 1, 6 anhydroMurNAc pentapeptides were
detected in the presence of β-lactams which were later confirmed as the AmpR effector
(Dik, et al., 2017). Previous to our in vivo analysis of P. aeruginosa muropeptides, 1, 6
anhydroMurNAc were known to be generated exclusively in the cytoplasm following the
activity of a N-acetyl β-glucosaminidase NagZ (PA3005) (Asgarali, et al., 2009).

NagZ

is established as an antibiotic target and small-molecule inhibitors of NagZ have been
synthesized which attenuate β-lactamase expression and impair β-lactam resistance
(Stubbs, et al., 2007, Yamaguchi, et al., 2012).
During our analysis of muropeptides in P. aeruginosa, we detected 1, 6
anhydroMurNAc peptides in the periplasm suggesting the existence of a novel
periplasmic β-N-acetylglucosaminidase. A periplasmic N-acetylglucosaminidase FlgJ
was identified in S. enterica which led us to analyze P. aeruginosa FlgJ/PA1085
(Herlihey, et al., 2014). In P. aeruginosa flgJ (PA1085) is a part of the flagellar assembly
operon and its role has been associated with flagellar biogenesis. The synthesis of
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flagellar units occurs in the cytoplasm and its assembly and transport is facilitated by the
activity of the flagellar transport system (Iino, 1974).

For the flagella to reach the

extracellular milieu, three barriers, namely the inner membrane, PG layer and the outer
membrane have to be traversed. It has been presumed that the peptidoglycan layer is
broken down by hydrolases that are present in the periplasmic space to facilitate the
flagellar insertion (Fein, 1979). The assembly and transport of the flagella have so far
not been studied in P. aeruginosa. FlgJ in Salmonella was the first account of an Nacetylglucosaminidase in the periplasm that breaks the PG allowing the insertion of the
flagella and in this process generates monosaccharides (Herlihey, et al., 2014). To
understand the role of FlgJ, a precise in-frame deletion was constructed using Gibson
cloning. This technique of deletion was adapted as it yields results in a much shorter
time than that we previously used involving yeast-system based recombination (Kalva, et
al., 2018).
Absence of flgJ resulted in diminished swimming motility and increased biofilm
formation which was restored by in trans complementation to the level of wild-type.
Motility and chemotaxis are one of the main virulence factors that help in establishing
infections in the host. Absence of FlgJ however did not show any difference in the
susceptibility profile of selected antibiotics. This would suggest to us that FlgJ is not
involved in antibiotic resistance. However, an interesting analysis will be to over-express
this protein and observe its effects on the MIC levels. Levels of N-acetylglucosaminidase
were determined in PAO∆flgJ and compared to that of PAO1 using 4-MUGlcNAc as the
substrate for N-acetylglucosaminidase. PAO∆nagZ was used as a control and it was
found that there was no difference in the levels between the flgJ deletion and the wildtype whole-cell extract. For further analysis the periplasmic extracts will be analyzed for
the enzyme activity.
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In Gram-positive organism such as Enterococcus faecalis one of the primary Nacetylglucosaminidases is AtlA (Eckert, et al., 2006). This enzyme comprises of three
domains, with a threonine/glutamate rich N-terminal, a catalytic central domain and
LysM domains at the C-terminal, each of which is required for the maximal hydrolytic
activity of the peptidoglycan (Eckert, et al., 2006). Upon comparisons of the protein
domains, we find that PA1085 has a similar conserved LysM domain. The LysM domain
is indicative of proteins that are capable of binding with the PG and is hence important
for eliciting the full enzymatic activity of the protein (Buist, et al., 2008). The conservation
of this sequence in FlgJ further reinforces our hypothesis that this enzyme may have an
N-acetylglucosaminidase activity. Domain analysis of PA1085 using the Carbohydrate active enzymes (CAZy) database also reveals that it belongs to the glycoside hydrolase
family of proteins GH73 (Cantarel, et al., 2009). Proteins belonging to this family are
known to cleave the linkage between N-GlcNAc and MurNAc (Hashimoto, et al., 2009).
Besides FlgJ, genome analysis of P. aeruginosa revealed a second periplasmic
glucosidase BglX (PA1726) which is yet to be characterized. Upon multiple sequence
alignment of NagZ, FlgJ and BglX, it was found that one of the active site residues of
NagZ, D244, are conserved on both FlgJ and BglX. This suggests the possibility of a
different periplasmic hydrolase that may generate the periplasmic monosaccharides. Our
research has explored the role of AmpP/PA4218 as an exporter of disaccharidepeptides. Alternatively, there may be another transporter which exports the cytoplasmic
monosaccharides into the periplasm.
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Chapter 5

Small-Molecule Library Screening For Pseudomonas aeruginosa AmpR Inhibitors
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5.1. Abstract

Pseudomonas aeruginosa has been classified by the World Health Organization as a
pathogen of “critical” importance. It causes serious acute and chronic infections often
resulting in life-threatening episodes. Previous research in our lab has identified players
in the amp system which plays a role in antibiotic resistance and virulence. AmpR has
an extensive regulon in P. aeruginosa and is intricately linked to antibiotic resistance,
recycling of the cell-wall and expression of virulence factors required for infection.
Although AmpR has been identified in many pathogens, its role in P. aeruginosa
appears to be more elaborate. In P. aeruginosa, AmpR has been shown to localize in
the membrane and exist as a dimer in the active form which is further explained in this
research through structural modelling. This research also explores AmpR as a novel
antibiotic target. A phenotypic screening assay has been developed fusing promoters
regulated by AmpR, PampC, to a lux operon cassette. This reporter was used to screen
scaffold-based combinatorial library for AmpR inhibitors. Positive hits identified from this
study will be further counter-screened using reporters with alternate AmpR regulated
promoters namely, PphzA1 and PmexE. Novel compounds that are identified in this study
can also be used for other pathogen with a homologous AmpR-AmpC system such as
Yesrsinia enterocolitica, Burkholderia cenocepacia, and Strenotrophomonas maltophila.

5. 2. Introduction

Pseudomonas aeruginosa is known for causing recalcitrant infections in mainly
immunocompromised patients and at least 10% of all nosocomial infections in the US
are due to this pathogen (Bodey, et al., 1983, Gaynes & Edwards, 2005). This
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opportunistic bacterium can cause a wide-range including both chronic and acute
infections in humans (Furukawa, et al., 2006). Some of the chronic infections are
respiratory tract and lung-associated resulting in chronic pneumonia, pan bronchiolitis,
and chronic obstructive pulmonary disorder (Rose, 1968, K. Yanagihara 2001, Boyer, et
al., 2005, Martinez-Solano, et al., 2008). One of the most archetypal chronic infections
linked with this pathogen is found in cystic fibrosis (CF) patients. CF lungs present with
mixed-infections, colonized by P. aeruginosa, Staphylococcus aureus, Haemophilus
influenzae, Methicillin-resistant S. aureus (Marks, 1990, Rayner, et al., 1990, Koch &
Hoiby, 1993, Tummler, et al., 1997, Miall, et al., 2001, Marshall, et al., 2016). Owing to
its incredible multi-factorial pathogenesis and propensity for antibiotic resistance, with an
increase in the patient’s age, P. aeruginosa reigns supreme amongst the other lungassociated infections (West, et al., 2002). These recurrent pulmonary infections result in
increased inflammatory responses and lung deterioration, ultimately causing high
morbidity and mortality (Yum, et al., 2014, Langan, et al., 2015). Besides chronic, P.
aeruginosa also possess the virulence arsenal for acute infections (Yahr & Greenberg,
2004). Notable ones include acute pneumonia, particularly in patients who are
hospitalized or are unable to mount a sufficient immune response against P. aeruginosa
(Pereira, et al., 2014). Other significant ones include acute keratitis occurring in up to
40% of cases found in US.

Besides these, sepsis due to bacteremia and wound-

infections due to burns or post-surgery and urinary tract infections are also observed
(Wu, et al., 1999, Estahbanati, et al., 2002, Kang, et al., 2003, Secher, et al., 2005,
Shigemura, et al., 2006, Migiyama, et al., 2016).
Underlying these two infection phenotypes are distinct groups of virulence factor and
their regulators (Furukawa, et al., 2006, Gellatly & Hancock, 2013). The prominent ones
that contribute to chronic infection include biofilm and alginate, often found in a CF lung
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(Pedersen, et al., 1990, Pedersen, 1992, Winstanley, et al., 2016). Acute infection is due
to release of exo- and endo-toxins, proteases and involves largely the quorum sensing
(QS) and type 3 secretion systems (T3SS) (Smith & Iglewski, 2003, Hauser, 2009). The
decision of an acute or chronic infection in the host is regulated by the environmental
signals which determine the gene expression levels of various virulence determinants.
Often, the inability to cure an acute infection results in genetic adaptive changes in the
organism resulting in a chronic infection (Furukawa, et al., 2006, Balasubramanian, et
al., 2013, Winstanley, et al., 2016). Thus, preventing the establishment of an acute
infection is of fundamental importance.
Previous studies in our lab have shown that a transcriptional factor involved in
regulating acute infection phenotypes is AmpR (PA4109) (Balasubramanian, et al.,
2015). AmpR has been the focus of research for long as it was recognized that it is a
pivotal point for regulating β-lactamase resistance (Normark & Lindberg, 1985,
Wiedemann, et al., 1998). In addition to its role as a cynosure in β-lactam resistance, in
P. aeruginosa it also acts as a “global” regulator (Balasubramanian, et al., 2012). The
extent of its regulation is limited to not just β-lactams, but towards many non-β-lactam
antibiotics as well as acute infections- related phenotypes. One of the major areas
where AmpR influence is seen is toward the quorum sensing (QS) regulated
phenotypes, including production of LasA, LasB proteases, phenazine pigments as well
as in biofilm formation (Balasubramanian, et al., 2012). It has been found that AmpR
regulates three of the four QS in P. aeruginosa; Las, Rhl, and PQS (Balasubramanian,
et al., 2014). These systems together improvise a majority of virulence factors affecting
acute infections. AmpR deletion also favors diminished virulence of P. aeruginosa in
animal models of toxicity (Balasubramanian, et al., 2012). In addition to virulence factors,
AmpR is also required for essential metabolic processes that promote survival in the
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host, such as iron uptake and response to oxidative-stress (Balasubramanian, et al.,
2012, Balasubramanian, et al., 2014).
Besides regulating multiple virulence and other metabolic processes, P. aeruginosa
AmpR along with other players of cell-wall recycling also plays a central role in
regulating β-lactam resistance (Kong, et al., 2005). Furthermore, its influence is not
limited to just β-lactams but to other antibiotics such as fluoroquinolones and
aminoglycosides (Balasubramanian, et al., 2012). Previous research in our lab has also
shown that AmpR creates cross-resistance between antibiotics in the presence of subinhibitory concentrations of β-lactam antibiotics (Kumari, et al., 2014).
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Figure 5. 1. AmpR regulon. AmpR which was previously known to be connected
to β-lactam resistance was shown to have an extensive regulon in P. aeruginosa.
Reprinted with permission from Oxford Publishing.
The increasing evidence that AmpR plays a massive role in the pathogenicity of P.
aeruginosa supports it as a candidate for a novel antibacterial target. The benefits of
inhibiting AmpR are multi-fold. The rising antibiotic resistance demands that we look into
identifying not just novel small-molecules that can be used as drugs but also develop
novel antibacterial targets. The targets that depart from showing lethality towards the
bacteria are preferred as that would not evoke rapid evolutionary protective responses
from the bacteria (Kaczor, et al., 2017). Rather, any target that deprives the organism of
its virulence arsenal and promotes a synergistic effect with other antibiotic targets is
preferred (Lynch & Wiener-Kronish, 2008, Silver, 2011). In addition, the AmpR-AmpC
system is found in many pathogens such as Yersinia enterocolitica, Strenotrophomonas
maltophila, Burkholderia cenocepacia (Seoane, et al., 1992, Proenca, et al., 1993,
Okazaki & Avison, 2008). Furthermore, this protein does not have its homolog in
humans hence makes it unique to bacteria.
This part of my dissertation project deals with further exploring AmpR and its
relevance in P. aeruginosa. Firstly, the localization of AmpR in membrane is reiterated
again, this time using both sucrose-gradient studies. In addition, we also describe a
reporter screen constructed for evaluation of small-molecule inhibitors of AmpR.
Furthermore, it has been shown that our reporter system can be used to detect for QS
inhibitors.
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5.3. Materials and Methods

5.3.1. Strains, media and growth conditions. P. aeruginosa PAO1 (Stover, et al.,
2000) and its derivatives (PAOΔampR) and Escherichia coli DH5α were used in this
study. For triparental mating experiments, Pseudomonas Isolation Agar (Difco, NJ, USA)
was used along with LB for P. aeruginosa selection. For plasmid selection and
maintenance, antibiotics at the following concentrations were used: Tetracycline (Tet) 20
μg/mL for E. coli, 100 μg/mL for P. aeruginosa, Carbenicillin (Cb) at 50 μg/mL for E. coli,
Chloramphenicol (Cm) and Kanamycin (Km) at 20 μg/mL for E. coli and at 50 μg/mL for
P. aeruginosa.
5.3.2. Membrane fractionation. Membrane fractions were isolated using previously
established protocols. PAO∆ampR and PAO∆ampR (pAmpR-His6) cells were streaked
on LB-agar. A single colony was inoculated next day in LB with and without antibiotics
and grown until an OD600 of 0.2. PAO∆ampR (pAmpR-His6) was induced with 1Mm
IPTG and incubated for 6 h with shaking before harvesting. Cells were recovered by
centrifugation at 5,000x g for 15 min at 4°C and washed with equal volume of 20mM of
Tris-Cl. The culture was then resuspended in lysis buffer containing 20mM Tris-cl, pH 8,
0.1M NaCl, 1mM EDTA, 100 µg of DNase I, 1mg/ml Lysozyme and 1X Roche complete
protease inhibitor cocktail. Following disruption of the cells on ice with sonication (15
cycles of 10-s pulse on and 30-s pulse off; amplitude, 40%), the cell lysate was
centrifuged at 4,000 x g for 10 min at 4°C to remove unbroken cells. The supernatant
was ultra-centrifuged at 36,000 rpm (Beckman Coulter Ti45 rotor) for 3 h at 4°C, and the
pellets containing membrane were resuspended in membrane buffer containing 25%
sucrose, 20 mM Tris, pH 7.4, and1X Roche complete protease inhibitor cocktail. The
membrane fractions were aliquoted and stored at -80°C. All Western blots were
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developed according to previous protocols. Briefly, equal amounts of proteins were
loaded on a 12% SDS-PAGE gel and run at 100 Volt for 1 h. The proteins were then
transferred to a polyvinylidene difluoride (PVDF) membrane (Bio-Rad) and blocked with
3% BSA in Tris-buffered saline (TBS) at 4°C overnight or at room temperature for 1 h.
The membrane was washed after blocking with TBST three times for ten minutes each
and probed with mouse-anti-His antibody (Biolegend, 1: 3,000) for 2 h at room
temperature or at 4 °C overnight. Membranes were subsequently washed with TBST,
incubated with anti-mouse IgG horseradish peroxidase-conjugated antibody (1: 5,000)
(Bio-Rad) for 1.5 h. The membranes were washed with TBST and developed using
SuperSignal West Pico Chemiluminescent Substrate (Pierce). The membrane fraction
was confirmed using Lactate dehydrogenase enzyme activity assay.

5.3.3. Modeling of AmpR. The monomer structure of AmpR effector binding domain
from Citrobacter freundii was obtained from protein data bank (pdb ID 3KOS.pdb). The
python script MakeMultimer.py was used to construct the dimer structure from BIOMT
transformation matrices contained in the pdb file. The visual molecular dynamics (VMD)
software was used to visualize and mutate structure (Humphrey, et al., 1996).

5.3.4. Reporter construction for luciferase assays. Reporters were constructed with
fusion of AmpR regulated promoters upstream of the lux operon. Specifically, PampC and
PphzA, which are respectively regulated by AmpR, with and without induction, were
selected (Balasubramanian, et al., 2012). PampC (~ 100 bp) was amplified from P.
aeruginosa

PAO1

genome

using

primers

EL04_ampC_forward_Xho

and

EL

05_ampC_reverse_BamH1 and cloned into pGEMT vector (PROMEGA). This was
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ligated into kanamycin resistant pMS402 plasmid (11.8Kb) upstream of a promoterless
luxCDABE operon (Olsen, et al., 1982, Duan, et al., 2003). The operon encodes for all
the synthase as well as the substrate for luciferase. This plasmid pMS402 (PampC) is
henceforth known as pHK478. This plasmid was further digested with Pac1 restriction
enzymes to yield an 8 Kb product that was ligated with Pac 1 digested pCDS101
plasmid containing the CTX backbone including sequences required for integration of
plasmid into the Pseudomonas genome. This ligation product is electroporated in to
Lucigen Electro-competent cells and plated on tetracycline and kanamycin. Resulting
clones were analyzed by PCR and sequenced. Colonies containing the resulting plasmid
with PampC is henceforth referred to as HK502. HK502 is then mated into P. aeruginosa
PAO1 to yield PAOattB::PampC-lux, henceforth known as HK504. ampC is regulated by
AmpR specifically in the presence of an inducer such as imipenem. A second reporter
strain is constructed with PphzA which is regulated by AmpR without any inducer.
Plasmid pCDS101 contained the PphzA with luxCDABE operon and was introduced into
P. aeruginosa PAO1 and PAOΔampR by triparental mating. The final clones are
PAOattB::PphzA-lux and PAO∆ampRattB::PphzA-lux and are known as SD98 and
SD94, respectively. The strains were validated by PCR amplification, sequencing and by
phenotypic assay for luciferase activity.

Table 5. 1. Strains, plasmids and primers used in this study.
Strains

Relevant phenotype and genotype

Reference/
Source

Escherichia coli
F- Φ80lacZΔM15 Δ(lacZYA argF)U169 deoR
recA1 endA1 hsdR17 (rk-mk+) phoA supE44 λ- thi-1 gyrA96 relA1
Pseudomonas aeruginosa
PAO1
Wild-type
DH5α
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New England
Biolabs
(Holloway, et

al., 1979)
PAO∆ampR
PAO∆ampR (pAmpR)
PAOattB::PampC-lux
PAO1attB::PphzA-lux
PAO∆ampRattB::Pphz
A-lux
Plasmids

PAO1 containing in-frame deletion of ampR
PAOΔampR containing ampR on plasmid
pMMB67-EH
PAO1containing PampC upstream of luxCDABE
operon
PAO1containing PphzA upstream of luxCDABE
operon
PAOΔampR containing PphzA upstream of
luxCDABE operon

pGEMT

TA cloning vector for PCR products; ApR,
ColE1 f1 ori lacZα

pRK600

CmR; colE1 tra+RK2 mob+; Helper plasmid for
conjugation

pRK2013
pMMB67EH-Gm
pOC19

pMS402

This study
This study
This study

Promega

KmR; colE1 tra+ RK2 mob+; Helper plasmid for
conjugation
GmR; IncQ, RSF1010, lacIq Ptac expression
vector with ampR::aacC1 insertion at DraI

(Figurski &
Helinski,
1979)
(Finan, et al.,
1986)
(Furste, et
al., 1986)

GmR; pMMB67EHGM containing 933-bp EcoRIBamHI ampR-His6 fragment from pOC11

(Caille, et al.,
2014)

KmR, TcR Expression reporter plasmid carrying
the promoter less luxCDABE;

(Olsen, et al.,
1982, Duan,
et al., 2003)
(Becher &
Schweizer,
2000)
Personal
Communicati
on with
Surette lab

mini-CTX lux

TcR ,luxCDABE based reporter vector with site
specific integration at attB site in P. aeruginosa
chromosome

pCDS101

Modified MINI-CTX with phzA1 promoter
directionally cloned upstream of the luciferase
operon

pHK478

PampC with Xho1-BamH1 sites, directionally
cloned upstream of the luciferase operon in
pMS402.

This study

pHK502

8KB Pac1 digest from pCDS101 containing
sequence for integrase mediated recombination
with PAC1 digested pHK478 containing PampC

This study

Primers
EL04_ampC_forward_
Xho

5’ACACTCGAGAGGAGATATACCATGGATTCC
CGTTTGC-3’

This study

EL05_ampC_reverse_
BamH1

5’-GGATCCTCAACCCAGAGGCGGCG-3’

This study
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Figure 5.2. Construction of PAO1::PampC-lux. The strategy is to construct reporters
that fuse promoters under direct regulation with AmpR. AmpR has been shown to bind
to promoter region of AmpC. From the first plasmid pMS402, the region comprising of
ampC promoter with the lux cassette and the marker for kanamycin was digested using
Pac1. From the second plasmid, pCDS101- a derivative of mini-ctx lux plasmid, the
region comprising of sequences required for integration in the Pseudomonas genome is
digested with Pac1. These two fragments are ligated and electroporated into E. coli. The
resulting plasmid contains the ampC promoter upstream of a promoterless Lux cassette
and is integrated into Pseudomonas genome following triparental mating.
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5.3.5. Luciferase Assay of reporter strains. The reporter strains PAO1attB::PampC-lux,
PAO1attB::PphzA-lux and PAO∆ampRattB::PphzA-lux were streaked on LB -agar plate with
antibiotics. Overnight grown stocks were resuspended in fresh LB to an OD600 of 1. The
bacteria were then re-diluted to an OD600 of 0.02 and grown in LB until OD600 0.2. For
PAO1attB::PampC-lux, the culture was divided into two flasks where one was treated with
sub-inhibitory concertation of imipenem (0.1µg/ml). The cultures were distributed into 96
well plates. This was then placed in the Biotek Synergy plate reader. The initial OD600
and luminescence values was recorded in kinetic mode over three hours at which time
the highest levels of luminescence were reached. The relative luminescence units (RLU)
were normalized to cell number using OD600. Z’ value of the assay was compared with
the values for positive and negative controls, which in the case of PAOattB::PampC-lux
was the induced and uninduced cultures. For PAOattB::PphzA-lux, negative control was
PAO∆ampRattB::PphzA-lux.

5.3.6. Primary screen with compounds from Torrey Pines. The primary screen was
done using compounds from Torrey Pines. The initial screen was done by measuring the
luciferase activity of PampC-lux and PphzA1-lux and the compounds. The growth (OD600)
was measured. The respective controls for each condition will be maintained, for e.g.
wells without any small molecule compound were kept. The Torrey Pines Institute
chemical library contains around 30 million compounds based upon 40 different
molecular scaffolds (Nefzi, et al., 2004). The scaffolds are arranged according to
positional scanning format and scaffold ranking, which increases chances of identifying
an active compound. The library contains approximately 8000 samples which cover over
30 million compounds. These libraries have been used for drug discovery process as
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when compared to other libraries these have the advantage of being able to screen a
large number of compounds at the same time (Lopez-Vallejo, et al., 2012). The
compounds that show a significant amount of decrease in the luciferase activity and no
significant change in OD600, will be considered for further screens.

5.3.7 Statistical analysis. In the primary screen with compounds from Torrey Pines, a
20% decrease in luciferase activity considering the positive control as 100% and the
negative control as 0% were selected. To assess the assay quality, z’ values were
quantified in PAOattB::PampC-lux under induction and negative controls PAOattB::PampClux without induction using previously described equation (Zhang, et al., 1999). For
PAOattB::PphzA1-lux, the reporter fusion in ampR deletion was considered as negative
control. Z’ values were considered significant above 0.7.

5.4. Results
5.4.1 AmpR is localized in the membrane. Our previous analysis performed
bioinformatically found that AmpR has a transmembrane domain and is membrane
associated (Caille, et al., 2014). This was further proven through LacZ-PhoA studies that
AmpR has a periplasmic domain (Caille, et al., 2014). Localization was further
investigated using protease protection experiments. This showed that incubation with
proteinase K resulted in degradation of AmpR found in spheroplasts (Caille, et al., 2014).
In this research, we probed the localization of AmpR again using ultracentrifugation
which show that AmpR localizes in the membrane. The membrane fractions were
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confirmed further using enzyme assays. Lactate dehydrogenase, an enzyme found
specifically in the membrane was associated with the AmpR fractions.

Figure 5.3. AmpR fractionates in the membrane. Fractionation studies using PAOampR
(pAmpR-His) found that P. aeruginosa AmpR resides in the membrane. The fractions were
further confirmed by enzyme analysis. Lactate dehydrogenase is found primarily in the inner
membrane in bacteria. Fractions containing AmpR were consistently found to have a higher
level of this enzyme when compared with the cytoplasmic fraction.(CF-cytoplasmic fraction,
MF- Membrane fraction, UI-Uinduced, In-Induced)

5.4.2 Gly102Glu leads to structural instability whereas Asp135Asn stabilizes
AmpR dimer. Previous experiments have indicated that Glycine 102 and Aspartate 135
were critical residues for AmpR to act as an activator of AmpC β-lactamase. Substitution
of Aspartate 135 with Asparagine led to an inducer-independent hyper-expression of
PampC(Caille, et al., 2014). It was presumed that this may be due to structural stabilization
of the dimer. In the dimer model, residue 135 in the dimer is also located adjacent to one
another (Figure 5.4A). Hence, replacing charged amino acid Aspartate with uncharged
asparagine leads to structure stabilization of the AmpR dimer model. As this mutation
results in constitutive hyper-expression of AmpC, it further supports our hypothesis that
AmpR is active as a dimer.
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Figure 5. 4. Protein models of AmpR mutants. In panel A replacement of
charged Aspartate with Asparagine leads to stabilization of AmpR dimer. This
explains the constitutive high-level expression of AmpC. In Panel B, two negative
charged E102 residues in the dimer interface will destabilize the dimer due to
strong electrostatic repulsion. This explains the loss of phenotype seen in the
G102E mutant.
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Previous literature in Citrobacter freundii has shown that substituting Glycine 102
with glutamate resulted in a constitutive hyper-expression of AmpC (Bartowsky &
Normark, 1993). This was however not the case in P. aeruginosa, where substitution
resulted in an inability to induce AmpC (Caille, et al., 2014). When the structural model
was looked at, it was observed that upon AmpR dimerization, the residues 102 of each
monomer are closely oriented (Figure 5.4 B). As Glutamate is a charged amino acid, it
resulted in the repelling of monomers due to strong repulsive electrostatic interactions
and leads to a structural destabilization of the dimer formation, hence leading to a noninducible phenotype for AmpC. Such destabilization and the detailed atomistic
interactions can be explored by performing molecular dynamics simulations.

5.4.3 Validation of reporter constructs. The reporters constructed were validated
without compounds to check for luciferase activity. For validation of PAOattB::PampC-lux,
the luciferase activity generated over six hours was monitored with a reading taken at
every hour. Imipenem which has been demonstrated to be a strong inducer of AmpC
activity was used as an inducer. It was found that the activity was highest at 3 hours.
The luciferase activity of the PphzA1-lux was compared with and without induction in
both PAOI and PAOampR background. It was found that deletion of AmpR abolished
luciferase expression, validating its use as a negative control for the reporter PAO1PphzA1-lux (Figure 5.5).
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Figure 5.5. Luciferase activity in the reporter constructs. The luciferase activities in
the reporters were checked with and without induction. PphzA1 is regulated by AmpR
in the absence of induction; as can be seen here. The luciferase detected in the
PAO1::PampC-lux (UI) and PAOΔampR::PphzA1-lux (UI and I) which were our negative
controls for each reporter were similar. All values are normalized to PAO::PampC-lux
uninduced.
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5.4.4 Primary screen of Torrey Pines compounds. After validating our reporters with
respective controls, PAO::PampC-lux (Z’=0.88) was used to screen the scaffold-based
combinatorial library available at Torrey Pines. The scaffold-based design of the library
allows screening for numerous compounds at once. As the compounds were dissolved
in Dimethyl formamide (DMF), an initial screening for solvent tolerance was done to
determine growth at increasing concentrations of DMF.
Primary screen with the compounds provided a few hits. The analysis of the primary
compounds was done at dilutions of 5x and 10x, monitoring the bacterial growth at the
same time as luciferase (Figure 5.7). Finally, compounds were used at 10x dilution as
that was found to affect growth the least. After normalizing the luciferase activity with
growth, compounds that showed 20% decrease in luciferase as compared to the positive
control were considered for a secondary screen (Figure 5.8). It was also found that the
positive hits could be structurally divided into two groups of pyrrolidine-based and
guanidine-based compounds. These were then targeted for a secondary screen using
PAO1-PampC-lux and PAO1-PphzA1-lux.

5.5. Discussion
Genomic and proteomic data from our lab demonstrated the extensive role of AmpR in
virulence and antibiotic resistance in P. aeruginosa (Balasubramanian, et al., 2012,
Balasubramanian, et al., 2014, Kumari, et al., 2014). Much of this data was further
confirmed by phenotypic assays (Balasubramanian, et al., 2012). This research explored
further into AmpR and its localization in P. aeruginosa. The presence of AmpR in the
membrane is interesting as transcriptional regulators are typically known to exist in the
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Figure 5. 6 Optimizing compound concentrations for screening. Initial screening
of compounds was done in both a 5x and a 10x dilution of compounds. 5x dilution with
many compounds were found to inhibit growth with no significant effect on luciferase
activity. Hence, compounds were used at 10 x dilutions for all subsequent assays.
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Figure 5.7. Primary screening of scaffold ranking library.Primary screening of the scaffold ranking library using
compounds at a concentration of 5µM. Samples that inhibited luciferase activity >20% when compared to positive control
(PAO1::PampC-lux, induced) were further analyzed for secondary screening.
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cytoplasm. However, previous models of transcriptional regulator in Rhizobium melliloti
showed the presence of membrane-associated transcription factors, NodD (Schlaman,
et al., 1989). The location of AmpR in the membrane also has implications towards the
identification or localization of the AmpR effectors (Lee, et al., 2016). The AmpR
effectors may be located to the periplasm, in addition to being found in the cytoplasm.
Also, different studies have shown that AmpR exists as a dimer and a tetramer
(Vadlamani, et al., 2015, Dik, et al., 2017). Through mutational analyses of selected
residues in AmpR, our previous study identified phenotypic differences with regards to
AmpC expression (Caille, et al., 2014). The role of the residues was further confirmed
with our research here which shows that AmpR is active as a dimer as mutations of
G102Glu results in de-stabilization of the dimer and Asp135Asn leads to stabilization of
the dimer. This occurs due to the gain or loss of charged amino acids, which results in
increased and decreased electrostatic repulsion, respectively.
It is known that AmpR along with other members of the cell-wall recycling pathway
regulate β-lactam resistance (Johnson, et al., 2013). Our principle for advocating AmpR
as a novel antibacterial target was to identify inhibitors that reduce virulence as well as
prevent induction of AmpC β-lactamase thereby helping in a synergistic action with βlactams. We also developed a novel cell-based screening with reporters using
luciferase. Previous knowledge regarding the AmpR regulon led us to use AmpC
promoter for the constructing the reporter screen (Balasubramanian, et al., 2012). In
addition, other promoters known to be regulated by AmpR such as PhzA1 and MexE
were developed for counter-screening (Balasubramanian, et al., 2012). Transcriptional
fusions were generated with these promoters with the luxABCDE operon. The primary
screens identified compounds that belonged to two distinct chemical compounds,
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pyrrolidine and guanidine-based compounds. Using this information, we can identify
compounds with similar structures that may specifically inhibit AmpR. Secondary
screening of the compounds identified so far can be done with the second reporter
system PphzA1. Furthermore, as the effectors of AmpR have been identified in our
previous studies, our reporter system can be used for a more targeted approach to
identify muramyl-peptide analogs inhibiting AmpR.

5.6 Acknowledgements. The structural modeling was done in collaboration with Dr.
Prem Chapagain and Dr. Jeevan GC at Department of Physics with College of Arts,
Sciences and Education at Florida International University. Th screening for smallmolecules was done in collaboration with Torrey Pines Institute, Florida. We are grateful
to Dr. Mark Guillanotti for providing us the compounds as well as intellectual input and
discussions.
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Chapter 6

Overview, Summary and Future Directions
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6.1. Overview

Pseudomonas aeruginosa is a Gram-negative, metabolically-versatile, ubiquitous
bacterium that is known for causing life-threatening infections in immunocompromised
people (Eng, et al., 1986, Kiehn, 1989). Commonly identified as a soil microbe, the
incredible ability of these bacteria to adapt and thrive in diverse environments has
contributed to its success as an important pathogen (Govan & Harris, 1986, Silby, et al.,
2011, Marvig, et al., 2015, Winstanley, et al., 2016). Although rare, P. aeruginosa can
cause infections such as folliculitis, otitis externa, and keratitis in healthy individuals
(Ramphal, et al., 1981, Mena & Gerba, 2009). In addition, P. aeruginosa is one of the
main pathogens that account for most of the hospital-acquired infections (Pittet, et al.,
1999, Cadro, 2004). Other serious infections in patients include burn-wound or postsurgery which leads to bacteremia that may proceed to fatal sepsis (McManus, et al.,
1985, Osmon, et al., 2004, Yildirim, et al., 2005). Age, prolonged intubation,
chemotherapy, HIV AIDS as well as the use of broad spectrum antibiotics can result in
lowering immunity leading to the manifestation of P. aeruginosa infection (Kielhofner, et
al., 1992, Caselli, et al., 2010). A notable disease that is almost always associated with
P. aeruginosa is cystic fibrosis (Emerson, et al., 2002, Marshall, et al., 2016).
Complicating P. aeruginosa infections is its remarkable intrinsic ability to thwart
multiple antibiotics (Lambert, 2002, Livermore, 2002). This single species harbors
numerous resistance mechanisms which include impermeability of the outer membrane,
active efflux of small molecules via efflux pumps, modification of the antibiotic target
rendering them unrecognizable and the production of hydrolytic enzymes specifically,
towards a group of drugs often used, the β-lactams (Hancock, 1998, Livermore, 2002,
Fisher, et al., 2005).
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A major mechanism of resistance specific to β-lactams is the expression of
hydrolytic enzymes that cleave the β-lactam ring rendering them ineffective. P.
aeruginosa harbors chromosomally encoded β-lactamases. However, it easily acquires
genes via horizontal transfer as well as plasmid, transposon or integron encoded (Zhao
& Hu, 2010, Breidenstein, et al., 2011). These enzymes include the Class A and D
extended spectrum β-lactamases as well as the Class B carbapenemases (Paterson &
Bonomo, 2005, Poirel, et al., 2010, Poole, 2011). In addition to these, three βlactamases are encoded on the P. aeruginosa genome. This includes PIB-1/PA5542;
Class D oxacillinase PoxB/PA5297, formerly known as OXA-50, and the Class C
cephalosporinase AmpC/PA4110 (Kong, et al., 2005, Fajardo, et al., 2014, Zincke, et al.,
2016). PoxB was recently characterized by our lab as a carbapenemase which leads to
resistance, especially upon down-regulation of the porin OprD whereas PIB-1 was found
to be a zinc-dependent imipenemase (Fajardo, et al., 2014, Zincke, et al., 2016).
The third chromosomal β-lactamase, AmpC (PA4110) is well-characterized in P.
aeruginosa and is known to be regulated by the transcriptional factor AmpR (PA4109)
(Lodge, et al., 1993, Kong, et al., 2005). Expression of ampC is inducible in the presence
of certain β-lactams and requires AmpR and its effector, a muropeptide generated by the
concerted activity of the proteins in the cell-wall recycling pathway (Jacobs, et al., 1997,
Dhar, et al., 2018). Cell-wall recycling is a process that is conserved in both Grampositive and -negative bacteria (Reith & Mayer, 2011, Johnson, et al., 2013). Recycling
of the cell-wall that occurs during growth, division and elongation was eventually linked
to its intrinsic role in AmpC induction and hence, β-lactam resistance (Goodell &
Schwarz, 1985, Lindquist, et al., 1989). The link between the two processes was
suggested when it was discovered that the signaling molecules which interact with
AmpR were not β-lactams but were speculated to be the cell-wall fragments generated
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in the presence of β-lactams (Lindquist, et al., 1989). This hypothesis was confirmed
when it was identified that AmpG and AmpD were required for ampC expression in C.
freundii and E. cloacae and that these genes were also involved in recycling of cell-wall
fragments or muropeptides (Korfmann & Wiedemann, 1988, Korfmann & Sanders, 1989,
Lindquist, et al., 1989, Jacobs, et al., 1994).
Since then cell-wall recycling has been studied mainly in E. coli (Park & Uehara,
2008). However, to better understand the details of this induction process special focus
has been given to pathogens that contain the ampR-ampC region, including members of
Enterobacteriaceae and in P. aeruginosa (Jacobs, et al., 1994, Balasubramanian, et al.,
2015). Many proteins of cell-wall recycling such as the lytic transglycosylases, amidases,
permeases, N-acetyl β-D glucosaminidases, and ligases are involved in the AmpC
induction process (Kong, et al., 2010, Dhar, et al., 2018). Among these, in P. aeruginosa
mutations of specific ones such as amidases- AmpDh2, AmpDh3 and AmpD; LMM
penicillin-binding proteins; N-acetylglucosaminidase NagZ; permease AmpG have been
shown to affect AmpC expression (Juan, et al., 2006, Kong, et al., 2010, Johnson, et al.,
2013, Ropy, et al., 2015). Many of these enzymes play a seminal role in generating the
muropeptide effector of P. aeruginosa AmpR as has been entailed in some detail in
Chapter 1 (Juan, et al., 2006, Asgarali, et al., 2009, Kong, et al., 2010). However, to date
the muropeptides generated in P. aeruginosa as well as the identity of the AmpR effector
remains elusive.
This dissertation delved into the role of cell-wall recycling intermediates as
determinants of β-lactam resistance in P. aeruginosa. This work investigated for the first
time muropeptides and their structure in P. aeruginosa and identified the specific
muropeptides that act as AmpR effectors. In addition, the role of AmpG and AmpP in the
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transport of muropeptides was analyzed in P. aeruginosa. We identified disaccharide
muropeptides as the substrates for these permeases. The identity of a putative Nacetylglucosaminidase was investigated. Finally, reporters were constructed to screen
for small-molecule inhibitors for AmpR.
6.2. Muropeptides in P. aeruginosa and AmpR effector. Cell-wall intermediates
are often generated when the cell divides. These products are released from the
peptidoglycan wall and structurally are composed of variations of sugars and peptides
(Glauner, et al., 1988). The sugars include N-acetylglucosamine (GlcNAc) and N-acetyl
muramic acid (MurNAc) and the peptides are composed of L-alanine, ɣ-D-glutamine,
meso-diaminopimelic acid (m-DAP), and D-alanine (Glauner, et al., 1988). The
composition of the PG is conserved mostly across Gram-negative bacteria (Schleifer &
Kandler, 1972, Vollmer & Holtje, 2004). The main variation found in Gram-positive
bacteria is the presence of L-Lysine in place of m-DAP as the third amino-acid of the
peptide chain (Schleifer & Kandler, 1972).
In P. aeruginosa PAO1 we were able to detect upto 20 distinct muropeptides using
liquid chromatography with tandem mass-spectrometry (Chapter 2, Table 2.2). A method
to quantitate the muropeptides was developed. For our study, we used P. aeruginosa at
late-log phase of growth to investigate the muropeptide levels. It is well-appreciated that
the PG undergoes structural modifications based upon the phase of bacterial growth. In
E. coli it was found that bacteria in the exponential phase of growth had higher crosslinked muropeptides compared to one that is not dividing (Glauner, et al., 1988, Keep, et
al., 2006). In vitro activity of PG degradative enzymes such as the lytic transglycosylases
on the isolated murein sacculus at log-phase led to a higher level of muropeptide
products compared to one obtained at stationary phase (Lee, et al., 2013). In our
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research, a protocol was developed wherein we can isolate and detect muropeptides
using LC/MS/MS from bacterial extracts. This work was done in collaboration with Dr.
Mobashery’s lab at UND. The conditions used for LC/MS were established previously
and we were able to identify muropeptides up to picomolar concentration (Lee, et al.,
2013). The muropeptides that were generated are the results of numerous enzymes
found in the cytoplasm and the periplasm (Chapter 1, Table 1.2). Using synthetic
standards of muropeptides available with our collaborator, we were able to quantitate the
absolute number of muropeptides (molecule/cell) in the bacterial cell (Chapter 2, Table
2.1).
The total ion chromatogram (TIC) did not reveal any specific muropeptide; hence
extracted ion chromatogram was used and muropeptides detected using synthetic
muropeptides (Chapter 2, Figure 2.3). The most abundant muropeptide detected was
the disaccharide-tetrapeptides (N-acetylglucosamine- 1, 6 anhydro MurNAc L-Ala-D-Glum-DAP-D-Ala) (Chapter 2, Table 2.1). Disaccharides with varying number of aminoacids were detected; however, pentapeptide which is the full amino acid side chain was
present in minute quantities. These were the products of lytic transglycosylase with
exolytic activities. So far, P. aeruginosa has shown the presence of eleven LTs all of
which have shown to have exolytic activity (Lee, et al., 2017). Monosaccharides such as
1, 6 anhydro MurNAc tri and tetrapeptides were also detected indicating the presence of
N-acetylglucosaminidase. Identification of 1, 6 anhydroMurNAc peptides in the periplasm
led us to postulate the presence of a second N- acetylglucosaminidase, FlgJ. The role of
this enzyme in cell-wall recycling and antibiotic resistance is the focus of chapter 4.
Presence of a cell-wall active drugs such as β-lactams in the environment trigger the
generation of certain muropeptides that act as AmpR effectors (Jacobs, et al., 1997).
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The bacteria grown in LB media without β-lactam were compared with the bacteria
exposed to non-lethal concentration of β-lactam (cefoxitin). Cefoxitin is a strong inducer
of β-lactamase and more stable to its hydrolytic activity (Jacoby, 2009). Overall, it was
found that the levels of muropeptides upon β- lactam induction were decreased (Chapter
2, Table 2.1). Relative levels of individual muropeptides were similar; however, one
discriminatory feature was consistently increased presence of pentapeptides upon
induction. There was a 46-fold induction of N-acetylglucosamine 1, 6 anhydro N-acetyl
muramic acid pentapeptide in the presence of β-lactam stress and the 1,6 N-acetyl
muramic acid pentapeptide was detected only upon induction. This increase probably
occurs as cefoxitin acts by targeting PBPs. Upon binding with low molecular mass PBPs
(LMM PBP), both the transpeptidase and endopeptidase functions of these enzymes are
lost, and there is an increase of their specific substrates (Lee, et al., 2015). In such
cases, the pentapeptide containing muropeptides (substrates of LMM-PBP) may
increase relatively in the cytosol. As there was a significant increase in the levels of the
pentapeptides upon induction, it was further analyzed if these muropeptides act as
AmpR effector. A β-lactamase assay with synthetic constructs indeed revealed that
these muropeptides were capable of inducing β-lactamase expression (Chapter 2,
Figure 2.3). A subsequent study also confirmed our findings by clearly elucidating the
binding and interaction of these muropeptides with AmpR (Dik, et al., 2017).
P. aeruginosa cell-wall recycling has been found to deviate from that of
Enterobacteriaceae. P. aeruginosa has multiple amidases whose down regulation is
required for the maximal β-lactamase expression (Juan, et al., 2006). It has two inner
membrane permeases hypothesized to play a role in cell-wall recycling in P. aeruginosa
(Kong, et al., 2010). AmpR itself in P. aeruginosa has been found to have a more
extensive regulon when compared to its counterpart in E. cloacae and C. freundii
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(Balasubramanian, et al., 2015). Previous research in C. freundii had shown that the 1, 6
anhydro muramic acid tripeptide can act as the AmpR effector (Jacobs, et al., 1994).
This was however not found to be the case in P. aeruginosa (Chapter 2, Table 2.2).

6. 3. AmpG and AmpP play a role in cell wall recycling. P. aeruginosa has two E.
coli AmpG homologs, PA4393/AmpG and PA4218/AmpP. The MIC of certain β-lactams
was decreased in PAO∆ampG (Chapter 3, Table 3.1). This decrease in MIC can be
explained by the diminished levels of β-lactamase expressed in PAO∆ampG (Chapter 3,
Figure 3.2). It is known that AmpG is conserved across many Gram-negative bacteria
and plays a role in muropeptide transport (Li, et al., 2016, Perley-Robertson, et al.,
2016). Based on our previous research and significant homology of AmpP with E. coli
AmpG, we also hypothesized that AmpP plays a role in muropeptide transport, probably
by shuttling muropeptides from the cytoplasm into the periplasm (Kong, et al., 2010).
When the muropeptides levels were compared between the different fractions, it was
found that disaccharides accumulate in the periplasm and cytoplasm respectively in
PAOΔampG and PAOΔampP (Figure 3.8). This suggests that these permeases play a
role in transporting disaccharide-peptides into and out of the cytoplasm. When the
periplasmic extract of muropeptides was isolated, mostly disaccharides were detected in
all strains as compared to the whole cell preparation (Figure 3.5). This is expected as
the enzyme N-acetylglucosaminidase that cleaves the two sugar units GlcNAc and
MurNAc, is known to be cytosolic. However, a minor amount of monosaccharides were
found in all the periplasmic preparation, indicating the presence of a putative periplasmic
N-acetylglucosaminidase (Figure 3.6). Larger peptides that included the cross-linked and
the tetrasaccharide peptides were also detected at higher levels in the preparation used
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for whole cell extracts (Figure 3.7). This probably reflects the type of preparatory method
used for isolating whole-cell muropeptides, as it involves sonication whereas the
periplasmic preparation is done by a gentler osmotic shock. To summarize, our analyses
showed the presence of muropeptides in both whole-cell as well as periplasmic
preparation. Distinctions between mutant strains were made at relative levels of
individual muropeptides.

Increased levels of periplasmic disaccharide-muropeptides

were found in ampP and double-deletion strains whereas decreased levels were seen in
ampG deletion strains. This indicates that AmpP can transport muropeptides from the
cytoplasm into the periplasm. This method of muropeptide analysis can be used to
analyze relative levels or trends of individual muropeptide or to detect presence or
absence of specific muropeptides between different strains.

6.4. Role of PA1085 in P. aeruginosa. PA1085 is the fifth gene of a seven-gene operon
in P. aeruginosa and is involved in flagellar biosynthesis and assembly. P. aeruginosa is
a monotrichous organism and motility is one of its primary virulence factors (Gellatly &
Hancock, 2013). In our previous analyses of muropeptides, we were able to consistently
detect monosaccharide muropeptides in the periplasmic space indicating that there may
be a periplasmic enzyme that generates these products from the peptidoglycan (Lee, et
al., 2016). The only characterized N-acetylglucosaminidase in P. aeruginosa is NagZ
(PA3005) which is cytosolic. It was found that a periplasmic homolog of this enzyme as
characterized in S. enterica known as flgJ. This enzyme is part of the flagellar operon
and is hypothesized to hydrolyze the PG and enables the insertion of the flagellar units
into the PG and its extrusion though the outer membrane into the extracellular milieu
(Kerridge, et al., 1962, Herlihey, et al., 2014). In-silico analysis of the P. aeruginosa
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PAO1 genome led to the identification of PA1085. There was 31% homology between
FlgJ of P. aeruginosa and S. enterica. Sequence alignment also showed that the
residues that are required for this activity were conserved between P. aeruginosa and S.
enterica FlgJ. In an effort to understand the role of flgJ in P. aeruginosa, an in-frame
deletion mutant was constructed. It was found that with the loss of flgJ, swimming
activity was affected whereas swarming and twitching were not (Figure 4.3). Motility also
influences other phenotypes such as biofilm formation (O'Toole & Kolter, 1998). Loss of
flgJ resulted in an increase in biofilm over 48 hours (Figure 4.4). NagZ (PA3005) in P.
aeruginosa is required for maximal β-lactamase expression and its absence leads to a
decrease in MIC towards selected antibiotics. (Asgarali, et al., 2009). However, deletion
of flgJ did not lead to any changes in the MIC of antibiotics (Figure 4.5). The levels of Nacetylglucosaminidase in whole-cell extracts were also unchanged with the loss of FlgJ
(Figure 4.6).

6.5. Screening of small molecule library for AmpR inhibitors. The premise for this
aim is built upon the previous research which demonstrated that AmpR has an
expansive regulon in P. aeruginosa and is connected to various virulence and antibiotic
resistance regulatory networks (Balasubramanian, et al., 2012). For the identification of
AmpR inhibitors, we developed a reporter assay using the luciferase operon luxCDABE
fused to promoters known to be regulated by AmpR (Becher & Schweizer, 2000). The
reporter used for the primary screening was PampC-luxCDABE (Figure 5.2). The
luciferase assay was used as it is a one-step assay which does not require any
manipulation such as addition of exogenous substrate or an inducer (Craney, et al.,
2007). Using this system, a primary screening was initiated with the scaffold based
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combinatorial library available at Torrey Pines Institute that allows the screening of
millions of compounds arranged around 79 core scaffolds. The primary screening of the
library was done at a final concentration of 5µM of the compounds, monitoring the
growth of bacteria at the same time. Samples that inhibited PampC activities by 20-40%
when compared to the positive control were analyzed further (Figure 5.8). Based on the
core structures, the samples that showed inhibition were either guanidine or pyrrolidinebased. This corroborates with a recent study which used this chemical library and
identified a guanidine based compound with anti-bacterial activity against all the
ESKAPE

(E-Enterococcus

pneumoniae,

A-Acinetobacter

faecium,

S-Staphylococcus

baumanii,

P-

aureus,

Pseudomonas

K-Klebsiella

aeruginosa,

E-

Enterobacter species) pathogens (Fleeman, et al., 2015). Pyrrolidine-based compounds
synthesized in-house have previously been demonstrated to be inhibitors of quorum
sensing. Our previous research also identified AmpR as a regulator of QS. It would be
interesting to further determine if the pyrrolidine compounds available from Torrey-Pines
available are AmpR-specific and QS inhibitors.

6.6 Future directions
This research is one of the first reports of the muropeptides identified in P.
aeruginosa using LC/MS/MS. It is also the first report that demonstrated a method to
quantitate muropeptides without radioactive-tagging as well as reported on the structural
nature of the individual muropeptides. We studied the effect of β-lactams on
muropeptide levels and the identity of the AmpR effector. This research led to the advent
of many unanswered questions. The gaps in knowledge have been addressed in
sections. The first part deals with the study of muropeptides in P. aeruginosa and its
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relevance to antibiotic resistance. Following are further ideas that can be pursued to
illustrate better the relevance of muropeptides in P. aeruginosa.
I.

Investigate muropeptides in clinical-strains and correlate with virulence in host.

Muropeptides generated during cell-wall recycling and synthesis may differ among the
different P. aeruginosa strains. As muropeptides are significant in maintaining virulence,
it would be pertinent to investigate their levels in clinical isolates. In this research we
used PAO1 and its isogenic mutants for all our investigations (Lee, et al., 2016). Future
studies should elucidate the muropeptide levels, found intracellularly and the
muropeptides released into media from P. aeruginosa clinical-isolates. A correlation
between the released muropeptides and disease phenotypes has been demonstrated in
pathogens such as Bordetella pertussis, Neisseria gonorrhea, and N. meningitides
(Cookson, et al., 1989, Chan & Dillard, 2016). Such an investigation can be undertaken
using clinical isolates of P. aeruginosa and the trend of muropeptides generated therein
compared with the lab strain PAO1. The protocol developed in the current study to
isolate and quantitate muropeptides can be used for the different strains. Future studies
can determine whether the structural nuances, levels, and composition of muropeptides
alter the pathogenesis of the organism and the interaction with host receptors. This can
be done by incubating an immune cell line such as the Mono Mac 6 (MM6) cells or the
human embryonic kidney cell line (HEK293T) with muropeptiedes followed by evaluation
of the gene expression levels of Tumor Necrosis Factor-α (TNF-α) (Wolfert, et al., 2007).
TNF-α is known to be stimulated when exposed to muropeptides (Wolfert, et al., 2002).
Alternatively, stimlaution of the NOD receptors can be investigated in HEK-Blue hNOD1
and HEK-Blue hNOD2 reporter cell lines (Torrens, et al., 2017).
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II.

The mechanistic details of the interaction of muropeptide with receptors of the
immune system can be investigated.
It is well appreciated that specific muropeptides such as the muramyl dipeptides are
recognized by immune receptors in host such as NOD1, NOD2, Cryopyrin and Tolllike receptors among others (Wolf & Underhill, 2018). The mechanism of binding
and interaction of the muropeptides with these host receptors can be investigated.

III.

Investigate the expression of cell-wall recycling genes in different strains.
A hallmark feature of P. aeruginosa is genetic adaptation found within a strain,
depending on whether it causes an acute versus a chronic infection (Klockgether &
Tummler, 2017). For instance, the expression of the genes in the cell-wall recycling
pathway may be different in an alginate producing strain, a phenotype found often in
chronic infections. The muropeptide profile of a hyper-alginate producer PDO300 can
be compared with that of non-alginate strain PAO1 (Mathee, et al., 1999).

In

addition, the extent of sequence conservation of the cell-wall recycling genes in
clinical isolates can be discerned by in silico analyses using PAO1 as the reference
strain. This can be followed up by comparing the expression of cell-wall recycling
genes of these strains under different growth conditions.

IV.

Changes in muropeptide profile when exposed to a different antibiotic as well as
experimental analysis of muropeptide-AmpR binding.
In this study we established that the total levels of muropeptide change in the
presence of an inducer such as cefoxitin which is known to be a strong inducer of
AmpC β-lactamase (Jacoby, 2009). The changes in the muropeptide profile when P.
aeruginosa is exposed to sub-lethal concentrations of β-lactams such as cefotaxime,
ceftriaxone and ceftazidime which are not strong inducers of AmpC β-lactamase can
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be investigated (Jacoby, 2009). It will be interesting to note the changes in the
muropeptide profile and to determine the generation of AmpR under these
conditions. Furthermore, it was established that GlcNAc 1, 6 anhMurNAc
pentapeptide and 1, 6 anhMurNAc pentapeptide were able to bind with the AmpR
effector binding domain using molecular dynamic simulation and non-denaturing
mass-spectrometry (Dik, et al., 2017). An in vivo cross-linking study followed by pulldown of AmpR using specific antibodies can be also done to confirm these
muropeptides as effectors. Previous study using molecular simulation dynamics
focused on the important residues for effector binding in P. aeruginosa AmpR (Dik, et
al., 2017). Using site-directed mutagenesis, these residues can be replaced to
determine their effect on AmpC expression.
The second part of the research dealt with the role of AmpG and AmpP in P.
aeruginosa as muropeptide transporters. This was the first attempt of looking at these
transporters in an in vivo setting. However, there are still unanswered questions.
I.

Role of AmpP as a muropeptide transporter can be confirmed with a transport assay.
This research elaborated on the role of the permeases AmpG and AmpP in P.
aeruginosa. Further investigation can be done to confirm our hypothesis that AmpP
acts a disaccharide-muropeptide exporter to the periplasmic space. As a previous
study using fluorophore-conjugated muropeptides has shown that AmpP is unable to
import disaccharide-muropeptides, in future (Perley-Robertson, et al., 2016) it can be
assessed whether AmpP can export muropeptides from the cytoplasm, by monitoring
the levels of fluorescence in the media, in the absence and presence of ampP
expression.
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II.

Role of AmpG and AmpP in antibiotic resistance and recycling can be studied in
clinical-isolates of P. aeruginosa.
The extent of conservation of these two proteins involved in cell-wall recycling has
not been studied yet. As this study primarily looked at the recycling pathway in
PAO1, in future other clinical isolates and strains of P. aeruginosa and the role of
AmpG and AmpP therein can be anlyzed

III.

Role of FlgJ as an N-acetylglucosaminidase can be confirmed through protein
purification.
In the current study, we used an in-frame deletion mutant of flgJ to identify whether it
was involved in producing N-acetylglucosaminidase and antibiotic resistance.
However, we were unable to obtain any clear results. A better approcach may be to
purify this protein and study its activity on purified PG. The products generated in this
reaction can be studied using LC/MS. This would not just confirm FlgJ as an Nacetylglucosaminidase but would also extend to identifying if it has any other
alternate enzyme activity.

IV.

Besides FlgJ other putative N-acetylglucosaminidase can be mapped and
investigated.
It may be that FlgJ is not an N-acetylglucosaminidase. In that case there must be an
alternate enzyme that is generating the monosaccharides. One of the fulture
directions will be to analyse the genome for any paralogs of FlgJ as well as NagZ.
Similarities will also be chalked out according to the domains of the enzymes.

V.

Analyze for an alternate transporter that shuttles monosaccharides into the
periplasm.
Another possibility is that the periplasmic monosaccharides are not being generated
there, but cytoplasmic ones are being transported into the periplasmic space. This
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would mean that similar to inner membrane permease AmpP which can transport
disaccharides,

there

may

be

another

permease

which

can

transport

monosaccharides. It may be useful to do bioinformatically analyze whether there any
other inner membrane permeases that show homology with AmpG and AmpP.
The third part of the research investigated small-molecule inhibitors of an important
virulence factor in P. aeruginosa known as AmpR. We were able to identify inhibitors
through primary screening of compounds using our luciferase reporters. Following steps
are further required to complete the investigation.

I.

Identify individual family of drugs by secondary screening.
Secondary screening will be done with the individual family of drugs that were
identified. Alternate promoter fusions PphzA1 and PmexE will be used to confirm that
inhibition of luciferase activity occurs by AmpR inhibition. AmpR is known to regulate
phzA1 and mexE expression, positively and negatively (Balasubramanian, et al.,
2012). Hence, the compounds identified so far, that decrease phzA1 expression and
increase mexE expression, as inferred from luciferase activity, will be most likely
AmpR inhibitors. Compounds selected post-secondary screening wherein scaffolds
that inhibited AmpR activity will be further scrutinized using different functional
groups.
2. Synthesize and investigate the activity of individual drugs using tertiary screening.
The deconvoluted hits from the secondary screening will determine the individual
compounds that will be screened on a tertiary screen. For this, individual compounds
previously identified will be synthesized and their activity as luciferase inhibitors wil
be checked using all three promoter systems.
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Following the identification of individual compounds and their analysis as AmpR
inhibitors, they will be further analysed for properties regarding their effects on
resistance and virulence. This wil include the following analysis:
MIC and synergy test: The MIC of the individual compound will be analysed by
monitoring OD600 by broth microdilution analysis (EUCAST, 2000). The synergistic effect
of these compounds with commonly used P. aeruginosa antibiotics such as β-lactams,
fluroquinolones, and aminoglycosides will also be investigated suing checkerboard
assays (Doern, 2014).
Cytoxicity assay: After the synthesis of the individual compounds, the cytotoxicity will be
ascertained by a XTT based assay (Page, et al., 1993).
Canorhabditis elegans assay:

C. elegans ahs been established as a god model

for analysis of P. aeruginosa pathogenesis (Tan, et al., 1999, Balasubramanian, et al.,
2012). Compounds selected so far will be tested for their effect on C. elegans by the
fast- and slow-killing methods (Brenner, 1974).
The compounds selected will be analysed for their AmpR inhibition in clinical isolates of
P. aeruginosa. This will include PA14, mucoid strain such as PA2192, Liverpool LES and
PA7.
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Appendix

L-arginine regulates Pseudomonas aeruginosa pathogenesis through quorum
sensing
Supurna Dhar, Katherine Vandenburg Veronica Perez, Emmanuel Duarte, Horatio
Priestap, Kalai Mathee, Amir Khodamzaddeh
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Abstract
With the current widespread abuse and overuse of broad-spectrum antibiotics,
resistance among bacteria is increasing at an alarming rate. Besides, the classical
antibiotics that are either bacteriostatic or bactericidal, alternate targets and pathways
that diminish bacterial pathogenicity are being sought after. One of these alternate
approaches focusses on impeding the communication that takes place through chemical
signaling between bacteria also known as quorum sensing (QS). This practice is called
anti quorum-sensing. Panax ginseng is a well-established inhibitor of quorum sensing.
However, previous studies were unable to decipher the active chemical compound in
these extracts that was responsible for the anti-quorum sensing property. One of the
compounds that were identified in ginseng extracts in high concentrations was L-arginine
(~80 mM). Further analysis with this particular amino acid on Chromobacterium
violaceum showed a significant inhibition of QS regulated violacein production. In this
study, L-arginine was further examined for its effects on the QS phenotypes using the
opportunistic pathogen, Pseudomonas aeruginosa as a bio-monitor strain. L-arginine
was found to reduce multiple QS regulated virulence factors as well as levels of Acyl
Homoserine Lactone (AHL) which is one of the signaling molecules involved in QS.
Keywords: Virulence, proteases, biofilm, amino acid
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Introduction
The role of Pseudomonas aeruginosa, a major nosocomial pathogen is wellestablished in critical infections of the respiratory tracts including pan bronchiolitis,
chronic obstructive pulmonary disorder, and pneumonia which are characterized by
complicated treatment and often therapeutic failure (Garau & Gomez, 2003, Valderrey,
et al., 2010). This is especially seen in cystic fibrosis patients in whom chronic
colonization of P. aeruginosa in the lungs is the result of this pathogen's inherent and
acquired capacity to resist conventional antibiotic treatment (Lyczak, et al., 2000,
Lyczak, et al., 2002, Jansen, et al., 2016).
With accelerated antibiotic resistance, the discovery of novel antibiotics must be
prioritized (Silver, 2011). A novel approach to anti-bacterial drug discovery is to look for
compounds that, without killing the bacteria maim its capacity to establish infections. As
the process interrupted therein is not essential for the pathogen's survival, it does not
evoke evolutionary responses from the bacteria to develop resistance, thereby
increasing the long term chances of therapeutic success (Pepper, 2008, Brown, et al.,
2009).
One such alternative target is the quorum sensing (QS) mechanism (O'Loughlin, et
al., 2013, Eibergen, et al., 2015, Ali, et al., 2017).

QS is a form of bacterial

communication achieved through the production and secretion of chemical signals. P.
aeruginosa has four systems regulating quorum sensing: Las, Rhl, Pqs, and IQS (Lee, et
al., 2013). The synthases in each system produce small molecules 3-oxo-C12homoserine lactone (C12-HSL), N-butanoyl-homoserine lactone (C4-HSL), 2-heptyl-3hydroxy-4-quinolone

(PQS)

and

2-(2-hydroxyphenyl)-thiazole-4-carbaldehye,

respectively (Papenfort & Bassler, 2016). Conventionally, P. aeruginosa QS was known
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to exhibit hierarchy with Las system at the top of the series; however, current research
suggests that regulator RhlR can affect the expression of certain target genes of the Las
system (Pesci, et al., 1997, Dekimpe & Deziel, 2009).
The signature signal is species specific and cross-communication may occur
(Bassler, et al., 1997). These chemical signals allow large populations of microbes to
synchronize and coordinate gene expression (Miller & Bassler, 2001, Waters & Bassler,
2005). It is well appreciated now that subsequent to the “quorum” formation in P.
aeruginosa, QS can regulate an arsenal of virulence factors including extracellular as
well as cell-surface associated factors thereby impacting P. aeruginosa host
pathogenesis and clinical outcomes. A few of them include the production of secreted
factors such as proteases, elastases, rhamnolipids, phenazine compounds like
pyocyanin and siderophores such as pyoverdine and pyochelin (Latifi, et al., 1995,
Pearson, et al., 1997, Reimmann, et al., 1997). P. aeruginosa motility such as swarming
phenotype as well as biofilm formation has also been linked to quorum sensing.
Herbal medicines have always been a source of many antibiotics. In recent years
however, they have been mined for their anti-QS properties (Panda, et al., 2016).
Previous literature and experiments in the lab have shown that Panax ginseng, a
Chinese herb does not alter P. aeruginosa bacterial growth but rather suppressed the
production of LasA, LasB, down-regulated the synthesis of AHL molecules, reduced
swarming motility, inhibited biofilm formation, and dispersed preformed biofilms (Song, et
al., 2010, Wu, et al., 2011). Major components of Panax ginseng are the ginsenosides,
among which over 30 have been discovered and extensively studied (Leung & Wong,
2010). Experimental analyses of the ginsenosides exhibited no alteration of quorumsensing phenotypes (Song, et al., 2010).
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Aside from the ginsenosides, aqueous extracts of P. ginseng contain many other
non-nitrogen and nitrogen-based compounds including organic acids, peptides, amines,
nucleic acids and free amino acids (FAA)(Attele, et al., 1999). Studies have shown that
the FAA content of P. ginseng constitutes about 45% of the total amino acids and that
arginine was responsible for about 60% of the total FAA (Kwon, et al., 1990, Park, et al.,
1990). In this study, we hypothesize that the high content of free arginine in P. ginseng
contributes to the anti-QS effects seen in its aqueous extracts. To investigate this, the
effects of L-arginine on the quorum sensing phenotypes were analyzed.

MATERIALS AND METHODS
Bacterial strains, growth media and culture conditions. Pseudomonas aeruginosa
PAO1 (Holloway & Morgan, 1986), PAOΔretS, PAOΔalgDΔpelΔpsl, were used for
analysis of QS phenotypes. Staphylococcus aureus (ATCC 12600) was used for the
assay of LasA protease (Kessler, et al., 1993). All bacteria were maintained on Luria
broth (LB) and grown overnight at 37 ⁰C. L-arginine (Sigma-Aldrich) dissolved in LB for
the assays.

Growth curves. The effect of L-arginine on PAO1 growth was determined by monitoring
the O.D.600 for 16 hours. Briefly, an overnight culture of PAO1 was spun down. The cells
were washed with 0.85% saline to remove spent media and diluted to O.D. 1 in fresh LB.
From this, the culture was diluted further to an O.D. of 0.025 in fresh LB media in 48-well
plates (Falcon) for monitoring growth.

L-arginine at the desired concentrations was

added and the absorbance at 600nm was monitored at one-hour intervals using BioTek
Synergy HT (Winooski, VT, USA) plate reader for 17 hours at 37 ⁰C.
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Swarming assay. The assay was performed on plates containing 0.65% agar with Larginine at the test concentrations. An overnight culture of PAO1 was diluted to an OD600
of 1. One µL of this culture was spotted onto autoclaved-sterile discs. The plates were
placed in a 30⁰C incubator and the swarming motility was measured every 24 and 48
hours (Henrichsen, 1972, Kohler, et al., 2000).

LasA staphylolytic assay. The LasA protease activity was determined as previously
described (Kessler, et al., 1993, Kong, et al., 2005). Briefly, P. aeruginosa was grown
overnight with and without L-arginine. A 20 µL of the culture supernatant was added to
180 µL of boiled S. aureus. The lysis of S. aureus was monitored every 10 minutes by
recording the OD600 at 37 ⁰C for an hour. The activity was noted as the decrease in
OD600 per hour.

LasB elastolytic assay. Elastin Congo red (ECR, Sigma, St. Louis, MO) was used to
determine the role of L-arginine in regulating the elastolytic activity of P. aeruginosa
PAO1 as described before (Ohman, et al., 1980). Briefly, 900 µl of ECR buffer containing
100 mM Tris, 1 mM Cacl2, pH 7.6-7.5 was made with 20 mg of ECR and vortexed to
dissolve. To this, a 100μl aliquot of P. aeruginosa supernatants was added. This mixture
was incubated with shaking at 37 ⁰C for one hour. Insoluble ECR was removed by
centrifugation. Activity was expressed as the change in OD495 after one-hour incubation
(Nishino & Powers, 1980, Ohman, et al., 1980).
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Pyocyanin assay. Overnight cultures of P. aeruginosa PAO1 with L-arginine was
grown for 18-20 hours to obtain bacteria at stationary phase. The optical densities of
all bacteria were normalized before the assay. 5 ml of the supernatant was extracted
into a tube containing 3 ml of chloroform and vortexed. This was centrifuged, and the
top layer removed. To the bottom layer, 1 ml of 0.2 N HCl was added. This was
vortexed and centrifuged. The top (pink) aqueous phase was removed into a cuvette
and the absorbance at 520 nm recorded. The absorbance is multiplied by 17.072
indicating the concentration of pyocyanin produced per ml of culture (μg/ml) (Kurachi,
1958, Essar, et al., 1990).

Biofilm assay. Biofilm assay was performed in tubes as described previously (Friedman
& Kolter, 2004, O'Toole, 2011). Briefly, overnight cultures of PAO1 grown on LB agar
plates were resuspended in LB to a final dilution of 0.0025. The test samples contained
L-arginine at 25 and 50mM. PAOΔretS and PAOΔalgDΔpelΔpsl were kept as positive
and negative controls, respectively (Goodman, et al., 2004). All the tubes were
incubated at 37 ⁰C for 24-48 hours. Subsequently, the culture was discarded and the
tubes washed in bins containing water and left at room temperature for 10 minutes. This
was stained with 0.1% crystal violet. The dye was removed after 20 minutes and the
tubes were washed thoroughly with running tap-water. The attached dye was then
solubilized with absolute ethanol and biofilm formation was quantified by recording the
absorbance at 590 nm.

AHL assay by GC/MS. AHL extraction from PAO1 supernatants was done using
previously described protocols (Makemson, et al., 2006). P. aeruginosa cultures were
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grown for 18-20 hrs and their OD normalized. The cells were spun down and the
supernatant was removed in a separate tube and prepared for AHL detection by gas
chromatography/mass spectrometry (Cataldi, et al., 2004, Kusar, et al., 2016). Briefly,
the supernatant is divided in equal volumes into two separate tubes. One was treated
with 20µL/mL acetic acid and the other with 10µL/mL of 8N NaOH. These samples were
both further extracted three times with equal parts of acidified ethyl acetate on a rotating
platform at room temperature. The acidic and basic extracts were dehydrated at 35 ⁰C
until only a pellet is left. These are resuspended in DMSO and concentrated 20-fold
before analyses. For mass-spectrometry controls, synthetic samples of P. aeruginosa
N-butanoyl AHL and N-dodecanoyl AHL (Sigma-Aldrich) at a concentration of 500 ppm
were subjected to the same extraction. The analyses were done by GC-QTOF. The
instruments used were Agilent GC coupled to a Q-TOF, with a HP-5MS-UI column (30 m
x 0.25 mm x 0.25 µm). Data was acquired over 9.83 min with an initial temperature of
150 ⁰C held for 0.5 min, with an increase to a final temperature of 275 ⁰C, at 15 ⁰C per
minute.

RESULTS
L-arginine shows dose-dependent effect on growth. The growth of PAO1 without Larginine was compared to the growth with 25, 30, 35, 40, 45, and 50mM of L-arginine in
the media. On monitoring growth of PAO1 over 15-17 hours, a decreased growth rate
was observed with 45 and 50mM of arginine, during the log phase. P. ginseng contains
very high concentration of L-arginine (80Mm) and our preliminary experiments indicated
that anti-QS effects were noticed specifically a higher concentration of L-arginine.
Henceforth, experiments were conducted in the presence of two concentrations of L-
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arginine, 25 and 50mM. However, all experiments were conducted after cultures
reached stationary phase with normalization of OD 600 of all cultures before assay.
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Figure 1. Growth of PAO1 in presence of L- arginine. A. The growth of PAO1 at 0,
25, 30, 35, 40, 45 and 50mM of L-arginine was monitored over 15-17 hours at 37 ⁰C.
There was a significant difference in growth between PAOI (0mM) and PAO1 (45 and
50mM) during log-phase, as determined by unpaired t-test (p <0.05). B. The image of
the plate after 17 hours of growth is shown. The PAO1 cultures grown with 0, 25 and 50
mM were chosen for further analysis of QS phenotypes. All the cultures were
normalized to the same O.D. before continuing the assays.

L-arginine reduces production of LasA protease. P. aeruginosa is known to produce
a host of secreted virulence factors which includes proteases that are instrumental in
establishing acute infections (Schad & Iglewski, 1988). One of these is LasA which is a
staphylolytic metalloendopeptidase whose regulation is controlled by QS (Ohman, et al.,
1980, Kessler, 1995). Expression of LasA can be analyzed spectrophotometrically by
monitoring the change in OD600 due to lysis of S. aureus (Kessler, et al., 1993, Engel, et
al., 1998). The LasA protease activity was quantified in our control which contained
supernatant from PAO1 cultures and compared with our testing solutions which had
supernatants from PAOI grown with 25 and 50 mM of L-arginine. Supernatants from
PAO1 exposed to L-arginine both at the lower 25mM and the higher concentration of 50
mM showed a dose-dependent decrease in production of this protease, which was not
statistically significant (Figure 2).
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Figure 2. LasA activity in PAO1 supernatants in presence of L-arginine. Las
A was quantified as the change in OD600 over one hour at 37 ⁰C per µg of protein.
The levels of LasA produced by PAO1 in presence of L-arginine were reduced.
However, the decrease was not statistically significant (p> 0.05) as determined
unpaired t-test.

L-arginine reduces production of LasB elastase. The P. aeruginosa LasB elastase is
also under the control of QS. This protease degrades elastin which is measured using
the Elastin Congo Red assay (Ohman, et al., 1980). Under normal circumstances, the
supernatant of a P. aeruginosa culture degrades elastin leading to an increase in OD495.
It was found that the production of elastin by P. aeruginosa was significantly reduced at
the higher concentration of L-arginine of 50 mM, when compared to the supernatant
extracted from the strain PAO1 grown without any L-arginine (Figure 3).

Figure 3. LasB activity in PAO1 supernatants in presence of L-arginine. Elastase
activity is expressed as the absorbance at OD495 per microgram of protein in PAO1
supernatants. The levels of elastase were decreased significantly in PAO1 with 50mM
L-arginine, p< 0.05 as determined by unpaired T-test.
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L-arginine reduces pyocyanin formation. To further investigate if L-arginine affects
the QS-dependent production of pyocyanin. Pyocyanin is one of the redox blue-green
pigments produced by Pseudomonads that is frequently associated with acute and
chronic infections (Caldwell, et al., 2009). Compared to PAO1 cultured without Larginine, the pyocyanin produced in the presence of L-arginine was significantly
reduced. (Figure 4).

Figure 4. Effect of L-arginine on pyocyanin production. Increasing concentrations
of L-arginine led to a decrease in pyocyanin production in PAO1. This decrease was
statistically significant at both 25 and 50mM (*p< 0.05 , 0mM vs 25 mM, 0mM vs
50mM, as determined by unpaired T- test).
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L-arginine reduces biofilm formation. Biofilm formation is a chronic-infection
phenotype that is in-part regulated by QS (Davies, et al., 1998). Positive control
PAOΔretS

showed

a

hyper-biofilm

formation

whereas

negative

control

PAOΔalgDΔpelΔpsl showed negligible biofilm as quantified by crystal violet (Figure 5).
Presence of L-arginine resulted in a decrease in biofilm formation in a dose-dependent
manner.
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Figure 5. Effect of arginine on biofilm formation. The strains tested were PAO1 in
increasing concentrations of L-arginine. As positive control of the assay PAOΔretS
which is a biofilm hyperproducer and PAOΔalgDΔpelΔpsl a non-biofilm producer were
also assayed. A. After 24 hours, a significant difference (*p< 0.05)was observed
between PAO1 and PAO1 cultured with 25 and 50 mM of L-arginine, as determined by
unpaired t-test. B. After 48 hours, a significant difference (*p<0.05) was found between
PAO1 with 0 mM of L-arginine and 50mM of L-arginine, as determined by unpaired ttest.

L-arginine

reduces

production

of

acyl-homoserine

lactone

(AHL).

Direct

identification of AHL was achieved from supernatants by gas-chromatography/massspectrometry. For extraction of AHLs, PAO1 supernatants were treated with acid and
base, according to previously established protocols (Makemson, et al., 2006). The acid
stabilizes the lactone ring whereas the base leads to opening of the lactone ring and
destabilizes the signaling molecules. As positive controls for the assay, N-butyryl-LHomoserine lactone (C4-AHL) and N-(3-Oxododecanoyl)-L-homoserine lactone (C12AHL) were dissolved in LB and extracted using the same procedure as the test samples.
The presence of signaling molecules was also analyzed in LB media, and the
supernatants extracted from PAO1 culture with and without L-arginine. It was found that
cultures grown with L-arginine at 50 mM reduced the AHL production as seen from the
decreased peak intensity (Figure 6).
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Figure 6. A. Panel shows the representative fragmentation spectra of an acylhomoserine lactone. B and C. Panel shows the media control for the experimental
samples. LB treated with acid and bases are analyzed for the representative ions. D.
Supernatant from PAO1 growth culture without arginine in the growth media was treated
with acid and examined for fragmentation spectra. The circled ions were found in the
culture supernatant indicative of AHL. E. Panel shows the same supernatant extracted
from PAO1 and treated with base. The alkaline treatment breaks the lactone ring and
destabilizes the AHLs. Here this is confirmed as we don’t observe any of the ions from
the spectra. F. Panel shows the supernatant extracted from PAO1 cultured with 50mM
L-arginine. As can be observed, the levels of ions were far lower; especially the most
abundant ion with m/z 143 was detected at reduced levels.

DISCUSSION
Given the abundance of research that illustrates QS as a critical element of bacterial
pathogenesis,

it

is

but

natural

that

identifying

anti-QS

compounds

as

alternative/synergistic therapies will be advantageous.
Previous studies in our lab examined herbs with known medicinal properties
(Adonizio, et al., 2008, Song, et al., 2010). One of these, Panax ginseng, has known
immunomodulatory and anti-QS properties (Larsen, et al., 2004, Song, et al., 2010, Wu,
et al., 2011, Schneper L., 2012). Experiments with ginsenosides purified from P. ginseng
did not account for the anti-QS effects (Song, et al., 2010). Besides ginsenosides, P.
ginseng contains many other bioactive compounds one of which is free amino-acids
(Hou, 1977). In this study, the ability of arginine to alter QS was discerned by measuring
QS-dependent production of secreted virulence factors such as protease LasA, elastase
LasB, and pyocyanin of P. aeruginosa. Furthermore, we also determined the effect of
arginine on phenotypes critical for host-colonization and sustained infection such as
motility and biofilm formation.
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Arginine affects the production of QS-regulated virulence factors. The
extracellular virulence factors are significant for causing acute infection succeeding
colonization. Production of alkaline LasA protease and elastase LasB is determined by
the presence of both C-12 and C-4 HSL secreted respectively by the Las and Rhl QS
systems (Gambello & Iglewski, 1991, Gambello, et al., 1993, Reimmann, et al., 1997).
LasB elastase has immunomodulatory properties and is essential to cleave any elastin
containing tissue in a host such as the human lung and is one of the chief components
permitting invasive infections (Heck, et al., 1990, Galloway, 1991). LasA is a metalloendopeptidase which has been implicated as an important virulence factor particularly in
corneal infections (Preston, et al., 1997). Along with these proteases, the presence of Larginine also resulted in decreased production of pyocyanin. Pyocyanin is a blue-green
phenazine pigment which is a redox-active compound and facilitates the formation of
reactive oxygen stress resulting in tissue injury (Mavrodi, et al., 2001). Previously, it has
been shown that extracts of 5% ginseng cause a significant reduction in protease and
elastase production. There was, however, a dose-dependent effect wherein the lower
concentration of ginseng appeared to increase elastase activity slightly (Song, et al.,
2010). In our results, we also witnessed a dose-dependent effect of L-arginine
supplementation with increased anti-QS activity observed at higher concentrations
(Figure 2, 3, and 5). This decrease in production of virulence was correlated with a
decrease in production of HSL molecules as determined by GC/MS in the presence of
50mM L-arginine (Figure 7).

Arginine affects biofilm formation. Previous studies with P. ginseng have shown
reduced swarming motility and biofilm formation in P. aeruginosa PAO1. In our study, we
examined the formation of biofilm upto 48 hours. Biofilms are an organized structure
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composed of polysaccharides (Pel, Psl, and alginate), extracellular DNA and proteins
that encase the bacterial community thereby protecting it from certain host-defenses and
antibiotics (Flemming & Wingender, 2010).

Biofilm development is a multi-factorial

process that depends on swarming and twitching motility and QS (production of C12HSL by LasI synthase) (O'Toole & Kolter, 1998, Patriquin, et al., 2008). In our study, we
saw a progressive decrease of biofilm formation in the presence of increasing
concentrations of L-arginine (Figure 5). This decrease could be due to the inhibition of
AHL production/transport as well as to the reduced swarming motility that is observed
with L-arginine at these concentrations. This is an interesting observation as previous
studies done with PA14 which employed a much lower concentration of L-arginine
(4.8mM) showed a robust increase in biofilm formation with a reduction in swarming
motility owing to modulation of the secondary metabolite c-di-GMP by L-arginine
(Bernier, et al., 2011).

In mice burn-wound model, arginine has shown to prevent bacterial dissemination
and sepsis (Everett, et al., 2017). Depletion of arginine in burn-wound was associated
with increased arginase. Supplementation with L-arginine at concentrations deemed
safe for use in humans, post P. aeruginosa infection, resulted in the decreased bacterial
spread and prolonged animal survival (Everett, et al., 2017). This suggests that arginine
may be a valuable alternate therapy for prevention of sepsis in burn-wound patients. The
physiologic role of arginine in the human body is well-documented and some mirror the
effects of P. ginseng, including stimulating the immune system and exhibiting anti-cancer
properties (Tong & Barbul, 2004). Consuming L-arginine in doses larger than normal
dietary intake has also been linked to improved endothelial dysfunction and overall
vascular health (Kamada, et al., 2001). As an anti-pseudomonal agent, L-arginine has
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shown increased biofilm susceptibility to antibiotics both within mature biofilms and in
aerobic/anaerobic conditions (Borriello, et al., 2006). Studies on the effects of inhaled
buffered L-arginine in the treatment of CF has shown a significant improvement in
thoracic gas volume, arterial PO2 and specific conductance (Solomons, et al., 1971). Our
results also highlight the probability that L-arginine by reducing bacterial virulence may
be a beneficial additive or alternate component of combination therapy in P. aeruginosa
infections.
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